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Preeclampsia is a hypertensive, multisystem disorder of pregnancy, which is a leading 
cause of maternal and fetal/neonatal morbidity and mortality. It is defined as new-onset 
hypertension (≥ 140 mmHg systolic or ≥ 90 mmHg diastolic) combined with proteinuria 
after the 20th week of pregnancy.1 Eclampsia is defined as the occurrence of tonic-
clonic convulsions in a woman with preeclampsia. The overall worldwide estimates of 
the incidence of preeclampsia and eclampsia are 4.6% and 1.4% of all deliveries, with 
an incidence in the Netherlands of 3.3% and 0.1% respectively.2 In developing countries, 
incidence is considerably higher, up to 15.6% and 4.0% respectively for preeclampsia and 
eclampsia.2 Preeclampsia was the leading cause of maternal mortality in the Netherlands 
between 1993 and 2005, with a ratio of 3.5 per 100,000 live births (overall maternal 
mortality 12.1 per 100,000 live births). Eclampsia complicated 44% of these cases, and 
cerebral haemorrhage (45%) was the leading mode of death.3
The central nervous system can be involved during the course of preeclampsia in 
the form of hyperreflexia, headaches, visual disturbances, mental status changes and 
eclampsia. The ancient writings of the Egyptians, Chinese and Indians already make 
mention of eclampsia.4 The Greek described it as follows:  ‘In pregnancy, the onset of 
drowsy headaches with heaviness is bad; such cases are perhaps liable to some sort of fits 
at the same time.’ They named this phenomenon “eclampsia”, derived from the Greek 
word, “eklampsis”, which means “shining forth” or “sudden flashing”.  Until 1739, eclampsia 
was seen as a form of epilepsia. In the second half of the 18th century, eclampsia was 
recognized as a separate entity: first, it was thought eclamptic fits could develop due 
to uraemia, but other substances were also proposed to be the toxic initiator. At that 
time, the term toxaemia originated and treatment consisted of phlebotomy and purgation. 
In 1906, treatment with magnesium sulphate was introduced by Horn, which drastically 
changed the management of (pre)eclampsia.4-6
Although the pathophysiology of preeclampsia remains enigmatic, more information 
has become available throughout the years. Through the examination of placental bed 
biopsies, Robertson & Brosens et al.7,8 were the first to pose that preeclampsia is associated 
with shallow trophoblast invasion and a subsequent reduction in placental perfusion. 
Roberts et al. in 19899 postulated that preeclampsia is an endothelial cell disorder and that 
the reduction in placental perfusion causes release of damaging factors into the maternal 
circulation. The currently leading hypothesis is that these factors may lead to a maternal 
inflammatory response and generalized endothelial dysfunction, which alters the vascular 
reactivity.6,10 A two-stage model is proposed; the first stage consisting of poor placentation 
resulting in release of substances by the placenta which enter the maternal circulation, 
the second stage consisting of the effect of these substances (combined with constitutional 








Cerebral consequences of (pre)eclampsia
Posterior Reversible Encephalopathy Syndrome
The pathophysiology of eclampsia has not been completely elucidated. Two theories 
have been proposed for the development of eclamptic seizures: the underperfusion 
versus the overperfusion theory. Endothelial dysfunction and failure of autoregulation 
of cerebral blood flow is thought to play a role in both. Under normal conditions, with 
intact cerebrovascular autoregulation, an increase in systemic blood pressure leads to 
higher arteriolar resistance in the brain through adaptation of vessel diameter. This 
mechanism causes the brain to maintain a relatively constant blood flow during changes 
in perfusion pressure. In the underperfusion theory, “overautoregulation” of the cerebral 
vasculature in the setting of hypertension is hypothesized, resulting in vasospasm, which 
subsequently leads to ischaemia, infarction and cytotoxic edema. This theory is based on 
angiographic narrowing of cerebral blood vessels that have been observed in eclampsia.12,13 
Currently, focus is shifted more towards the overperfusion theory. This theory poses that 
a combination of endothelial dysfunction and an increase in blood pressure results in 
failure of autoregulation of cerebral blood flow. This may subsequently give rise to both 
vasoconstriction and forced vasodilatation in different regions of the brain (the so-called 
‘sausage string phenomenon’).14,15 Hyperperfusion and consequently vasogenic edema 
develop, with a predilection for the posterior parietal areas of the brain.16-19 Because 
normal cerebral autoregulation requires an intact vascular endothelium, breakthrough of 
the blood brain barrier may also occur in the setting of mild hypertension and endothelial 
damage.20,21 
In the scheme of this overperfusion theory, an eclamptic seizure and the acute phase 
following this seizure are considered a form of the Posterior Reversible Encephalopathy 
Syndrome (PRES); several studies have shown that PRES is seen in nearly all eclamptic 
patients.22-24 PRES is considered a reversible neurotoxic and neurometabolic condition 
characterized by a typical clinico-radiological syndrome, first described by Hinchey et al. 
in 1996.25 Computed Tomography (CT) features in PRES include either hypodense areas 
consistent with edema or no specific abnormalities, and magnetic resonance imaging (MRI) 
shows a characteristic pattern of hyperintense areas consistent with edema, predominantly 
in the white and gray matter of parietal and occipital lobes.26,27 In PRES, cerebral edema 
is thought to be predominantly vasogenic by nature.22,23,28 Vasogenic edema occurs when 
there is breakthrough of the blood brain barrier with allows  intravascular proteins and 
fluid to penetrate into the parenchymal extracellular space. PRES has also been associated 
with numerous systemic conditions in non-obstetric patients of all age categories, such 
as systemic lupus erythematosus, acute glomerulonephritis and immunosuppressive 
therapy.29-31 The exact mechanism leading to cerebral edema in PRES is not understood, 







The distribution of cerebral edema in PRES may be related to local levels of perfusion in 
vascular watershed areas or regions with mainly end-arterial vascular supply. In addition, 
cerebral vessels have an extensive sympathetic neural supply, stimulation of which will 
increase the upper limit of autoregulation. This sympathetic innervation is less pronounced 
in the posterior arteries.26,28
Both (pre)eclampsia and PRES have long been held to be entirely reversible disorders 
without any consequences for future health.25,32 However, this reversibility has recently 
been questioned for both conditions.29,33 The cerebral vasogenic edema which can be seen 
during the acute moment of eclampsia and PRES usually resolves, but in addition, cytotoxic 
edema can be demonstrated in a considerable number of patients. Cytotoxic edema occurs 
due to a disruption in cellular metabolism, leading to cellular retention of sodium and water 
and subsequent swelling of the cells. It has been suggested that vasogenic interstitial edema 
can progress to the extent that it may cause decreased regional perfusion to ischaemic 
levels resulting in cytotoxic edema. Imaging abnormalities are described after eclampsia 
and PRES several weeks after the resolution of clinical symptoms.23,34 The persistence of 
such abnormalities and their possible consequences remains to be elucidated. Available 
studies on long-term consequences of PRES are reviewed in chapter 2.
Cerebral white matter lesions
While edema (PRES) is seen in eclampsia in the acute phase, on long-term (several 
years) follow-up this edema has disappeared. Neuroimaging studies which were carried 
out several years after (pre)eclampsia revealed cerebral white matter lesions (WML), 
or hyperintensities. Women who suffered eclampsia (41%) or preterm (< 37 weeks) 
preeclampsia (47%) demonstrated WML more often and more extensive compared to women 
with term preeclampsia (14%) and control women who had a normotensive pregnancy 
(21%).35,36 These atypical WML are located mostly in the frontal areas of the brain.37 At first, 
it was hypothesized that these WML may be a direct consequence of the PRES episode. 
Vasogenic edema may progress to such an extent that regional cerebral perfusion pressure 
decreases to ischaemic levels leading to areas of cytotoxic edema in severe cases. This 
cytotoxic edema may later appear as infarctions or WML on MRI.35,38 Several findings 
contradict this hypothesis; 1) WML in formerly eclamptic and preeclamptic women are 
mainly located in the frontal areas of the brain instead of the occipito-parietal lobes, the 
most common location for PRES,37 2) WML are not only found in eclamptic women, but 
also in a significant percentage of women who suffered preeclampsia who are generally 
not thought to have experienced PRES (although some of them may also have experienced 
PRES without seizures39). Therefore, it is not plausible to hold PRES solely responsible 
for the development of white matter lesions in these women. If and to what degree the 
presence of PRES in formerly eclamptic women contributed to the development of WML is 








and information on possible preexisting presence of WML is lacking.35,36
WML are non-specific neuroimaging findings and little is known about their causes, 
the prevalence and the exact clinical importance in younger individuals of childbearing 
age. The few available studies have been performed in the elderly population. Postmortem 
studies in elderly subjects demonstrate that cerebral WML show a hypoxic response, 
arteriolar sclerosis, amyloid angiopathy and reduced endothelial vascular integrity, 
suggesting the pathogenesis of such WML to evolve around chronic hypoperfusion.40,41 In the 
middle-aged and older population, the presence and development of WML are associated 
with vascular risk factors and the presence of hypertension.42,43 
WML are considered part of the continuum of neuroimaging features representing 
cerebral small vessel disease, together with lacunar infarction and cerebral microbleeds.44 
Cerebral small vessel disease, or cerebral microangiopathy, is a term used for a syndrome 
of clinical, cognitive and neuroimaging findings which are thought to arise from affected 
perforating arterioles, capillaries and venules resulting in brain damage. 
Prevalence of WML in the elderly (e.g. 70 years or over) is high (up to 99%).45-48 
In younger individuals (< 40 years of age), prevalence has been reported to range from 
0.5% to 32%49-55 and in individuals age 60-70, prevalence rates of 22.7% to 100% have been 
described.49,56-58 In the elderly, WML have been associated with cognitive decline, stroke 
and dementia.45,59-61
In chapter 6 and 7 of this thesis another possible explanation for the presence of 
WML in formerly (pre)eclamptic women is discussed, which is independent of pregnancy 
in and of itself. WML may be an early expression of a constitutional susceptibility for 
cardiovascular and cerebrovascular disease.36,42,43 Endothelial vascular disorders and 
hypertension, found to be related to WML in the elderly, are also present in (pre)eclamptic 
women. Preeclampsia and atherosclerosis are both associated with similar risk factors 
such as chronic hypertension, obesity, metabolic syndrome and insulin resistance.62 
Microvascular dysfunction may be the predominant mechanism for both cardiovascular 
disease and preeclampsia as women with preeclampsia have higher risk of cardiovascular 
events and stroke later in life.63,64 Preterm preeclampsia seems to be related to an even 
greater risk for cardiovascular disease in later life.63 Therefore, pregnancy could be 
considered an early stress test for the cardiovascular system. Women at risk might not 
be able to optimally compensate for the vascular challenges associated with pregnancy 
and subsequently develop preeclampsia.65 Both WML and preeclampsia may therefore be 
consequences of a constitutional susceptibility of cardiovascular disease. Consequently, 
WML may develop independent of, and may have been present prior to pregnancy.
Whether the WML found in formerly preeclamptic and eclamptic women are 








Cognitive functioning following (pre)eclampsia
In general, shortly postpartum (up to several months), women frequently report cognitive 
deficits which are clustered under the terms ‘mommy brain’ or ‘maternal amnesia’. It has 
been shown that recently postpartum women show a small, but significant, impairment 
on some measures of cognition that place relatively high demands on executive cognitive 
control.66-68 Although not much is known about short-term postpartum cognitive functioning 
following a pregnancy complicated by (pre)eclampsia, preeclamptic women do not seem 
to be more cognitively impaired compared with normotensive women.69 These cognitive 
deficits described directly postpartum may be viewed from an adaptive perspective; rather 
than being a negative consequence of pregnancy, these cognitive changes may be seen as 
cognitive reorganization, in which social  cognition which is relevant to maternal or fetal 
wellbeing is enhanced to the cost of other cognitive tasks.68 
 However, clinical experience learns that formerly preeclamptic women may 
complain of memory and concentration problems up until years following their pregnancy. 
Women may seek attention from their general practitioner, obstetrician, a neurologist or 
psychologist. On short-to-medium term (up to 2 years), self-reported memory complaints 
in formerly eclamptic women have been described. Using structured telephone interviews 
in 123 formerly eclamptic women, 18% reported problems with concentrating after 6-24 
months.70 Two pilot studies focused on objective cognitive functioning measured by 
neurocognitive tests in preeclamptic, but not eclamptic women, on short-to-medium 
term (within 1.5 years).71,72 Formerly preeclamptic women scored significantly lower on an 
auditory-verbal memory task compared to controls71, which implies impaired word learning 
capacity. In addition, formerly preeclamptic women seem impaired in visual perception 
(WAIS III Digit Symbol Coding task) and divided attention (Paced Auditory Serial Addition 
Test).72 These studies were performed in small cohorts (n = 10 and n = 29 respectively).
 On long-term (several years) follow-up, subjective self-reported cognitive 
problems are still reported. Women who had preeclampsia reported significantly more 
loss of memory and/or concentration compared to parous controls 11 months to 9 
years later.73 Aukes et al. evaluated self-reported cognitive functioning in 30 eclamptic, 
preeclamptic and healthy parous women several years following the index pregnancy. 
Formerly eclamptic women reported significantly more cognitive failures in life compared 
to controls, and those who had multiple seizures reported even more.74 Formerly eclamptic 
women also scored lower on a vision-related quality of life questionnaire than controls, 
however none of these women demonstrate visual field loss.75 Vision-related quality of life 
impairment in eclamptic women may therefore be related to problems concerning higher-
order visual functions. Because cognitive problems in such a young cohort of women, 
who are in the midst of their lives, are cumbersome and deserve attention, this thesis 
focusses not only on subjective, but also objective cognitive functioning several years 








using a questionnaire. In chapter 3 of this thesis, subjective cognitive functioning 
following preeclampsia will be studied. Objective cognitive impairment can be measured 
using neurocognitive tests/tasks. Many standardized test are available for a wide range 
of cognitive functions.76,77 In chapter 4 objective cognitive functioning in the domains 
of sustained attention and executive functioning is described and in chapter 5 a broad, 
standardized cognitive test battery is studied comprising several cognitive domains (visual 
perception, motor functions, working memory, long-term memory, speed of information 
processing, attention and executive functioning), measured in both preeclamptic and 
eclamptic women. Tasks for both the posterior (PRES) and the anterior brain areas are 
incorporated (WML). Since neuropsychological complaints in daily life and neurocognitive 
test results may be influenced by emotional aspects such as anxiety and depression77, 
this is also studied in chapter 5. In chapter 6 the relationship between subjective and 
objective cognitive functioning and WML is studied.
Depression and anxiety following preeclampsia
Emotional lability in women during pregnancy and after childbirth is common, since 
these are major life events requiring many physical but also social adjustments. While 
most of these complaints are transient and within the normal range of difficulties, the 
development of mood and anxiety disorders following pregnancy are not uncommon. The 
overall postpartum rate is approximately 12% for depression disorders and 8% for anxiety 
disorders.78
Psychological aspects following a pregnancy complicated by preeclampsia have 
been described in the literature: both depression and anxiety disorders have been found, 
the latter mainly in the form of posttraumatic stress disorder (PTSD).79 It is known that 
depression and anxiety often co-occur and are strongly correlated.80 Most studies have 
focused on anxiety and depression as a consequence of a preeclamptic pregnancy. Such 
pregnancies are often associated with interventions and infant hospitalization which might 
have been experienced as traumatic. Even more so, preeclampsia, and to a larger extent 
eclampsia, is potentially life threatening for both mother and fetus. Hence, a pregnancy 
complicated by an eclamptic seizure may be experienced as even more traumatic and may 
have a larger impact. Only one of the studies performed has focused on this specific group 
of eclamptic women.  Andersgaard et al. found that 14% of these women report depression 
within 2 years following their pregnancy.70
The literature concerning anxiety and depression disorder following preeclampsia 
is not conclusive; some studies find an increased prevalence while others fail to show this. 
However, in general the evidence points to positive associations of anxiety and depression 
with previous preeclampsia, within 1.5 years following pregnancy.71,72,81-83 Several years 
following severe early onset preeclampsia with preterm birth, women experience more 








Whereas the experience of a preeclamptic pregnancy may give rise to depression 
and anxiety, it is less well known that depression and anxiety itself may also be a risk factor 
for the development of preeclampsia. Both depression and anxiety in early pregnancy 
seem associated with the subsequent development of preeclampsia (odds-ratio of 2.5 and 
3.2 respectively).85 The biochemical mechanism behind this course of events has not been 
revealed so far.
Screening for depressive symptoms and anxiety can be executed using self-report 
measures. In this thesis, anxiety and depression several years following a (pre)eclamptic 
pregnancy is studied (chapter 5). The relationship of anxiety and depression with subjective 
cognitive functioning (chapter 3 and chapter 5) and objective cognitive tests (chapter 5) 








Aims of this thesis
• To review the literature for long-term consequences of Posterior (Reversible) 
Encephalopathy Syndrome in eclampsia and preeclampsia and in the non-obstetric 
population. (Chapter 2)
• To assess self-reported cognitive functioning, quality of life and social functioning in a 
large cohort of formerly preeclamptic women. (Chapter 3)
• To evaluate executive functioning and sustained attention in women with a history of 
eclampsia. (Chapter 4)
• To study long-term neurocognitive functioning in a large group of formerly preeclamptic 
and eclamptic women using objective neurocognitive tests and  to determine the 
relationship with subjective cognitive failures, anxiety and depression. (Chapter 5)
• To determine the relationship between neurocognitive functioning and cerebral white 
matter lesions in formerly preeclamptic and eclamptic women. (Chapter 6)
• To assess whether pregnancy in and of itself has a relationship with the presence of 
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This review summarizes the long-term consequences of the Posterior Reversible 
Encephalopathy Syndrome (PRES) that have been described in the obstetric literature 
(eclampsia and preeclampsia) and compares these with data from the non-obstetric 
literature. Preeclampsia is characterized by new-onset hypertension and proteinuria after 
the twentieth week of pregnancy. Neurologic symptoms include headache, visual deficits, 
confusion, seizures, and in the most severe cases intracranial haemorrhage. Eclampsia 
is an acute cerebral complication of preeclampsia, defined as the occurrence of tonic-
clonic seizures in pregnant or recently postpartum women. With severe preeclampsia, in 
conjunction with neurological symptoms, or eclampsia, neuroimaging changes consistent 
with PRES can be seen. PRES is a specific clinico-radiological syndrome presenting 
with headaches, visual impairment, seizures and altered mental status. Characteristic 
neuroimaging features are consistent with cerebral edema predominantly in the parietal 
and occipital lobes. In addition to preeclampsia/eclampsia, PRES has been associated 
with various conditions in the non-obstetric population, i.e. severe hypertension, 
transplantation or autoimmune disease in combination with immunosuppressive therapy 
or high-dose chemotherapy for various malignant conditions. Long-term sequelae of both 
preeclampsia/eclampsia and other PRES-related conditions are poorly described. Following 
eclampsia or preeclampsia, non-specific white matter lesions may be found on MRI, which 
may or may not be related to the PRES-episode. Previously (pre)eclamptic women report 
cognitive failures, however, no neurocognitive impairment has been shown so far.
Various non-obstetric PRES-related conditions have been described with long-term 
neuroimaging abnormalities as well as cognitive problems, epilepsy or visual impairment. 
While no firm conclusions can be drawn due to the heterogeneity of reported cases, some 
general comments can be made. Since most persistent long-term problems are present in 
the non-obstetric population, the main determinant for these long-term problems may be 
the underlying condition which gave rise to the PRES episode. In addition, most reports 
suggest that late diagnosis or inadequate therapy may contribute, emphasizing the need 







Long-term consequences of Pres
The Posterior Reversible Encephalopathy Syndrome in pregnancy
Background and aims
Preeclampsia is a hypertensive, multisystem disorder of pregnancy, and is a leading 
cause of maternal and fetal/neonatal morbidity and mortality. It is defined as new-
onset hypertension combined with proteinuria after the twentieth week of pregnancy. 
The central nervous system can be involved during the course of preeclampsia in the 
form of hyperreflexia, headaches, visual disturbances, mental status changes, eclampsia 
and, in the most severe cases, intracranial haemorrhage. Eclampsia is an acute cerebral 
complication of preeclampsia, defined as the occurrence of tonic-clonic seizures in 
pregnant or recently postpartum women. Eclampsia is responsible for significant maternal 
and neonatal morbidity and mortality worldwide. The overall worldwide estimate of the 
incidence of preeclampsia and  eclampsia is respectively 4.6% and 1.4% of deliveries, 
with an estimated 15.6% and 4% in developing countries and 3.3% and 0.1% in developed 
countries.1,2 Eclampsia incidence has significantly decreased since the introduction of 
management guidelines for eclampsia and preeclampsia, including the use of magnesium 
sulfate for seizure prophylaxis. The underlying pathophysiology of preeclampsia includes 
hypertension and generalized endothelial cell dysfunction. Eclampsia is considered to be 
a form of the Posterior Reversible Encephalopathy Syndrome (PRES).3,4 In some women 
with severe preeclampsia, particularly those with neurological symptoms such as severe 
headache or visual disturbances PRES may also occur.3,5 PRES was coined reversible, since in 
the first series of 15 patients (among whom 3 women with eclampsia), described by Hinchey 
et al. in the mid-nineties, both the clinical and the neuroimaging abnormalities seemed 
to resolve after normalisation of the blood pressure and removal of the underlying cause.6 
However, since this original publication several reports have been published in which long-
term neuroimaging abnormalities and/or neurological and cognitive problems appear to 
persist. For instance, subjective cognitive dysfunction and impaired vision-related quality 
of life have been reported in the years following preeclampsia.7-9 Whether or not these 
symptoms are related to the PRES episode is unknown. Unfortunately, systematic follow-
up of PRES patients is largely lacking, both in obstetric and in non-obstetric cohorts. We 
aimed to review the literature for existing information on possible long-term sequelae 
of PRES in preeclampsia and eclampsia and to compare this to follow-up studies in non-
obstetric patients with conditions related to PRES.
Literature search strategy
The search strategy included a MEDLINE search up to June 2013 limited to publications 
in the English language and to reports of human patients. The following Medical 







leukoencephalopathy syndrome, hypertensive encephalopathy, MRI, neuroimaging, 
cognition disorders, quality of life, epilepsy and vision disorders. In addition, the following 
Pubmed terms were reviewed: posterior reversible encephalopathy syndrome, PRES, RPLS, 
leukoencephalopathy, preeclampsia, eclampsia, long-term, white matter lesions and white 
matter hyperintensities. Abstracts were reviewed for suitability by the first two authors; 
follow-up of the described subjects had to be available for either clinical characteristics, 
neuroimaging or both. The bibliographies of the available articles were subsequently cross-
referenced. The literature retrieved consisted mainly of isolated case reports as well as 
some small case series. In total 1695 articles were identified of which 55 were deemed 
suitable (i.e. described follow-up of clinical characteristics, neuroimaging or both, were 
written in English and involved human patients) and included in this review.
Posterior Reversible Encephalopathy Syndrome (PRES): definition and diagnosis
PRES, also known as the Reversible Posterior Leukoencephalopathy Syndrome 
(RPLS), reversible posterior cerebral edema syndrome, or reversible occipito-parietal 
encephalopathy, is a condition that has been associated not only with preeclampsia and 
eclampsia, but also with numerous systemic conditions in non-obstetric patients of all ages. 
As shown in Table 1, it has been described in conjunction with malignant hypertension, 
sepsis, allogeneic bone marrow or stem cell transplantation, solid organ transplantation 
or autoimmune disease, in combination with immunosuppressive therapy and/or high-
dose chemotherapy for various malignant or chronic autoimmune conditions. Several 
other conditions have anecdotally been associated with PRES.10-13 PRES is a neurotoxic 
and neurometabolic condition characterized by a typical clinico-radiological syndrome.6 
(Holocephalic) headaches, visual impairment such as blurred vision, visual field defects or 
blindness, focal neurological deficits, seizures, altered mental status and, in some patients, 
coma are the symptoms and signs typically observed.10,11,14-16 Computed Tomography (CT) 
features of PRES consist of either hypodense areas consistent with edema or no specific 
abnormalities.6 Magnetic resonance imaging (MRI) shows a uniform and characteristic 
pattern of T2 and fluid-attenuated inversion recovery (FLAIR) hyperintense areas consistent 
with edema, which predominantly affect the white and gray matter of the parietal and 
occipital lobes.17 Diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) 
mapping are the techniques of choice to distinguish between vasogenic and cytotoxic 
cerebral edema. In PRES cerebral edema is primarily thought to be of vasogenic nature. 
Water mobility is increased, as demonstrated by normal, decreased but sometimes also 
increased DWI signal intensity of the hyperintense T2 regions while ADC mapping shows 
increased signal intensity. Vasogenic edema (due to temporary insufficiency of the blood-
brain barrier for water diffusion) is generally reversible, while cytotoxic edema implies 
local infarction. In cytotoxic edema, there is decreased water mobility consistent with a 
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unchanged or enhanced in the area of the hyperintense DWI signal) is decreased, showing 
hypointense on the ADC image.18-20 In severe cases, it has been suggested that vasogenic 
interstitial edema can progress to the extent that it may cause decreased regional perfusion 
to ischaemic levels resulting in cytotoxic edema.18 Although the posterior regions of the 
brain appear most commonly affected, the frontal lobes, the inferior temporal-occipital 
junction, the cerebellum, basal ganglia, brain stem and deep white matter may be involved 
as well.15,21,22 This distribution of cerebral edema may be related to local levels of perfusion 
in vascular watershed areas or regions with mainly end-arterial vascular supply. Perfusion 
scanning using 99mTc-HMPAO SPECT has rarely been used in PRES research and results are 
not conclusive; both hyper- and hypoperfusion have been described.23,24
Posterior Reversible Encephalopathy Syndrome (PRES): prevalence and pathophysiology
The incidence of PRES has not been established to date. Hinchey et al.were the first 
to describe 15 patients, with various comorbid conditions, including 3 women with 
eclampsia. Non-obstetric conditions included renal insufficiency, malignant hypertension, 




























thought that the common denominator for the development of PRES is the presence of 
some degree of hypertension in combination with cerebrovascular endothelial dysfunction, 
as can be seen in women with preeclampsia.21 The cause of PRES in non-obstetric patients 
who are treated with immunosuppressive or chemotherapy is not completely understood. 
Hypertension (sometimes associated with corticosteroid treatment) in combination with 
low magnesium/calcium ratio, and brain microvascular physiologic changes induced by 
the therapy are thought to play a role, a mechanism which is in some aspects similar 
to preeclampsia.6,24 Acute severe hypertension may play a role in PRES, but in 20-30% 
of women with eclampsia, blood pressure values have been reported to be within the 
usual cerebral autoregulatory range.25 While the exact pathophysiological mechanism for 
the development of cerebral edema in PRES remains unclear, impaired cerebrovascular 
autoregulatory capacity is likely to be involved. The cerebrovascular endothelium plays 
an important role maintaining autoregulation, acting through vasomotor effectors which 
control cerebrovascular resistance in vascular wall lining pericytes.26,27 Furthermore, the 
cerebrovascular endothelium also functions as the blood-brain barrier, which prevents 
bulk flow of water and solutes by tight junctions between the endothelial cells.26 PRES is 
thought to develop when an increase in blood pressure, in conjunction with endothelial 
cell dysfunction, exceeds the upper limit of cerebrovascular autoregulation and results 
in forced vasodilatation of the cerebral resistance vessels. Subsequent hyperperfusion, 
capillary bed injury, and eventually break-through of the blood brain barrier with resulting 
vasogenic edema are thought to be its pathophysiological hallmarks.21 
PRES and long-term neuroimaging features
The neuroimaging studies reporting short- or long-term follow-up in preeclampsia and 
eclampsia are summarized in Table 2 (upper part). Liman et al.28 describe focal gliosis in 
40% of women who had PRES associated with preeclampsia-eclampsia, after an average of 
nine days (minimum two days, maximum thirty-eight days). Zeeman et al.18 found that 19% 
of eclamptic women had imaging abnormalities such as white matter infarction and areas 
of gliosis after six to nine weeks. Our group29,30 found that on long-term follow-up (average 
seven years), the prevalence of cerebral white matter lesions (WML) in both formerly 
eclamptic (41%) and preterm preeclamptic women (37%) was significantly higher compared 
to age-matched women who had had a normotensive pregnancy (17-21%). These atypical 
lesions were predominantly found in the frontal lobes, and less often in the parietal, 
insular and temporal lobes, which is not the typical distribution pattern of PRES.31 While 
the pathogenesis of these white matter lesions remains to be elucidated, an increased 
propensity for cerebrovascular disease in women with a history of preeclampsia may be a 
factor in the development of these WML. Table 2 (lower part) summarizes studies reporting 
short- or long-term follow-up in a variety of primarily non-obstetric conditions underlying 
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patients with a large variety of PRES-associated underlying conditions and age ranges. Some 
of these studies also included eclamptic and preeclamptic women11,22,32,35,36,38,39,42; only half 
of them compared outcome variables based on the underlying cause of PRES.22,32,25,28 All 
reports describe imaging abnormalities, frequently consisting of non-specific white matter 
lesions and infarction, in a wide frequency range (15-70%) of PRES patients.11,19,22,32-36,38-43 
Furthermore, a variety of clinical symptoms is described, such as neurological deficits, 
visual abnormalities, cognitive impairment, and even death. These clinical symptoms might 
or might not be directly related to the PRES-episode and/or the underlying condition. 
The time span between initial and follow-up MRI investigations differed widely, between 
twenty-four days and six years in individual series. Liman et al. specifically studied the 
clinico-radiological differences between PRES in preeclampsia/eclampsia on the one hand 
and PRES in non-obstetric conditions (immunosuppression, infection/sepsis, autoimmune 
disorders and chemotherapy) on the other.28 Women with preeclampsia/eclampsia had less 
severe edema compared to the other predisposing conditions, had less often radiological 
evidence for cytotoxic edema, haemorrhage and contrast enhancement, and had less 
frequent residual structural lesions on follow-up imaging (40% had gliosis following 
preeclampsia/eclampsia, whereas infarction, haemorrhagic residua, cerebral atrophy and 
laminar necrosis were more prominent in non-obstetric conditions). Hefzy et al.38 found 
that patients with immunosuppressive therapy-related PRES, especially associated with 
allogeneic bone marrow transplantation, are more likely to have accompanying intracranial 
haemorrhage as compared to PRES related to eclampsia/preeclampsia. The reason for the 
high rate of PRES-related haemorrhage in this group is not clear. The authors speculate that 
allogeneic bone marrow transplantation induces a complex clinical state, in which graft-
versus-host effects, veno-occlusive disease, thrombotic microangiopathy and opportunistic 
infection synergizes with high dose immunosuppressive drugs. The combined effects may 
lead to increased cerebrovascular instability and an increased risk of haemorrhage.
PRES and long-term cognitive deficits
Women who suffered eclampsia/preeclampsia report more long-term (on average seven 
years) subjective cognitive difficulties related to memory and concentration compared to 
women who had uncomplicated pregnancies, using the Cognitive Failures Questionnaire.7,8 In 
conjunction with the WML seen on neuroimaging years later, it has been hypothesized that 
subtle neurocognitive problems may exist when measured by neurocognitive examination. 
Stroescu et al.10 describe a thirty-year-old woman with late onset post-partum preeclampsia 
who underwent both imaging as well as follow-up neuropsychological examination. In the 
acute phase, she had hyperintense abnormalities on FLAIR MRI bilaterally in the occipital 
and posterior parietal lobes. She was referred for neurocognitive examination 11 months 
later and showed decreased working memory and visual attention, spatial perception 




































Studies including preeclamptic and eclamptic patients
Zeeman 
2004 Eclampsia 27
22 (± 7), 
0/27 27 (100%) 6-9 weeks








Eclampsia 30/39 38, 0/30 39 (100%) 6.4 (± 5.6) years
3 T, T1/T2, 
FLAIR






0/24 10 (42%) 9.5 days
1.5/3 T, T1/T2,
FLAIR, DWI




IM, RF, HUS 34 45, 9/13 9 (26%) 27 days
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46, 7/16 Not described
Not 















HE = hypertensive encephalopathy, IM = immunosuppression, CT = chemotherapy, SOT = solid 
organ transplant, BMT = bone marrow transplant, AD = autoimmune disease, TTP = thrombotic 
thrombocytopenic purpura, RF = renal failure, SLE = systemic lupus erythematodes, HUS = haemolytic 
uremic syndrome






























Focal gliosis, infarction, post-
haemorrhagic residua, atrophy, laminar 
necrosis
Not described
41% White matter lesions, mostly frontal 30 formerly eclamptic women scored 
significantly worse on the cognitive 
failures questionnaire compared to 30 
healthy parous controls37% White matter lesions, mostly frontal
40% Focal gliosis Not described
55%
High DWI intensity in 6 (27%) indicative 
of cytotoxic edema; 2 progressed 
to infarction, 3 had residual lesions, 
gliosis, subacute infarction
Death (n = 5)





8-24% subcortical white matter, 56% 
brain stem, 53% deep white matter, 
40% thalamus
Not described
0% None Not described
34% Small residual infarcts in ~25% No recurrent seizures




Intracranial haemorrhage (ICH), 2 had 
delayed haematoma
Haemiparesis/haemianopsia (n = 1), 
death (n = 6)




11% infarcts in same areas involved in 
PRES episode
Recurrent PRES (n = 4), recurrent 
seizures (n = 5)
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CT, AD, IM, 
other
70 36 (25-52), 25/45 49 (70%) 90 days Not described
Preeclampsia/
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11 (± 4), 13/5 16 (100%) 28-56 days 1.5 T, T1/T2, MRA
Crasto
2004 IM, RF, SLE 12 44, 6/6 10 (83%)
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14/33 13 (100%)
30 (2-122) 
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0/10 9 (90%) 21-180 days
1.5 T, T1/T2, 
FLAIR, DWI
HE = hypertensive encephalopathy, IM = immunosuppression, CT = chemotherapy, SOT = solid 
organ transplant, BMT = bone marrow transplant, AD = autoimmune disease, TTP = thrombotic 






























28% Complete recovery or clear improvement of white matter lesions
Mild visual abnormalities after 76 days 
with partial remission MRI with a new 
ICH (n = 1), recurrent PRES (n = 2), 
hypertensive disease (n = 12)
Not described Not described Not described
43%
Higher blood pressure associated with 
incomplete resolution (p = 0.001); focal 
gliosis, infarction, post-haemorrhagic 
residua, atrophy, laminar necrosis
Not described, recurrent PRES (n = 1)
See Liman 2012b See Liman 2012b See Liman 2012b
55% Not described Some level of functional impairment (n = 37), death (n = 11)
Not described Not described Some level of functional impairment (n = 2)
19%
Residual haemorrhage basal ganglia, 
multiple frontal white matter 
abnormalities
Not described, partial facial nerve 
paresis (n = 1)
70%
Mostly occipital, parietal and frontal 
hyperintense lesions on FLAIR and 
T2-weighted images, 14/42 areas of 





Right occipital infarction Residual left inferior quadrantanopia, (n = 1), cognitive impairment (n = 1)
No follow-up 
imaging No follow-up imaging
Complete neurologic recovery in 
medical record/phone interview
14% Not specified
Death during follow-up (n = 5), long-
term neurological sequelae (n = 6) 
consisting of epilepsy (n = 4), persisting 
ataxia (n = 1), and mydriasis (n = 1)
26.3% Hippocampal sclerosis (n = 2), temporal lobe atrophy (n = 2), persistent lesions
Death (n = 1), long-term anticonvulsant 
therapy (n = 9) because of epileptiform 
discharges or repeated seizures







up MRI 19 months later she demonstrated bilateral parietal lobe infarcts. Andersgaard et 
al.44 interviewed 123 formerly eclamptic women 6-24 months postpartum by means of a 
structured telephone interview. They found that 2 patients had haemiparesis and dysarthria, 
11% had visual disturbances, 22% had concentration and memory problems, 18% reported 
frequent headaches and 10% had vertigo or balance problems. While such women may 
report subjective cognitive dysfunction recent data do not demonstrate impaired cognitive 
functioning using objective neurocognitive assessments.45,46 As persistent neuroimaging 
abnormalities have also been described following non-obstetric conditions underlying 
PRES, we reviewed the literature for cognitive deficits in these conditions as well. Legriel 
et al.42 found that the risk of an unfavourable functional outcome (measured as the ability 
to return to occupational or academic activities with minor or no mental deficits) was 
higher in non-obstetric causes of PRES than following PRES in preeclampsia/eclampsia. 
Stroescu et al.10 describe a fifty-one year old woman with systemic lupus erythematosus-
related PRES and hypertension. She had hyperintense abnormalities on FLAIR MRI 
bilaterally in the occipital lobes in the acute phase. At neurocognitive examination two 
months later, she had cognitive deficits; decreased working memory and visual attention, 
spatial perception deficits, decreased motor speed, visuospatial memory and executive 
dysfunction. No follow-up MRI was available. Stott et al.19 identified 6 patients with PRES; 
4 female and 2 male patients, 2 of whom were six-year-old children. One child had no 
long-term sequelae following chemotherapy related PRES. The other, with PRES related to 
bone marrow transplant and cyclosporine treatment, had persistent cognitive impairment, 
which the authors did not otherwise specify. While the effects of acute hypertensive crises 
such as PRES in pediatric patients are not exactly known, chronic hypertension without 
PRES has been related to the development of subtle cognitive dysfunction such as learning 
disabilities and deficiencies in executive function, which may interfere with normal 
developmental and/or learning abilities.47 It is unclear whether demonstrated cognitive 
impairment in children with chemotherapy or hypertension related PRES, can be ascribed 
to the single episode of PRES per se, or rather to the effects of the underlying disease and 
its treatment.
PRES and the development of epilepsy (seizure disorder)
PRES in preeclampsia/eclampsia
It may be hypothesized that PRES in preeclampsia/eclampsia in conjunction with persistent 
structural damage may give rise to an epileptogenic focus and delayed epilepsy. In the 
obstetric literature mesial temporal sclerosis has been described in several patients 
following preeclampsia/eclampsia. Lawn et al.48 found that of 26 women undergoing 
anterior temporal lobectomy for temporal lobe epilepsy (without other risk factors), 12 
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between the occurrence of (pre)eclampsia and the onset of epilepsy was one month to two 
years. None of these women had had seizures early in life, febrile convulsions, intracranial 
infection or perinatal injuries, all of these typically associated with subsequent temporal 
lobe epilepsy. Shah et al.49 followed 12 women who had eclampsia; 1 of them developed 
recurrent seizures within the first few months, but became seizure free on phenytoin 
therapy. Kastrup et al.50 describe 17 PRES patients who had an EEG at time of the acute 
episode, 3 of whom had preeclampsia and 3 had eclampsia. None of those 6 women had 
seizures at one and six months follow-up. Of the 17 PRES patients, 10 had a repeat EEG 
after six months, all without abnormalities.
PRES associated with autoimmune disease and/or immunosuppressive therapy
Baldini et al.51 describe a twenty-one year old woman who developed chronic epilepsy 
following PRES related to tacrolimus use after liver transplant for hepatitis B liver cirrhosis. 
Six and nine months after hospital discharge she suffered nocturnal generalized tonic–clonic 
seizures. While the frontal white matter lesion seen on MRI resolved within one year and 
the patient was seizure-free by that time (while using oxcarbazepine), she demonstrated 
persistent delta waves on the EEG. Solinas et al.52 describe three children (a ten-year-
old with acute glomerulonephritis, an eight-year-old with Kawasaki’s disease and a three-
year-old with nephrotic syndrome and corticosteroid therapy) with refractory temporal 
lobe epilepsy developing weeks to years following an episode of PRES (hypertensive 
encephalopathy). They all had hippocampal sclerosis, which is thought to be an acquired 
lesion secondary to seizure-associated damage or to vascular damage. In the study of 
Kastrup et al.50, the 2 patients with immunosuppressant-related PRES did not have seizures 
nor EEG abnormalities at 1 and 6 months follow-up.
PRES associated with thrombotic thrombocytopenic purpura
Belaramani et al.53 describe a twenty-eight year old man with 8 recurrent episodes of PRES; 
the first episode was associated with thrombotic thrombocytopenic purpura (TTP)–hemolytic 
uremic syndrome (HUS). Subsequent episodes were precipitated by severe hypertension 
and not associated with metabolic abnormalities or use of immunosuppressants. The 
patient developed chronic epilepsy in the form of generalized tonic-clonic seizures. Brain 
MRI (FLAIR) during one of the PRES-episodes showed edema in the parieto-occipital areas, 
which resolved 3 months later but scattered subcortical T2 and FLAIR hyperintensities 








PRES associated with malignant disease and chemotherapy
A cohort of 56 children with chemotherapy-related PRES was studied in which 55% had acute 
lymphoblastic leukemia, 9% had acute myeloid leukemia, 13% had non-Hodgkin lymphoma 
and 23% had solid tumors.40 Of these children 8% were found to have developed chronic 
epilepsy at long-term follow-up. Lucchini et al.14 describe 12 children with chemotherapy-
associated PRES, 4 (33%) of whom developed unprovoked generalized seizures (2 patients) 
and/or focal spikes on EEG (2 patients) after 10-124 months. The underlying disease 
was acute lymphoblastic leukemia in 9 patients, and Fanconi anemia, Langerhans cell 
hystiocytosis and immune hemolytic anemia in the others. In a study of children being 
treated for acute leukemia, 19/648 (2.9%) developed PRES.41 Of these 19 patients, 5 showed 
persistent MRI abnormalities and 9 (50%) required long-term anticonvulsant therapy, 
because of continued epileptiform discharges on EEG or repeated seizure episodes. Of 
these 9 patients, 6 underwent haematopoietic stem cell transplantation and 3 received 
prophylactic intracranial irradiation therapy and/or chemotherapy. 3 of these 9 patients 
manifested recurrent seizures even though they were treated with more than three 
different epileptic drugs. Belaramani et al.53 describe 5 children with PRES, 4 of whom 
had acute lymphoblastic leukaemia and one had a central nervous system germ cell tumor. 
All of them showed good initial clinical recovery. Ultimately, two died from recurrent 
malignant disease and one developed refractory epilepsy. This last patient’s MRI seven 
years after the episode of PRES revealed right hippocampal sclerosis, which however could 
be seizure-related rather than PRES-related. In the study of Kastrup et al.50, the 5 patients 
with chemotherapy related PRES did not have seizures or EEG abnormalities at 1 and 6 
months follow-up. In the study of Khan et al.54, the presence of leucoencephalopathy in 
children with seizures associated with haematological malignancies did not predict the 
development of uncontrolled seizures in the subsequent years.
PRES and visual impairment
PRES in preeclampsia/eclampsia
Visual abnormalities in the acute phase of severe preeclampsia and eclampsia are commonly 
described as blurred vision, homonymous haemianopsia, visual neglect, cortical blindness 
or visual anosognosia. These are thought to be due to the cerebral edema located in the 
occipital (visual) cortex or the temporal and parietal association cortices.6 Although in 
most patients the impairment seems to be reversible, in rare cases permanent blindness 
has been described. Moseman et al.55 report a twenty-one year old woman presenting 
with blurred vision one day after caesarean section for preeclampsia, which progressed 
to bilateral blindness and persisted at 5 month follow-up. No follow-up neuroimaging was 
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and 5 women with preeclampsia without seizures but with cerebral involvement in 
the form of cortical blindness. The duration of blindness ranged from 4-192 hours, but 
eventually all showed self-reported recovery of blindness as well as radiological recovery. 
Bandyopadhyay et al.57 describe a seventeen-year-old preeclamptic woman with reduced 
light perception, headache and confusion, one day postpartum. Following treatment, her 
vision returned to normal after seven days. Wiegman et al.9 investigated visual fields using 
automated perimetry and evaluated the presence of brain white matter lesions on MRI in 47 
women who had experienced eclampsia-related PRES on average ten years earlier. None of 
them demonstrated visual field defects while 36% of the women had cerebral white matter 
lesions on MRI, predominantly in the frontal lobes. Previously eclamptic women reported a 
somewhat worse vision-related quality of life compared to women who had normotensive 
pregnancies. Those previously eclamptic women who also had brain white matter lesions 
scored worse than those previously eclamptic without white matter lesions on MRI. While 
it may be hypothesized that  white matter lesions may interfere with higher-order visual 
functioning, no impairment on neurocognitive tests of visual perception and only a slight 
impairment in visuomotor speed are found following preeclampsia/eclampsia.46
PRES associated with autoimmune disease and/or immunosuppressive therapy
Lai et al.58 describe a thirty-five year old woman with SLE treated with cyclosporine who 
developed a generalized tonic-clonic convulsion and sudden binocular cortical blindness. 
CT scan showed bilateral hypodense lesions in the occipital lobe; on MRI T2-hyperintense 
lesions in the parieto-occipital regions were seen, not hypointense on apparent diffusion 
coefficient (ADC) images, consistent with vasogenic edema. She had complete recovery of 
vision and of neuroimaging findings at 4 months follow-up.
PRES associated with malignant disease and chemotherapy
Hemmaway et al.59 describe permanent cortical blindness in a sixty-year-old woman one 
year after PRES associated with chemotherapy for T-cell lymphoma. MRI showed bilateral 
T2 hyperintense lesions of the left occipital white matter in the acute phase. No follow-up 
MRI was acquired.
PRES associated with acute hypertension (hypertensive encephalopathy)
Iwama et al.60 describe T2 hyperintense areas in the posterior white matter at 5 months 
follow-up in a patient with hypertension-related PRES and bilateral total cortical blindness. 
Kim et al.61 describe a forty-six year old woman who developed intraoperative hypertension 
with subsequent PRES after surgery for intrauterine myoma. Visual acuity allowed light 







Bandyopadhyay et al.57 describe a case of PRES related to acute hypertension in a seventy-
five year old male with sudden, bilateral loss of vision. He had extensive occipital lobe 
infarction on CT imaging. After 6 months, visual acuity had returned to 20/80 bilaterally 
without complete recovery. Stott et al.19 describe one of 6 PRES patients with residual 
left inferior quadrantanopia. This patient developed acute hypertension following acute 
hepato-renal failure after a paracetamol overdose. MRI revealed small areas of cerebral 
infarction in the right occipital lobe.
Discussion
PRES is a clinicoradiological syndrome which has been associated with numerous systemic 
conditions in both obstetric (preeclampsia/eclampsia) and non-obstetric patients of all 
age categories. We reviewed the literature to identify possible long-term consequences of 
PRES, particularly in obstetric compared to non–obstetric patients. The literature mainly 
consists of small observational studies and case series, and follow-up was often only short-
term (several months). The reported cases illustrate the heterogeneous pathology that 
may underlie PRES, and this pathology itself may induce (sub)clinical structural cerebral 
damage, in addition to and independent of PRES. The published data may represent an 
overestimation of the true incidence of adverse sequelae following PRES, due to publication 
bias. On the other hand, long-term sequelae might be underreported because follow-up 
of PRES patients is frequently lacking and there is no systematic follow-up to elucidate 
potential subclinical effects.  Some general comments can be made.
On long-term follow-up, 41% and 37% of formerly eclamptic and preeclamptic 
women, particularly those with preterm preeclampsia, show WML on MRI compared to 
17% of age-matched women who had normotensive pregnancies.29,30 The pathogenesis 
of these WML remains to be elucidated: they may be a direct consequence of PRES or, 
alternatively, they may be related to an increased propensity for cerebrovascular disease 
in these women.62,63 In non-obstetric PRES patients, persistent MRI abnormalities, ranging 
from white matter lesions and focal gliosis to intracranial haemorrhage and infarction, are 
described more often, in 15-70%. However, these percentages need to be interpreted with 
caution. Haemorrhagic and major non-haemorrhagic stroke in non-obstetric PRES patients 
may be considered separate consequences of the underlying systemic pathology and, as 
such, occurring parallel to PRES, rather than its consequence. From this perspective, the 
remarkably low occurrence of major clinically recognizable sequelae after obstetric PRES 
and the often less severe course of disease may illustrate the fundamentally reversible 
nature of PRES. Severe preeclampsia with headaches or visual disturbances and eclampsia 
may very well be the “forme fruste” of PRES, since it very rarely occurs more than once, 
the underlying condition (i.e. pregnancy) is temporary, and most women are otherwise 
healthy. This could explain the more frequent occurrence of long-term sequelae in non-
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the PRES-episode itself.28,41
In formerly preeclamptic and eclamptic patients, subjective cognitive problems 
have been reported,7,8 while objective neurocognitive dysfunctioning on neurocognitive 
tests cannot be demonstrated.46 This suggests that at least in women in their child-bearing 
age PRES itself may not give rise to major structural or functional damage, but its effect 
in later life is unknown. Long-term cognitive dysfunction following PRES seems to play a 
more prominent role in the pediatric population. The developing pediatric brain appears 
to be particularly vulnerable to hypertension as well as seizure activity. The question is 
whether PRES itself is the damaging factor in this pediatric population, or whether it is the 
underlying condition with its associated effects.
Only one study describes a possible cause and effect relationship between eclampsia 
and the subsequent development of chronic epilepsy.48 However, this study employed 
retrospective data and it was not known whether mesial temporal sclerosis was already 
present prior to the eclamptic seizure. Most cases describing epilepsy following PRES 
were in children, especially in those receiving chemotherapy. Here again, the underlying 
condition, or even the medication giving rise to PRES might play a larger role in the 
development of cognitive dysfunction and/or epilepsy than the PRES-episode in and of 
itself.
The visual abnormalities occurring during obstetric and non-obstetric PRES seem 
reversible in most cases, especially in cases when PRES was diagnosed and managed in 
a timely manner. However, rare cases have been described to progress to irreversible 
(partial) blindness as a result of cerebral infarction.
While preeclampsia/eclampsia-related PRES is reversible in most cases it is a 
serious and potentially life-threatening obstetrical emergency. Most women will recover 
completely provided adequate treatment without delay. If not adequately treated cerebral 
edema may lead to severe complications such as intracerebral haemorrhage and major 
brain infarctions, and transtentorial herniation resulting in death. Most reports suggest 
that late diagnosis or inadequate therapy may influence the course of the disease, as 
incomplete edema resolution may be associated with higher mean arterial pressure levels 
and of longer duration.42
Treatment of PRES, while not evidence-based, is aimed at removing the causative 
agent (in case of pregnancy, delivery should be planned), blood pressure management 
and administration of anticonvulsive medication. In preeclampsia, in conjunction with 
endothelial dysfunction, alterations in the cerebral circulation may occur despite minimal 
elevation in blood pressure and a mild clinical picture. Therefore, prompt diagnosis is 
needed in those women who experience neurological symptoms, even with blood pressure 
in the non-severe range.3 Neuroimaging using MRI FLAIR and DWI sequences with ADC 
mapping are best used for diagnosis and assessment of potential irreversible damage due 
to cytotoxic edema. Diffusion imaging may discriminate between potentially irreversible 







levels have been associated with incomplete edema resolution,21 adequate blood pressure 
control is important. Lowering blood pressure in conjunction with magnesium sulphate 
administration for prevention of (recurrent) eclamptic seizures is recommended64 and 
termination of pregnancy.28
We recommend follow-up MR imaging six months later in women who experienced 
PRES in preeclampsia or eclampsia to assess reversibility of edema, particularly in those 
women who report long-term neurocognitive problems or visual disturbances. Atypical 
radiological findings like haemorrhage and infarction may predict poorer outcome.20
Conclusions
Long-term sequelae of both PRES in preeclampsia/eclampsia as well as non-obstetric PRES-
related conditions have been poorly described so far. It appears that obstetric PRES is 
associated with a less severe course of disease and less frequent occurrence of long-term 
adverse sequelae. In preeclamptic and eclamptic patients, white matter lesions on MRI 
were found years later which may be related to common vascular risk factors instead of the 
PRES episode per se. Formerly preeclamptic and eclamptic women may report cognitive 
difficulties, but these have not been confirmed by objective neurocognitive testing so far. 
In contrast, several non-obstetric PRES-related conditions have been described with long-
term neuroimaging abnormalities as well as overt cognitive problems, epilepsy or visual 
impairment. Whether these findings are related to the underlying cause of PRES rather than 
the PRES-episode itself remains to be established. Attention needs to be paid to timely and 
adequate treatment, as well as appropriate follow-up and support of PRES patients. With 
delayed treatment, PRES may lead to cerebral infarction and haemorrhage. Therefore, the 
need for early recognition and treatment of PRES is important, while the clinical findings 
of PRES are often non-specific. Areas for future research include identifying factors that 
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Objective: Previously preeclamptic women may express cognitive difficulties, which have 
largely been unappreciated or attributed to stresses of a complicated pregnancy. This 
study aimed to explore the scope of perceived neurocognitive and psychosocial problems 
as well as quality of life following preeclampsia.
Methods: Observational study. Through website promotion and e-mail, registrants of the 
USA-based Preeclampsia Foundation who experienced preeclampsia in the past 20 years 
were invited to complete a web-based survey. Participants were requested to ask an 
acquaintance that had a normotensive pregnancy to also complete the survey (controls). 
The Cognitive Failures Questionnaire (CFQ), abbreviated WHO Quality Of Life questionnaire 
(WHOQOL-BREF), Social Functioning Questionnaire (SFQ) and Breslau Short Screening Scale 
for DSM-IV Posttraumatic Stress Disorder were used in the survey. Analysis was performed 
using Mann–Whitney U tests and linear regression.
Results: 966 cases and 342 controls completed the survey (median age 34, median time 
since first pregnancy 4 vs. 5 years). Cases scored significantly worse on CFQ (median 35 
vs. 27), WHOQOL-BREF domains physical health (15 vs. 17), psychological (13 vs. 15), social 
relationships (13 vs. 15) and environment (15 vs. 16), and SFQ (8 vs. 7). All p < 0.001. 
Multivariable analysis showed an independent significant effect of eclampsia on CFQ and 
of migraine on all questionnaires and the effect of preeclampsia was still present after 
adjustment for confounders. Posttraumatic stress symptoms accounted for part of the 
relationships.
Conclusions: Previously preeclamptic women appear to perceive more cognitive and 
social problems, and report poorer quality of life compared to a group of women with 








Cognition, quality of life and soCial funCtioning following preeClampsia
Introduction
There is growing recognition that preeclampsia is not a transient event. The syndrome is 
associated with a greater incidence of hypertension, ischaemic heart disease or stroke later 
in life.1 Mechanisms of the increased risk for cardiovascular disease following a pregnancy 
complicated with preeclampsia remain unknown but risk factors for atherosclerosis such 
as chronic hypertension, dyslipidemia, obesity and glucose intolerance are likely to play 
a role. Formerly eclamptic women report cognitive difficulties related to memory and 
concentration; small studies have not clearly demonstrated these in preeclampsia.2-7 At long-
term follow-up, formerly eclamptic and preeclamptic women may demonstrate cerebral 
white matter lesions on MRI.8,9 The presence of both such lesions and chronic hypertension 
has been associated with cognitive decline in later life.10-12 Alternatively, a pregnancy 
complicated by preeclampsia may be experienced as traumatic, resulting in trauma-related 
psychopathology such as posttraumatic stress syndrome (PTSD) and depressive symptoms, 
known to influence cognitive functioning4,13-16 It is therefore possible that both biological 
constitution as well psychosocial factors are responsible for the neurocognitive difficulties 
reported by formerly preeclamptic women. We sought to determine the actual scope of 
cognitive problems and the impact of preeclampsia on quality of life and social functioning. 
Because few small studies so far have focused on cognitive and social functioning after 
preeclampsia, we aimed to make an inventory of the nature and extent of these issues in 
a large cohort of formerly preeclamptic women.
Methods
All registrants of the Preeclampsia Foundation were contacted through the foundation’s 
website (www.preeclampsia.org) and a mass e-mail, explaining the study aims and 
methodology. The Preeclampsia Foundation is a USA-based non-profit patient advocacy 
organization established in the year 2000 whose mission is to reduce maternal and infant 
illness and death due to preeclampsia and other hypertensive disorders of pregnancy, by 
providing patient support and education, raising public awareness, catalyzing research and 
improving health care practices. Free registration with the foundation is open to anybody 
who is interested in preeclampsia, but is mostly sought after by women who experienced 
the disease. The survey was online between April 29, 2010 and Oct. 4, 2010. At the start of 
the study, the Preeclampsia Foundation had 8677 registrants. This project was determined 
to be eligible for a Certificate of Exemption as reviewed by the Human Subjects Review 
Committee of the University of Washington, Seattle. Participation in the study was 
anonymous and without a request for any identifying information other than postal zip 
code and year of birth which were used to identify those women who erroneously filled 









Study participants were asked whether they had experienced any pregnancy-related 
hypertensive disorder, including preeclampsia (toxemia), HELLP syndrome, or pregnancy-
induced hypertension (PIH) during any of their pregnancies. Participation was allowed for 
women who had their first pregnancy after 1990 and had not been pregnant in the past 3 
months. The survey consisted of four web based questionnaires as well as an inquiry about 
current and past medical history including medication use, age, ethnicity, education level 
and characteristics of index and subsequent pregnancies (gestational age, birth weight, 
preeclampsia, HELLP syndrome or eclamptic seizures). Participants were requested to ask 
a friend or acquaintance of approximately the same age that had a normotensive pregnancy 
during the same year of the participant’s hypertensive pregnancy to complete the survey 
as a control subject. Women with current or past neurological conditions or women who 
lived in a country where English is not the first language were excluded.
Questionnaires
The Cognitive Failures Questionnaire (CFQ)
The CFQ is a validated questionnaire and contains 25 items scored on a five-point scale.17,18 
It assesses how often over the past 6 months errors were committed in daily tasks of 
everyday life. In this study we used 18 of the 25 questions. The answers to 7 questions 
could not be accessed from the anonymous collection tool. The loss of data weakens the 
power of the tool but is not expected to create a bias between case and control groups. 
From the 18 questions we derived a total score ranging from 0 to 72. Higher scores on the 
CFQ indicate more cognitive failures.
The World Health Organization Quality of Life BREF (WHOQOL-BREF) US version
The WHOQOL-BREF is a validated abbreviated version of the WHOQOL-100 that contains 100 
items developed to assess generic quality of life.19 The WHOQOL-BREF contains 26 questions 
in four domains: physical health, psychological, social relationships and environment. 
Items can be scored on a five-point scale. Higher scores indicate higher quality of life. The 
mean score of items within each domain is used to calculate the domain score, ranging 
from four to 20. The first two questions are general questions that do not pertain to one of 
the domains but are examined separately: question one pertains to overall perception of 
quality of life and question two pertains to overall perception of health.
The Social Functioning Questionnaire (SFQ)
The Social Functioning Questionnaire (SFQ) is a validated questionnaire that contains eight 
items covering the following domains: work, household tasks, financial matters, family 
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N = 1458 
N = 966 N = 342 
N = 1031 N = 360 
No consent
N = 12 
No English



















Age (years) 34 (19-60) 34 (20-57) 0.21
Education level Less than high school 2 (0.2%) 0 (0%) 0.75
High school 165 (17%) 53 (16%)
College/university 545 (58%) 199 (56%)
Doctorate/graduate school 254 (26%) 90 (26%)
Ethnicity Caucasian 868 (90%) 315 (92%) < 0.05
Hispanic/Latino 35 (4%) 5 (1%)
African American 22 (2%) 2 (1%)
Other 41 (4%) 20 (6%)
Time since 1st pregnancy (years) 4 (0-20) 5 (0-20) < 0.001
Number of pregnancies 1 510 (53%) 133 (39%) < 0.001
2 323 (33%) 123 (36%)
3 99 (10%) 58 (17%)
> 3 34 (4%) 28 (8%)
Eclamptic seizures 58 (6%)
Current psychiatric problems 168 (17%) 30 (9%) < 0.001
Past psychiatric problems 324 (34%) 75 (22%) < 0.001
History of migraine 389 (40%) 107 (31%) < 0.01
Antihypertensive medication 172 (18%) 4 (1%) < 0.001
PTSD 393 (41%) 43 (13%) < 0.001
Results are expressed as median (min-max) or number (percentage).







scored on a four point-scale, from which a total score can be derived with a range of 0–24. 
Higher scores indicate poorer social functioning. A score ≥ 10 is used as a cut-off point for 
poor social functioning.
The Breslau Short Screening Scale for Posttraumatic Stress Disorder (PTSD)
The Short Screening Scale for DSM-IV PTSD consists of seven items; five avoidance and 
numbing items and two hyperarousal items, scored 0 (no symptoms) or 1 (symptoms).21 A 
cut-off ≥ 4 was used to indicate a greater likelihood of PTSD. Results of this PTSD screening 
scale are used in the regression analysis to determine the effect of pregnancy-related PTSD 
on the other questionnaires.
Statistical analyses
Statistical analysis was performed using Predictive Analytics Software Statistics version 18 
for Windows (PASW Inc., Chicago IL, USA). All data were checked for normalcy of distribution 
using Shapiro–Wilk test and Levene’s test for homogeneity of variance. Demographic and 
pregnancy characteristics, the prevalence of past or current psychiatric problems and use 
of antihypertensive medication were analyzed using chi-square test. Single imputation was 
used to replace missing values (< 5% of total data) in the questionnaires using estimated 
means per group. The group variable was coded as 0 vs. 1. Statistical analysis to compare 
the total scores of the questionnaires and the individual CFQ questions between groups 
was done using Mann–Whitney U test. Individual questions of the CFQ and question one 
and two of the WHOQOL-BREF were analyzed using chi-square test as well. Spearman’s 
rho was used to assess correlations between the questionnaire scores. Univariable and 
multivariable linear regression with a forward stepwise inclusion was used to analyze the 
effects of group (cases vs. control), age, education level, elapsed time since first pregnancy, 
ethnicity, number of experienced pregnancies, eclamptic seizures, antihypertensive 
medication and history of migraines (a factor was selected for the multivariable analysis if 
p < 0.25 in the univariable regression, and the criterion for inclusion in the multivariable 
analysis was set at p = 0.05). Porcel et al. found a significantly higher prevalence of PTSD in 
the same group of women (43% vs. 14% in controls). (Porcel et al. personal communication) 




A total of 1458 women participated in the survey, of whom 1075 had some form of 
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Figure 1 depicts the number of excluded women plus the reasons for exclusion. Only 
participants from the USA, Australia, Great Britain, Canada and New Zealand were 
included. A total of 1308 participants were included for data analysis, including 966 cases, 
i.e. women who had some form of hypertensive disease during any of their pregnancies 
and 342 controls. i.e. parous women who had normotensive pregnancies. The self-reported 








































Table 2. Questionnaires: cases and controls







CFQ Total score 18 items 35 (3-66) 27 (5-62) < 0.001
WHOQOL-BREF Quality of life 4 (1-5) 4 (2-5) < 0.001
Satisfaction with health 3 (1-5) 4 (1-5) < 0.001
Physical health domain 15 (5-20) 17 (9-20) < 0.001
Psychological domain 13 (4-19) 15 (6-20) < 0.001
Social relationships domain 13 (4-20) 15 (4-20) < 0.001
Environment domain 15 (7-20) 16 (8-20) < 0.001
SFQ 8 (0-22) 7 (0-19) < 0.001








Parameter B SE (B) B SE (B)
CFQ total (18 items)
Group 8.16 0.72 7.49 0.71*
Age -0.26 0.06 -0.17 0.06*
Eclampsia 6.00 1.60 3.28 1.51*
Migraine 4.32 0.69 3.50 0.64*
Education College/university (reference)
Less than high school 10.04 8.37 4.41 7.91*
High school 4.97 0.91 4.13 0.86*
Doctorate/graduate school -1.51 0.77 -1.35 0.73*
WHOQOL-BREF Physical health domain
Group -1.35 0.16 -1.12 0.16*
Antihypertensive 
medication -1.22 0.21 -0.87 0.20*
Migraine -0.99 0.14 -0.84 0.14*
Education College/university (reference)
Less than high school -1.19 1.79 -0.44 1.71*
High school -1.02 0.20 -0.72 0.19*
Doctorate/graduate school 0.19 0.17 0.26 0.16*
WHOQOL-BREF Psychological domain
Group -1.63 0.17 -1.57 0.17*
Migraine -0.67 0.16 -0.52 0.16*
Education College/university (reference)
Less than high school -0.41 1.99 0.09 1.92*
High school -0.96 0.22 -0.88 0.21*
Doctorate/graduate school 0.25 0.18 0.28 0.18*
WHOQOL-BREF Social relationships domain
Group -0.99 0.21 -0.92 0.21*
Migraine -0.79 0.19 -0.72 0.19*
WHOQOL-BREF Environment domain
Group -0.80 0.15 -0.74 0.15*
Age 0.04 0.01 0.02 0.01*
Migraine -0.56 0.14 -0.48 0.13*
Education College/university (reference)
Less than high school -1.26 1.69 -0.76 1.66*
High school -0.68 0.18 -0.58 0.18*
Doctorate/graduate school 0.37 0.16 0.35 0.15*
Univariable effects are shown only for factors included in the multivariable analyses. * p < 0.05.
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Univariable Multivariable
Parameter B SE (B) B SE (B)
SFQ total
Group 1.56 0.25 1.45 0.24*
Migraine 1.09 0.22 0.94 0.22*
Education College/university (reference)
Less than high school 1.89 2.78 1.37 2.72*
High school 1.27 0.30 1.16 0.30*
Doctorate/graduate school -0.24 0.26 -0.28 0.25*
Univariable effects are shown only for factors included in the multivariable analyses. * p < 0.05.
Table 3. (continued)
prevalence of preeclampsia and/or HELLP syndrome among cases was 96.8% and 42 (3.2%) 
had gestational hypertension. Median age at the time of survey was 34 for both cases 
and controls. Median time since first pregnancy was 4 and 5 years respectively. Cases 
had significantly fewer pregnancies compared to controls. Fifty-eight cases (6%) reported 
having experienced eclampsia during one of their pregnancies. Cases more often reported: 
(1) current or past psychiatric problems requiring therapy, (2) a history of migraines and (3) 
use of antihypertensive medication. There was no difference in education level (Table 1).
Questionnaires
Cases scored significantly worse compared to controls on total scores and individual 
domain scores of all three questionnaires (Table 2 and Figure 2). This was also true for 
all the individual questions of the CFQ and question one and two of the WHOQOL-BREF: 
overall perception of quality of life and overall perception of health (p < 0.001). Results 
did not change when cases with PIH were excluded. On the SFQ, 385 (40%) cases and 73 
(21%) controls scored ≥ 10, indicating poor social functioning. When the 924 cases with 
preeclampsia or HELLP were divided in early (< 34 weeks) versus late onset (> 34 weeks) 
preeclampsia, no significant differences were found for any of the questionnaires. The 
total CFQ score of 18 questions demonstrated good reliability (Cronbach’s α = 0.91), as did 
the SFQ total (Cronbach’s α = 0.77) and the WHOQOL-BREF domains (Cronbach’s α = 0.82, 
0.85, 0.70 and 0.81 for physical health, psychological, social relationships and environment 
respectively).
Multivariable linear regression analysis
Table 3 shows the results of the multiple linear regression analyses incorporating group, 








Parameter B SE (B)






Less than high school 9.63 7.40*
High school 4.06 0.81*
Doctorate/graduate school -1.37 0.68*







Less than high school -1.27 1.60*
High school -0.88 0.18*





Less than high school -1.03 1.74*
High school -0.83 0.19*
Doctorate/graduate school 0.28 0.16*
* p < 0.05.
Table 4. Multivariable regression analysis including PTSD
pregnancies, eclamptic seizures, antihypertensive medication and history of migraines. The 
effect of group (cases vs. controls) remained significant on all outcomes (B 7.49 for CFQ, 
-1.12 WHO physical health, -1.57 for WHO psychological, -0.92 for WHO social relationships, 
-0.74 for WHO environment and 1.45 for SFQ). There was a significant effect of eclampsia 
on the CFQ (B 3.28), which decreased the effect of group from B 8.14 to 7.49. A history 
of migraines had a significant effect on all outcomes. Women using antihypertensive 
medication scored significantly worse only on the WHOQOL physical health domain. Elapsed 
time since first pregnancy did not have a significant effect on any of the outcomes, nor 
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Multivariable
Parameter B SE (B)








Less than high school -1.61 1.59*
High school -0.58 0.17*






Less than high school 2.71 2.52*
High school 1.11 0.28*
Doctorate/graduate school -0.29 0.23*
* p < 0.05.
Table 4. (continued)
on all outcomes (Table 4). The significant effect of eclampsia on the CFQ disappeared and 
the effect of group (cases vs. controls) was less strong, but still significant on all outcomes 
except for the WHOQOL social relationships domain. There was no significant interaction 
between PTSD and group for any of the outcomes.
Discussion
Years following their pregnancy formerly preeclamptic women appear to perceive more 
cognitive problems, poorer quality of life and social functioning, including psychiatric 
problems requiring therapy, compared to a group of women with normotensive 
pregnancies. This difference remained significant after correction for age, early vs. late 
onset preeclampsia, education level, time since first pregnancy, ethnicity, number of 
pregnancies, eclamptic seizures, antihypertensive medication and history of migraines. 
A history of eclampsia did not change the effect of preeclampsia itself in the regression 







function whereas a history of migraine appears to have a significant effect on all outcomes. 
There are several possible explanations for our findings. A pregnancy complicated by 
preeclampsia may be experienced as traumatic and result in PTSD or depression.13,22 These 
conditions may influence cognitive functioning, quality of life and social functioning in 
the long term. Indeed, we found a significant effect of PTSD on the questionnaires, which 
decreased the effect of preeclampsia. However, the effect of preeclampsia remained 
significant, suggesting that, in addition to psychological trauma, other factors also play a 
role. No differences were found for early vs. late onset preeclampsia, which suggests that 
the findings are not mediated by the effect of preterm birth and the stressors of caring for 
a premature child. We found that both preeclampsia and migraine independently influence 
self-reported cognitive functioning, quality of life and social functioning. Forty percent of 
cases and 31% of controls reported having migraine. The lifetime prevalence of migraine 
in women is 12–33%.23 Our percentages may overestimate the true incidence of migraine in 
our cohort because we did not use a structured questionnaire to determine the diagnostic 
criteria of migraine. Preeclampsia and migraine seem related and seem to share a common 
pathway, involving vasodilatation, vascular dysfunction and platelet aggregation. Both 
have been associated with cardiovascular disease and brain white matter lesions.1,8,24-27
To our knowledge, there have been no previous studies with long-term follow-up 
in preeclampsia, and the main strength of our study is that we were able to reach a 
large number of women. Prior studies have evaluated cognitive functioning in formerly 
eclamptic women. Six to twenty four months after eclampsia, 18% of 123 interviewed 
women reported problems with concentrating, 14% had symptoms of mental depression.3 
Formerly eclamptic women scored significantly lower on the CFQ than normotensive 
parous controls, but no difference was found comparing previously preeclamptic women 
with controls.2 In preeclampsia, small-scale studies evaluating objective neurocognitive 
functioning using a variety of tests have shown inconsistent results.4-7
A number of limitations of this study can be identified. An important issue is 
the potential for selection bias. About 12% of the Preeclampsia Foundation registrants 
responded to our call to participate in the study. Registrants with the Foundation are more 
likely Caucasian, higher educated, and more web connected. Our conclusions should be 
referenced to this group and generalized to others as deemed appropriate. In addition, it 
is plausible that women who experience the specific issues we investigated have a greater 
tendency to participate, which might overestimate the true scope. Also, only 342 controls 
responded to the preeclamptic women’s request to participate in the study, which might 
skew the results into a more positive result.
Due to an unfortunate technical error, only the first 18 questions of the CFQ were 
available online. However, internal consistency and reliability (α = 0.91) were good and 
the lost questions were evenly divided over the three domains described by Rast et al.17 
Therefore, we consider our shorter CFQ version a valid indication of cognitive problems in 
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checking medical records due to the anonymity of this study, which may introduce recall 
bias. However, participating women likely seek out the Foundation due to adverse events 
associated with hypertension and were likely to have had some form of hypertensive disease 
in pregnancy. The diagnostic criteria for preeclampsia, eclampsia and HELLP syndrome are 
mentioned on the Foundation’s website. In addition, if the case group contains women 
without hypertensive disease, this will bias exclusively toward the hypothesis. Since 
questionnaires elicit subjective answers, cognitive problems cannot be strictly defined. 
Lastly, the present study is descriptive. It is therefore not possible to draw firm conclusions 
on the causal relationship between preeclampsia and the outcomes of the questionnaires.
Our aim was to make an inventory of the nature and extent of long-term cognitive 
and psychosocial problems in formerly preeclamptic women. Although there is a potential 
for selection and recall bias, we feel our study emphasizes the need for further research 
in this field. Further study needs to focus on more accurately classifying the hypertensive 
categories and linking these to pregnancy outcomes. For example, perhaps women with a 
pregnancy loss or impaired infant have more significant cognitive dysfunctions. Moreover, 
women who had more than one pregnancy complicated by preeclampsia, whether or not 
they had a normal interval pregnancy, may have different recall of their symptoms. Our 
results would support the growing concern that preeclampsia cannot simply be considered 
a transient event. The subjective assessment of cognitive function, however, must be 
confirmed with objective neurocognitive testing. Further research should focus on the 
relationship between cardiovascular disease, migraine, brain white matter lesions and 
cognitive function.
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Objective: Recently, information has emerged that formerly eclamptic women may 
suffer cognitive impairment. This may be related to cerebral white matter lesions. The 
few available reports demonstrate inconsistent results. We sought to elucidate cognitive 
performance after eclampsia in a pilot study.
Methods: Twenty-six eclamptic, 20 preeclamptic, and 18 healthy parous women performed 
the Sustained Attention to Response Task (SART; the ability to sustain mindful processing 
of repetitive stimuli that would otherwise lead to habituation) and the Random Number 
Generation Task (RNG; executive functioning, i.e., inhibition and updating/monitoring).
Results: Average age was 40 years, elapsed time since index pregnancy was 9 years. 
Education levels did not differ. There were no intercurrent illnesses. No significant 
differences were found on SART and RNG scores between groups.
Conclusions: This study was not able to demonstrate evidence for impaired sustained 
attention and executive functioning after eclampsia. Studies including a much wider 
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Introduction
Eclampsia is an important complication of hypertensive disease during pregnancy. Cranial 
magnetic resonance imaging (MRI) within 24 hours following an eclamptic convulsion 
reveals vasogenic edema consistent with posterior reversible encephalopathy syndrome 
(PRES).1,2 PRES is a dangerous clinicoradiological entity characterized by headaches, altered 
mental functioning, decreased alertness, visual disturbances, seizures, or coma.3 Its 
pathophysiology is a matter of debate with current emphasis on failure of the autoregulatory 
capacity of the cerebral circulation in the presence of endothelial dysfunction and (often 
minimal) hypertension.3,4 In this scheme, it is thought that subsequent hyperperfusion of 
the cerebral circulation may lead to disruption of the blood-brain barrier and formation 
of vasogenic edema that is believed to be reversible, at least initially. Recent doubts as 
to the complete reversibility of PRES in eclampsia have been raised. It now appears that 
not all formerly eclamptic women demonstrate complete reversibility of the white matter 
abnormalities seen on initial MRI.2,5,6 Furthermore, formerly eclamptic women report 
cognitive dysfunction, specifically related to concentration, attention span, and memory.7,8 
These findings have challenged the paradigm that eclamptic women can expect full clinical 
recovery. Although formerly eclamptic patients report that their cognitive functioning is less 
efficient, it is unknown whether and to what extent this can be demonstrated objectively. 
Two small studies have been done in preeclamptic women so far, respectively 3 to 8 and 6 
to 18 months postpartum, in which some cognitive impairment was seen on auditory-verbal 
memory, visual perceptional speed, and divided attention, but results were inconsistent.9,10 
No data are available about cognitive functioning in women who experienced eclampsia.
Cognitive functioning consists of different domains.11 One of these domains and 
an important factor for daily human functioning is sustained attention, which reflects 
the capacity to maintain attentional activity over a longer period of time. Another 
domain pertains to executive functioning, which reflects the capacity to regulate 
behavior and control the contents of conscious thought. Problems that may arise due 
to impaired executive functioning are defective selfcontrol, emotional lability, irritability 
and excitability, impulsivity, rigidity, and attentional and behavioral difficulties. The 
subjective complaints of formerly eclamptic women seem to involve sustained attention 
and executive functioning, and therefore, neurocognitive tests suited to evaluate these 
functions were chosen. With this pilot study, we aimed to assess these two domains of 
cognitive functioning in formerly eclamptic women, more specifically, sustained attention 
and the executive functions of updating and inhibition involved in regulating the contents 









The University Medical Center Groningen (UMCG) is an academic teaching and tertiary 
perinatal referral hospital in The Netherlands. A small percentage of healthy women with 
uncomplicated pregnancies choose to deliver in the UMCG as well. The population in the 
northern part of The Netherlands is predominantly Caucasian. Since 1988, an electronic 
admission, diagnosis, and delivery database has been kept up-to-date. From 1988 until 
2005, 73 women were diagnosed with eclampsia. Eclampsia was defined as new onset 
of seizures after 20 weeks and within 1 week postpartum in women with preeclampsia. 
Preeclampsia was defined according to the standards of the International Society for the 
Study of Hypertension in Pregnancy.12,13 Of these 73 women, the medical records were 
reviewed for accuracy of diagnosis of eclampsia. Upon reviewing the medical records, one 
formerly eclamptic participant was excluded because the diagnosis of eclampsia could 
not be confirmed. Two women died from cerebral complications (both due to hypoxic 
encephalopathy following severe cerebral edema) as a result of eclampsia, and one 
woman succumbed to cervical cancer several years after pregnancy. Exclusion criteria 
were epilepsy or other neurological or psychiatric disorders known to influence cognitive 
functioning, a history of alcohol or substance abuse requiring therapy, or pregnancy at the 
moment of testing. Each woman was matched for age and year of index pregnancy with 
one formerly preeclamptic woman and one healthy parous control. Matching took place 
before the invitations were sent. In total, 69 formerly eclamptic women were contacted, 
of whom 26 agreed to participate in this neurocognitive study. Eighteen healthy parous 
control women and 20 preeclamptic women were also willing to participate. Many non-
participants in all groups mentioned the travel and time commitment as the reason for not 
being able to participate. Several formerly eclamptic women declined to participate due 
to fear of confrontation with their past illness and possible sequelae. All study participants 
were asked to complete a questionnaire related to current and past medical history and 
sociodemographic characteristics. The project was approved by the University Medical 
Center Groningen Institutional Review Board, and all women signed informed consent.
Sustained Attention to Response Task
The Sustained Attention to Response Task (SART) was used to measure the participant’s 
sustained attention, which is defined as the ability to sustain mindful, conscious processing 
of stimuli of which the repetitive qualities would otherwise lead to habituation and 
distraction to other stimuli. This means that one has the capacity to maintain attention 
to an activity during a longer period of time. Performance on this brief and conceptually 
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action slips in normal control participants.14,15 The task consists of repetitive computer-
administered visual stimuli in the form of digits ranging from 1 to 9. The participant has 
to press a key each time a digit appears, with exclusion of the digit 3. The digits follow 
each other in a rapid sequence (each digit appears for 250 milliseconds followed by an X 
presented for 900 milliseconds), with a total of 200 digits. Attention is required to withhold 
pressing when digit 3 appears. Several indices can be derived from SART performance: the 
number of omission errors (pressing the key when digit 3 appears), mean reaction time 
(RT) for correct responses (mean RT correct), pre-error RT (i.e., mean RTs of the four key 
presses prior to making an omission error), and a difference score calculated by subtracting 
pre-error RTs from mean RT correct. Note that higher difference scores are interpreted 
to be indicative of lapses in attention. That is, smaller pre-error RTs are relative to the 
usual time of responding (mean RT correct), indicating that the participant would be less 
engaged in consciously controlling her attentional resources and would be relying more on 
automatic responding.
Random Number Generation Task
The Random Number Generation (RNG) task was used to assess executive functioning. Two 
of those executive functions are response inhibition (the ability to inhibit strong automatic 
or dominant responses) and updating of working memory (the ability to monitor the 
relevance of incoming information and update and replace old information). Participants 
were instructed to say out loud numbers between and including 1 and 10 as randomly as 
possible. They were to provide a total of 100 numbers at a rate of one per second. The 
responses were entered into the RgCalc program (Lancaster, UK) to calculate various indices 
of randomness.16 Two different factors concerning executive functions of working memory 
have been derived, namely the updating/monitoring component, reflecting the degree to 








Age (y) 40 (6.3) 42 (6.3) 39 (7.4) 0.70
Elapsed time since index pregnancy (y) 9 (4.8) 10 (4.6) 9 (4.5) 0.83
Undergraduate/university 
education level (%) 9 (35%) 6 (32%) 6 (32%) 0.42
Nulliparous (%) 18 (69%) 12 (63%) 7 (37%) 0.08
EGA at delivery (wk) 33.0 (4.0) 34.0 (5.3) 39.6 (1.4) < 0.0001
Birth weight (g) 1819 (882) 2038 (1314) 3536 (374) < 0.0001
Results are expressed as mean or number; standard deviations and percentages are noted between 
parentheses. EGA = Estimated Gestational Age.









participants (n = 26)
Eclam
psia 
non-participants (n = 43)
Preeclam
psia 
participants (n = 20)
Preeclam
psia
non-participants (n = 18)
Control 
participants (n = 18)
Control 
non-participants (n = 14)
Age (y) 40 (6.7) 38 (6.7) 40 (6.2) 39 (4.3) 40 (6.9) 37 (5.9)
Elapsed time since 
index pregnancy (y) 8 (5.1) 10 (7.4) 6 (4.5) 7 (4.2) 6 (4.8) 5 (2.6)











EGA at delivery (wk) 33.2 (4.8) 32.6 (4.2) 34.5 (5.2) 35.3 (4.9) 40.0 (1.4) 39.7 (1.4)
Highest systolic blood 
pressure (mmHg) 194 (30) 194 (26) 181 (37) 173 (19)
Highest diastolic blood 
pressure (mmHg) 113 (16) 117 (12) 101 (14)* 111 (11)*
Multiple seizures (%) 13 (52%) 19 (42%)
* p = 0.04 between formerly preeclamptic participants and non-participants. Results are expressed 
as mean or number; standard deviations and percentages are noted between parentheses. EGA = 
Estimated Gestational Age.








Omission errors (n) 11 (5.1) 11 (6.3) 12 (6.0) 0.60
Mean RT correct (ms) 404 (50.1) 407 (58.6) 374 (58.6) 0.14
Pre-error RT (ms) 371 (40.5) 360 (47.9) 345 (43.7) 0.17
RT difference score (ms) 33 (29.9) 47 (39.9) 27 (30.4) 0.17
Results are expressed as mean; standard deviations are noted between parentheses. RT = Reaction 
Time.
Table 3. Sustained Attention to Response Task results
≥ 2 seizures (n = 12) Controls (n = 18) p-value
Omission errors (n) 13 (5.2) 12 (6.0) 0.87
Mean RT correct (ms) 382 (45.8) 374 (58.6) 0.71
Pre-error RT (ms) 362 (37.6) 345 (43.7) 0.29
RT difference score (ms) 20 (25.5) 27 (30.4) 0.54
Results are expressed as mean; standard deviations are noted between parentheses. RT = Reaction 
Time.
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working memory), and the inhibition component (the ability to inhibit strong prepotent 
responses such as counting).17,18 The updating/monitoring component consists of (1) mean 
repetition gap, the mean of the distances between two same numbers; (2) redundancy, 
the extent to which each number was selected with equal frequency; and (3) coupon, 
the mean number of responses before all the response alternatives from 1 to 10 were 
given. The inhibition component consists of (1) RNG, the frequency with which a particular 
number followed another number; (2) runs, the variance in length of successive ascending 
sequences of numbers; (3) combined adjacency, percentage of particular response pairs; 
and (4) turning point index, the number of responses that mark changes from ascending 
to descending sequences.16,18 The updating/monitoring and inhibition components were 
calculated as follows: first, the relevant indices were recoded such that higher scores 
indicated better performance for all indices. Second, these indices were transformed into 
z-scores and summed for each component. Cronbach’s α was 0.84 for the inhibition and 
0.83 for the updating/monitoring scores, indicating good internal consistency.
Statistics
Baseline characteristics were compared using the χ2 test, Kruskal-Wallis test, or one-way 
analysis of variance (ANOVA) where appropriate. One-way ANOVA was used to analyze 
the difference in the scores on the RNG and SART between the three groups; post hoc 
analysis (Student’s t-test) was done to look at differences more extensively. Outliers were 
truncated to a value of one unit higher/lower than the second highest/lowest score.19 The 
RNG and SART tests do not provide specific cutoff levels for normal or pathological states. 
Outcome data are therefore relative with regard to the other participants.14-16 All tests 
were two-tailed with α set at 0.05.
Results
Baseline characteristics of the three groups were similar, except for gestational age at 
delivery and birth weight, as expected (Table 1). The population in the northern part of 
The Netherlands is predominantly Caucasian, as were all women who participated in this 
study. When comparing formerly eclamptic women who participated (n = 26) with those 
who declined to participate (n = 43), no significant differences were found in age, elapsed 
time since index pregnancy, birth weight, and gestational age at delivery. There were also 
no significant differences in number of single versus multiple seizures and highest systolic 
and diastolic blood pressures. In the formerly preeclamptic and control group, participants 







Sustained Attention to Response Task
The frequency of omission errors (pressing the key when the digit 3 appears) did not differ 
between the groups, nor did the mean RT correct, the pre-error RT, and the difference 
score derived from the mean RT correct and pre-error RT. Thus, at group analysis, no 
difference was found comparing the three groups (Table 3). Formerly eclamptic women 
tended to be slower than controls. However, the difference was not statistically significant. 
To further explore performance in the formerly eclamptic group, specifically, the influence 
of multiple seizures, the subgroup of women who had more than one seizure was compared 
Table 5. Sustained Attention to Response Task results for single and multiple seizures
1 seizure (n = 9) ≥ 2 seizures (n = 12) p-value
Omission errors (n) 9 (3.8) 13 (5.2) 0.06
Mean RT correct (ms) 432 (35.6) 382 (45.8) 0.01
Pre-error RT (ms) 386 (31.8) 362 (37.6) 0.13
RT difference score (ms) 45 (26.5) 20 (25.5) 0.04









Inhibition -0.199 (2.78) -0.458 (4.26) 0.771 (2.88) 0.49
Updating/monitoring 0.644 (1.59) 0.135 (1.77) -0.151 (1.87) 0.31
Results are expressed as mean; standard deviations are noted between parentheses.
Table 6. Random Number Generation task results
≥ 2 seizures (n = 13) Controls (n = 18) p-value
Inhibition -0.041 (2.28) 0.771 (2.88) 0.47
Updating/monitoring 0.504 (1.88) -0.151 (1.87) 0.36
Results are expressed as mean; standard deviations are noted between parentheses.
Table 7. Random Number Generation task for multiple seizures
1 seizure (n = 9) ≥ 2 seizures (n = 13) p-value
Inhibition -0.659 (3.64) -0.041 (2.28) 0.60
Updating/monitoring 0.817 (1.45) 0.504 (1.88) 0.68
Results are expressed as mean; standard deviations are noted between parentheses.
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with controls. However, no significant differences were found (Table 4). Comparing single 
seizures with multiple seizures, the multiple seizure group had a significantly shorter RT 
than the single seizure group, very similar to the control group (Table 5). The decrease 
in RT prior to an error in the multiple seizures group is smaller than in the single seizure 
group and in the other groups, which means that they do not accelerate as much prior to 
making an error.
Random Number Generation
For RNG inhibition and updating/monitoring scores, no significant difference was found 
between the three groups (Table 6). Individual group analysis did not reveal any differences 
either. Comparing RNG inhibition and updating/monitoring scores of controls with the 
subgroup of those formerly eclamptic women who had multiple seizures and comparing 
single seizures with multiple seizures also failed to show statistically significant differences 
(Table 7, Table 8).
Discussion
This pilot study was not able to demonstrate evidence for impairment on elements of 
the working memory, specifically the RNG and SART tasks for sustained attention and 
executive functioning, in formerly eclamptic women on a group level, nor in women who 
experienced multiple seizures. Because one would anticipate the control group to achieve 
the best score, we do not give much credibility to the found differences on the SART mean 
RT and decrease in RT prior to an error between the single and multiple seizures group.
Information about whether women who have experienced eclampsia can expect 
problems with their neurocognitive functioning is important. Several such women 
demonstrate cerebral white matter lesions on MRI weeks to years later.2,5,6 In the general 
elderly population, cerebral white matter lesions have been associated with a decline 
in cognitive functioning and dementia.20,21 Sustained attention, also known as vigilance, 
refers to the capacity to maintain an attentional activity over a period of time. It involves 
the frontal areas of the brain. RNG measures executive functioning, in which prefrontal 
and parietal areas of the brain are involved.
In a recent pilot study, formerly preeclamptic women underwent neuropsychological 
testing 3 to 7 months after delivery and scored significantly lower on most indices of the 
auditory-verbal memory tasks compared with controls.10 In addition, considerably fewer 
words were learned and less recall was demonstrated after interference. In this study, no 
differences were found between formerly preeclamptic women and controls concerning 
tests for attention/concentration and executive functioning. Unfortunately, the sample 
size of that study was very small (n = 10) and did not include formerly eclamptic women. 







WAIS III digit symbol coding task and the Paced Auditory Serial Addition Test for divided 
attention. These women, however, also reported more posttraumatic stress symptoms, and 
after analysis with posttraumatic stress score as a covariate, the differences on the tests 
disappeared.9 Because of the inconsistent results in small groups, it is too early to accept 
the preliminary findings of these pilot studies as a valid reflection of the neurocognitive 
performance in formerly eclamptic women. A difference between the aforementioned 
studies and the study now performed is the interval between pregnancy and the moment 
of testing, which was 3 to 6 months and 6 to 18 months respectively in the other studies 
and was 3 to 19 years postpartum in this study.
The SART and RNG, both frontal lobe tasks, were specifically chosen to study the 
possible neurocognitive consequences of formerly eclamptic women, considering these 
women report complaints of attention and concentration problems.8 However, persistent 
brain lesions in formerly eclamptic women appear to predominantly occur in the posterior 
parietal areas of the brain.2,5,6 It might be that the perceived cognitive dysfunction of 
these women is incongruent with the actual brain lesions. Impairment on several other 
functions might be perceived by such women as attention and concentration problems. 
Alternatively, the presence, severity, and localization of brain white matter lesions in the 
group of formerly eclamptic women might be heterogeneous, making it difficult to detect 
neurocognitive impairment specifically related to certain brain regions.
When interpreting our data, there are several possible explanations for the lack 
of difference between formerly eclamptic women and controls. Obviously, the lack of 
difference may be real, which means that formerly eclamptic women do not demonstrate 
a problem with executive functioning and sustained attention. It may also be very possible 
that our study population was too small to detect any differences on the RNG and SART 
scores and hence a type II statistical error was introduced. However, even though the 
number of patients in this study may appear limited, in the context of the rare incidence 
of eclampsia it represents a sizeable study of which the results are clinically important. As 
was mentioned before, several formerly eclamptic women declined to participate because 
of fear of confrontation with the, often traumatic, experience of eclampsia. Therefore, 
some severe cases might have been missed in this study, which means that significant bias 
could have been introduced.
In conclusion, this pilot study was unable to demonstrate impaired sustained 
attention and executive functioning, important components of the working memory, in 
formerly eclamptic women. However, due to the aforementioned limitations of this study, 
specifically the introduction of a type II error and selection bias, it is not justified to 
extrapolate these results to formerly eclamptic women in general. Sample size calculation 
demonstrated that at least 50 to 100 women in each group are necessary to be able to 
demonstrate a possible significant difference on the individual components of the tests 
(using a difference of 1 for the RNG outcomes and 3 for the SART omission errors), which 
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the cognitive consequences of PRES in eclampsia are necessary and should concentrate 
on neurocognitive tasks of the posterior parietal parts of the brain. Additionally, it is 
interesting to include a group of women who have never been pregnant to elucidate a 
possible effect of pregnancy and motherhood on subsequent neurocognitive functioning 
in and of itself. To further elucidate neurocognitive functioning of formerly eclamptic 
women, studies incorporating larger groups of affected women and controls are needed, 
using a much wider range of different neurocognitive tests, specifically amplified to the 
posterior location of the brain lesions.
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Objective: Women who suffered preeclampsia and eclampsia may report subjective 
cognitive difficulties in daily life, the interpretation of which is cumbersome, since 
these are affected by emotional factors. Previous studies only included preeclamptic 
women investigated shortly after pregnancy. We aimed to determine whether these 
subjective reports of cognitive difficulty could be interpreted as reflecting objective 
cognitive dysfunction. Therefore cognitive functioning was assessed using standardized 
neurocognitive tests in both preeclamptic and eclamptic women several years following 
the index pregnancy.
Methods: 46 formerly eclamptic, 51 formerly preeclamptic and 48 control women who 
had normotensive pregnancies, age-matched, participated in this study. Average elapsed 
time since index pregnancy was 7 years. Neurocognitive tests were divided into 6 domains; 
visual perception, motor functions, working memory, long-term memory, attention and 
executive functioning. Subjective cognitive functioning was measured by the Cognitive 
Failures Questionnaire (CFQ) and anxiety/depression by the Hospital Anxiety and 
Depression Scale (HADS).
Results: Both preeclamptic and eclamptic women performed worse on the motor functions 
domain (p < 0.05), without differences on the other domains. They scored worse on the 
CFQ (p < 0.01), the HADS anxiety (p < 0.01), and depression (p < 0.05) scales.
Conclusions: Women who suffered eclampsia and/or preeclampsia demonstrate no 
objective cognitive impairment as compared to controls. Contrary to the well-structured 
test setting, both groups do report more cognitive failures, which are thought to reflect 
neurocognitive dysfunction in complex, stressful daily-life situations. Such report 
of cognitive failures may be compounded by anxiety and depression. Future studies 








NeurocogNitive fuNctioNiNg followiNg preeclampsia aNd eclampsia
Introduction
Women who suffered preeclampsia and/or eclampsia report cognitive problems years 
following the index pregnancy.1,2 Although the actual prevalence of subjective cognitive 
difficulties is unknown, they appear to be related to memory, concentration and vision-
related tasks of everyday life.1-4 
In general, the validity of such subjective reports of cognitive functioning 
remains controversial, since they are also strongly influenced by non-cognitive factors, 
such as symptoms of anxiety and depression.5,6 Preeclamptic women may exhibit such 
psychopathology following the experience of a complicated pregnancy.7-9 Alternatively, 
women who suffered (pre)eclampsia may have structural brain abnormalities, such as 
white matter lesions, potentially causing neurocognitive dysfunction.10-14
Two small studies evaluated neurocognitive test performance in preeclamptic (but 
not eclamptic) women within 1.5 years following the index pregnancy and found impairment 
on some, but not on all cognitive tests.8,15 Another small study found no evidence for 
impaired executive functioning and sustained attention.16
Since longer follow-up of neurocognitive performance is lacking, we aimed to study 
cognitive functioning in a relatively large group of women who suffered preeclampsia and 
eclampsia using standardized neurocognitive tests and relate this to self-reported cognitive 
dysfunction and measures of anxiety and depression. We hypothesized that eclamptic 
women will demonstrate worse performance compared to preeclamptic women, and that 
both groups would perform worse than controls. Since other studies focused on more limited 
subdomains of cognitive functioning, we chose to cover a broader range of neurocognitive 
functions including tasks associated with the posterior brain areas (e.g. visual functioning 
tasks) as well as the frontal brain areas (e.g. attention and executive functioning).
Methods
Participants
All eclamptic, preeclamptic and control women with normotensive pregnancies, who 
were enrolled in a previous follow-up study, received a new invitation.10,11 Recruitment 
and selection criteria have been published previously.10,11,14 Eclampsia and preeclampsia 
were defined according to international criteria.17 Preeclampsia was defined as de novo 
hypertension after 20 weeks’ gestation and properly documented proteinuria. Eclampsia 
was defined as new onset of seizures in women with preeclampsia. Early-onset (pre)
eclampsia was defined as indicated delivery before 34 weeks’ gestational age. Medical 
records were reviewed for accurateness of diagnosis and to extract clinical and demographic 
characteristics. This project was approved by the University Medical Center Groningen 







performed between November 2008 and January 2012.
Exclusion criteria were epilepsy, a known cerebrovascular accident, demyelinating 
disorders, intracranial infections, a history of any cranial neurosurgical procedure, 
the inability to understand Dutch or pregnancy at the moment of testing. Women who 
indicated the presence of a mood disorder were not excluded. For all women, elapsed 
time since the index pregnancy had to be at least 12 months. Of the 63 eclamptic women 
who participated in the previous studies,10,11,14 48 (76%) could be contacted again and were 
willing to participate in the present study. Of the 74 preeclamptic and 75 parous control 
participants participating in previous studies,10,11,14 respectively 47 (64%) and 43 (57%) 
could be contacted again and were willing to participate. Four preeclamptic women who 
delivered in other hospitals and who had heard about the study requested to participate 
in the current study, which was allowed. Six additional control participants were included. 
During the study, 2 eclamptic women were excluded as they showed signs of malingering or 
underachievement. This was evaluated by the Amsterdam Short-Term Memory (ASTM) test, 
a symptom validation test presented as a short-term memory task.18,19 The ASTM test is a 
valid, standardized and widely used test to indicate malingering. Excluding these women 
did not significantly alter the results. 1 control was excluded because she had professional 
knowledge of the neurocognitive tasks. 46 eclamptic women, 51 preeclamptic women and 
48 controls remained available for analysis.








Age (y) 39 (6.5) 39 (6.7) 40 (7.3) 0.56
Caucasian 44 (96%) 51 (100%) 46 (96%) 0.40
Elapsed time since 
index pregnancy (y) 8 (2-20) 6 (1-18) 6 (1-27) 0.02





EGA at delivery (wk) 32 (22-42+1) 34+4 (26+2-41) 40 (36+2-40+2) < 0.01
SGA < 10th percentile 14 (30%) 20 (39%) 4 (8%) < 0.01
Early-onset (pre)eclampsia 
< 34 wk 28 (61%) 24 (47%)
Nulliparous at  index 
pregnancy 40 (87%) 34 (67%) 21 (44%) < 0.01
Level of education
Average 18 (39%) 24 (47%) 18 (38%)
0.59
High 28 (61%) 27 (54%) 30 (63%)
DART IQ 99 (11.1) 98 (10.7) 99 (10.5) 0.87
Antidepressants (n) 0 (0%) 6 (12%) 2 (4%) 0.99
Results are expressed as mean (SD), median (min-max) or number (percentage). EGA = Estimated 
gestational age, SGA = Small for gestational age, DART = Dutch Adult Reading Test.
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level was categorized according to the system of Verhage as described by Bouma in 2012 
(1 being the lowest (less than primary school), and 7 the highest (academic degree, such as 
bachelor/master)).19 None of the women were in the low education group (category 1 en 2). 
Average was defined as category 3-5 and high as category 6-7. The Dutch Adult Reading Test 
(DART; Dutch version of the National Adult Reading Test) was used to determine premorbid 
intelligence.19,20 The DART is a valid, standardized test based on the assumptions that 
reading ability (of irregular words) is relatively independent of brain disorders, and that it 
is a strong predictor of intelligence in the normal population.19,20 No significant difference 
was found between the groups. One participant had sufficient knowledge of the Dutch 
language to fulfil the tasks, but the DART could not be administered. Another participant 
was unable to complete the DART due to dyslexia. The population in the northern part of 
the Netherlands is predominantly Caucasian, as was our study population.
Cognitive failures questionnaire (subjective cognitive functioning)
The Cognitive Failures Questionnaire (CFQ) evaluates the number of errors committed in 
the completion of daily tasks.21 Subjects were asked to complete the questionnaire based 
on their experiences in the past 6 months. The CFQ consists of 25 items, each scored on a 
5-point scale (0-4). The total scale ranges from 0-100, with higher scores indicating more 
cognitive failures. A cut-off point for the CFQ total score based on the Dutch population 
was set at 44.22 Three subscales, Forgetfulness (8 items), Distractibility (8 items) and False 
Triggering (8 items) were derived.23 Forgetfulness is defined as a tendency to let go from 
one’s mind something known or planned. It includes questions like “Do you read something 
and find you haven’t been thinking about it and must read it again?” Distractibility pertains 
to social situations or interactions with other people such as being absentminded or easily 
disturbed and contains questions like “Do you fail to hear people speaking to you when you 
are doing something else?” False triggering pertains to interrupted processing of sequences 
of cognitive and motor actions and contains questions like “Do you fail to notice signposts 
on the road?”
Neuropsychological tests (objective measures of cognitive functioning)
Participants completed a battery of 16 standardized, reliable and valid neuropsychological 
tests divided into 6 cognitive domains.19,24 These tests are sensitive to cognitive impairment 
and have been validated in different populations (normal subjects, neurological and 
psychiatric patients) using different methods (e.g. correlational and factor-analytic 
studies as well as neuroimaging studies). Each cognitive domain consisted of verbal and 
non-verbal tasks. Tests were administered in a fixed sequence according to standardized 
instructions for each measure by two advanced doctoral students who were well-trained 







10-minute break halfway). Measures were scored in a standardized fashion outlined in the 
administration manual of each test.
Visual perception
Visual perception was measured using a Dutch Incomplete Figures Test (GIT-2).25 Visual 
processing speed was measured using the Digit Symbol Coding (WAIS-III-NL) test, Symbol 
Search (WAIS-III-NL)26 test and the Dutch Stroop Color-Word Test part 1 (Word Reading) and 
part 2 (Color Naming).27
Motor functions
Visuomotor speed was measured using the Grooved Pegboard Test28 for both the dominant 
and non-dominant hand and the Trail Making Test part 5 (Motor Speed; Delis-Kaplan 
Executive Function System (D-KEFS)).29
Working memory (WM)
Visuospatial WM was assessed using the Corsi Block-Tapping Test (backward and forward 
version), a total product score was derived from the number of correct sequences and 
the block span.30 The task is considered a non-verbal analog to Digit Span (WAIS-III-NL), 
which was used to measure verbal WM together with the Letter-Number Sequencing Test 
(WAIS-III-NL).26
Long-term Memory (LTM)
Visuospatial LTM was assessed by the Dutch version of the Location Learning Test 
(administration procedure II).31 A total score was derived. Verbal LTM was measured by the 
Dutch version of the Rey Auditory Verbal Learning Test32 in which subjects had to learn 15 
words in five successive trials. A total score was derived.
Attention
Part 1 (Visual Scanning), part 2 (Number Sequencing) and part 3 (Letter Sequencing) of 
the Trail Making Test (D-KEFS) were used to measure attention.29 These conditions were 
designed to quantify key component skills that are required for performing the Number-
Letter Switching condition described below.
Executive functioning
Inhibitory control was assessed by part 3 (Inhibitory Control) of the Dutch Stroop Color-
Word Test.27 Part 4 of the Trail Making Test (Number-Letter Switching) is similar to ‘Part B’ 
of the original Trail Making Test.29,33 It measures divided attention and cognitive flexibility. 
Fluency tasks consisted of the Verbal Fluency Test (animals and professions) and the Figure 
Fluency Test (Dutch version of the Ruff Figure Fluency Test) for visuospatial fluency.34,35 
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The Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) is a self-report screening scale which 
entails 14 items scored on a 4-point scale (0-3).36 Items were divided into two subscales: 
anxiety and depression, each with a maximum score of 21, with higher scores indicating 
more symptoms.
Statistical analyses
Statistical analysis was performed using IBM Statistical Package for the Social Sciences 
version 20 for Windows (IBM inc., Chicago IL, USA). Raw test scores were used. Data were 
checked for normalcy of distribution using distribution curves, Shapiro-Wilk test and 
Levene’s test for homogeneity of variance. Small deviations from a normal distribution 
due to an outlier were accepted. For measures (Trail Making Test) that were not-normally 
distributed, logarithmic transformation was employed. There were no differences in 
outcomes between these transformations and non-parametric tests. Patient characteristics 
were analyzed using Kruskall-Wallis test for non-normally distributed data and χ2 test for 
categorical data. Antidepressant use was analyzed using Fisher’s exact test comparing both 
patient groups to controls. Single imputation was used to replace two missing values in the 
questionnaire (due to a missed question) and two missing values (due to missing test forms) 
in the tests using estimated means for the whole group. Mean and median values were 
calculated before and after imputation to ensure the absence of differences. CFQ and HADS 
outcomes were analyzed using One-way ANOVA, corrected for elapsed time since index 
pregnancy, and χ2 test for cut-off scores. Significant outcomes were further analyzed using 
a Helmert contrast (which compares a level to the mean of subsequent levels, i.e. controls 
vs. preeclampsia/eclampsia and preeclampsia vs. eclampsia), because we hypothesized 
that both the preeclamptic and the eclamptic group would score worse than controls, 
and the eclamptic group was expected to score worse compared to the preeclamptic 
group. Pearson’s correlation coefficient was used to describe the relationship between 
the CFQ and the HADS scores. Multivariate analysis using MANOVA was performed on the 
different neurocognitive test domains, corrected for elapsed time since index pregnancy. 
Significant MANOVA results were subsequently tested using univariate analysis (ANOVA). 
Effect sizes (partial η2) were calculated in order to estimate the strength of significant 
effects between groups.37 An effect size of partial η2 = 0.01 was defined as small, η2 = 0.06 
as medium and η2 = 0.14 as large.37 In order to detect a medium effect size of  η2 = 0.06 
on the multivariate analysis of the test domains for 3 groups, with a power of 0.80 and 
α of 0.05, inclusion of 33 (2 test measures) to 45 women (5 test measures) in each group 
was needed.38 Multivariable linear regression analyses with backward stepwise inclusion 
with test outcomes as the dependent variables were performed with group (controls vs. 







(HADS) total score as predictors. We checked for the effect of elapsed time by adding this 
factor as predictor, however, elapsed time did not significantly change the outcomes of the 
other predictors. Differences were considered statistically significant at p < 0.05.
Results
Participants
In total, 46 eclamptic women, 51 preeclamptic women and 48 controls were available 
for analysis. As shown in Table 1 and as expected, there was a significant difference in 
gestational age at delivery, birth weight and the number of small for gestational age 
children between the groups. Elapsed time since index pregnancy was slightly longer in 
the eclamptic group compared to the preeclamptic group and controls. Since women with 
early-onset (pre)eclampsia did not show different results compared to women with late-
onset (pre)eclampsia, results for this subgroup are not separately discussed.
Cognitive failures questionnaire (subjective cognitive functioning)
When comparing the three groups, significant differences were found for the CFQ total 
score and the subscales Forgetfulness, Distractibility and False Triggering (Table 2). Using 
Helmert contrast, scores were significantly worse for preeclamptic and eclamptic women 
vs. controls (p < 0.01), but not between preeclamptic and eclamptic women. The effect size 
statistics indicate moderate effects. As shown in Figure 1, significantly more preeclamptic 
and eclamptic women compared to controls scored a considerable number of cognitive 








F(2, 142) Effect size 
(partial η²)
p-value
Cognitive failures questionnaire (CFQ)
Total score 43 (16.4) 47 (15.8) 36 (11.0) 6.91 0.089 < 0.001
Forgetfulness 16 (5.8) 18 (6.1) 13 (4.1) 8.37 0.104 < 0.001
Distractibility 14 (5.8) 15 (5.8) 12 (3.6) 4.34 0.059 0.01
False triggering 12 (5.2) 13 (5.0) 9 (3.9) 7.40 0.095 < 0.001
Hospital anxiety and depression scale (HADS)
Total score 12 (6.6) 11 (5.8) 8 (5.5) 6.20 0.081 < 0.005
Anxiety 7 (3.8) 6 (3.4) 5 (3.1) 6.08 0.077 < 0.005
Depression 5 (3.5) 4 (3.4) 3 (2.9) 3.87 0.054 0.02
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total score was 0.93, 0.86 for the subscale Forgetfulness, 0.84 for Distractibility and 0.83 
for False Triggering, indicating good reliability.
Anxiety and depression
Significant differences were found for the HADS total score, anxiety and depression 
subscales, as shown in Table 2. Using Helmert contrast, eclamptic and preeclamptic women 
had similar scores, but significantly worse compared to controls (p < 0.01). The effect size 
statistics indicate moderate effects. Cronbach’s α was 0.81 for the HADS Anxiety subscale 
and 0.80 for the Depression subscale. Anxiety and depression subscales were strongly 
correlated (0.62).
Neuropsychological tests
Multivariate analysis of neuropsychological test domains only revealed a significant result 
for motor functions (p < 0.05) (Table 3) due to a significant difference in visuomotor speed 
measured by the Trail Making Test part 5 (D-KEFS) (p < 0.001). The effect size statistics 
indicate small effects except for a medium effect in visuomotor speed. Further analysis 
of visuomotor speed using Helmert contrast showed that eclamptic women scored worse 
than preeclamptic women (p < 0.05) and that both patient groups scored worse compared 
to controls (p < 0.01).

































Percentage of formerly preeclamptic and eclamptic women and 
controls with high Cognitive Failures Questionnaire (CFQ) score (cut-




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Relationship between CFQ and HADS
Significant correlations between the CFQ total score and the HADS anxiety (0.37) and 
depression (0.54) scores were found in the total group of participants (p < 0.05 for all 
coefficients).
Multivariable regression analysis
Multivariable linear regression analyses with backward stepwise inclusion with test 
outcomes as the dependent variables were performed with group (controls vs. preeclampsia 
and eclampsia), subjective cognitive failures (CFQ) and anxiety/depression (HADS) total 
score as predictors. Elapsed time since index pregnancy did not significantly change the 
outcomes of the other predictors. We found that CFQ score was associated with WAIS-III 
Symbol Search (β = -0.22, p < 0.01), Trail Making Test part 1 (β = 0.21, p = 0.01), Grooved 
Pegboard score non-dominant hand (β = 0.20, p = 0.02), Dutch Incomplete Figures Test 
(β = 0.22, p = 0.02), Stroop Color-Word Test part 2 (β = 0.17, p = 0.04) and part 3 (β = 0.24, 
p = 0.003) and the Tower Test (β = 0.18, p = 0.06). HADS total score was associated with 
the Corsi Block-Tapping Test (β = -0,17, p = 0.04), Dutch Incomplete Figures Test (β = -0.29, 
p = 0.003), Tower Test (β = -0.27, p = 0.004) and the WAIS-III Letter-Number Sequencing Test 
(β = -0.23, p = 0.006). Group (controls vs. preeclampsia and eclampsia) was not significantly 
associated with any of the tests, meaning that women with preeclampsia scored similar to 
controls, but for the Trail Making Test part 5 (β = 0.26, p = 0.001), as was shown previously 
in the multivariate analyses (MANOVA).
Discussion
This study aimed to assess cognitive functioning using standardized neurocognitive tests 
in a relatively large group of both formerly preeclamptic and eclamptic women with an 
average follow-up of 7 years. Aside from minor slowing in motor speed, no differences were 
seen in objective measures of visual perception, working memory, long-term memory, 
attention and executive functioning as compared to controls. Preeclamptic as well as 
eclamptic women reported significantly more cognitive failures in daily life and scored 
significantly higher for anxiety and depression, factors which were associated with some, 
but not all neurocognitive tests. There was no effect of early-onset (pre)eclampsia.
Objective cognitive functioning was the primary outcome of this study. No objective 
cognitive impairment besides a slightly slower visuomotor speed was found in (pre)
eclamptic women compared to controls. Women with eclampsia did not demonstrate worse 
performance than preeclamptic women. Our findings are consistent with our previous 
study assessing executive functioning and sustained attention in formerly (pre)eclamptic 
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women, did not show impaired performance on the majority of neurocognitive tests, except 
for a significantly lower score on an auditory-verbal memory task15, on the Digit Symbol 
Coding Test (WAIS-III) and the Paced Auditory Serial Addition Test (divided attention), 
which were explained by a difference in posttraumatic stress symptoms.8
The present study found no differences in neurocognitive test results, although there 
was a difference in CFQ score, a measure of self-reported cognitive failures representing 
daily life conditions. A possible explanation for this lack of agreement between objective 
neurocognitive tests and subjective cognitive failures is that subtle cognitive differences 
between (pre)eclamptic women and controls may not come to surface in a well-structured 
test setting. Such test setting is usually quiet with few distractions, there are clear time 
points for task initiation and completion, and the subject is asked to complete one task 
at a time. This is in contrast with daily-life challenges, which are usually unstructured 
with numerous distractions, all of which require significant cognitive flexibility as well as 
cognitive self-evaluation and executive control of behavior.39-42
The CFQ was developed as a valid self-report instrument to measure the tendency 
to make mistakes in everyday life. In this study, the CFQ score did show an association 
with scores on tests measuring visual perception, visuomotor speed, attention and 
executive functioning, which suggests that the CFQ is indeed related to objective cognitive 
functioning. On the other hand, we found that the CFQ strongly relates to anxiety and 
depression. Anxiety and depression were present to a larger extent in (pre)eclamptic 
women as compared to controls. In the literature, executive functioning, or the control 
of complex, goal-directed behavior is the cognitive ability, which is most susceptible to 
stress.39-42 As a consequence, women with (pre)eclampsia who indicate more anxiety and 
more depressive symptoms may therefore be more vulnerable for cognitive failures in 
complex, and perhaps more stressful daily life conditions compared to controls.43 The 
prevalence of posttraumatic stress disorder seems to be increased following a preeclamptic 
pregnancy, even after several years.44-46 Moreover, anxiety and depression in women who 
suffered (pre)eclampsia may be a cause, rather than a consequence of experiencing long-
lasting cognitive failures in daily life. It is possible that symptoms of anxiety and depression 
were already present prior to the index pregnancy, but these were not specifically asked 
for when including patients into the study. Both depression and anxiety in early pregnancy 
seem to be associated with the subsequent development of preeclampsia (odds-ratio of 
2.5 and 3.2 respectively).47 The precise biochemical mechanism behind this course of 
events remains speculative: distress conditions during pregnancy may directly change the 
hypothalamic-pituitary (HPA) axis resulting in increased cortisol levels and concomitant 
changes in cellular immunity, associated with hypertension and endothelial dysfunction.48
Alternatively, women who suffered eclampsia or preeclampsia more often 
demonstrate cerebral white matter lesions on long-term follow-up MRI compared to parous 
control women.10,11 One could expect that the presence of such lesions may influence both 







subjective complaints at a relatively young age appear to be related to cerebral structural 
abnormalities, such as white matter lesions, and cognitive decline in later life.5,6,49 
Therefore, it cannot be excluded that the cognitive complaints found in this study are 
related to white matter lesions, even in patients who did not show objective cognitive 
disturbances.
The main strength of this study is that it is, to date, the largest study with well-
defined groups of formerly preeclamptic and eclamptic women to report both subjective 
cognitive functioning and standard neurocognitive test results in the long-term and relate 
these to emotional factors such as anxiety and depression. There are several limitations 
to this study, one of which is the lack of pre-pregnancy information on neurocognitive 
functioning. In view of the rare incidence of eclampsia, a prospective study design is 
not feasible. Second, approximately 70% of the women who participated in the study of 
Aukes et al.10,11 could be contacted again and were willing to participate in the study now 
reported which may have given rise to selection bias. However, most non-participating 
women could not be contacted because of change of address and/or phone number. Other 
non-participating women mentioned the time and travel burden as the main reason not to 
participate, although some declined because of fear of confrontation with the traumatic 
experience of their complicated pregnancy. Third, the wide range in elapsed time since 
index pregnancy reflects the rare incidence of eclampsia. Despite careful matching, 
elapsed time since index pregnancy was slightly longer in eclamptic women, however, 
controlling for elapsed time did not significantly alter the results. Fourth, the effect of 
subsequent pregnancies following the index pregnancy can not be excluded. Nine women 
had preeclampsia during a subsequent pregnancy. Last, it was not possible to reliably 
recruit more previously eclamptic women into this study. In the context of the rare 
incidence of eclampsia this represents a sizeable study showing results which are clinically 
important.
In summary, formerly preeclamptic and eclamptic women do not show clear 
neurocognitive impairment years after the index pregnancy but for minor slowing in 
motor speed. They express cognitive failures that are thought to reflect neurocognitive 
dysfunction in complex, and stressful daily-life situations. Such report of cognitive failures 
may be compounded by symptoms of anxiety and depression. Indeed, the CFQ may be 
interpreted as a measure of executive control of behavior, in which people with anxiety 
and depression experience cognitive failures mainly in complex and stressful daily life 
events.40 In this scheme high levels of stress hormones seem detrimental for executive 
control and make a person susceptible for cognitive failures.41 Moreover, they might be 
an indicator for development of cognitive dysfunction at older age. Either way, subjective 
cognitive difficulties in such a young cohort of women should be taken seriously and these 
women deserve long-term follow-up.
Future studies should focus on the relationship between subjective and objective 
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lesions. Follow-up studies (i.e. 20-30 years) would provide insight whether there is a 
relationship between (pre)eclampsia and subjective cognitive difficulties earlier in life and 
dementia and cerebrovascular disease later in life.
Acknowledgements







1. Aukes AM, Wessel I, Dubois AM, Aarnoudse JG, Zeeman GG. Self-reported cognitive 
functioning in formerly eclamptic women. Am J Obstet Gynecol 2007; 197: 365.e1-6.
2. Postma IR, Groen H, Easterling TR Tsigas EZ, Wilson ML, Porcel J, et al. The brain study: 
Cognition, quality of life and social functioning following preeclampsia; an observational 
study. Pregnancy Hypertens 2013;3:227-34.
3. Andersgaard AB, Herbst A, Johansen M, Borgström A, Bille AG, Øian P. Follow-up interviews 
after eclampsia. Gynecol Obstet Invest 2009;67:49-52.
4. Wiegman MJ, De Groot JC, Jansonius NM, Aarnoudse JG, Groen H, Faas MM, et al. Long-
term visual functioning after eclampsia. Obstet Gynecol 2012;119:959-66.
5. Van Doorn RRA, Lang JWB, Weijters T. Self-reported cognitive failures: A core self-
evaluation? Pers Indiv Differ 2010;49:717-22.
6. Haley AP, Hoth KF, Gunstad J, Paul RH, Jefferson AL, Tate DF, et al. Subjective cognitive 
complaints relate to white matter hyperintensities and future cognitive decline in patients 
with cardiovascular disease. Am J Geriatr Psychiatry 2009;17:976-85.
7. Stramrood CA, Wessel I, Doornbos B, Aarnoudse JG, van den Berg PP, Schultz WC, et al. 
Posttraumatic stress disorder following preeclampsia and PPROM: A prospective study with 
15 months follow-up. Reprod Sci 2011;18:645-53.
8. Baecke M, Spaanderman ME, Van der Werf SP. Cognitive function after pre-eclampsia: An 
explorative study. J Psychosom Obstet Gynaecol 2009;30:58-64.
9. Gaugler-Senden IP, Duivenvoorden HJ, Filius A, De Groot CJ, Steegers EA, Passchier J. 
Maternal psychosocial outcome after early onset preeclampsia and preterm birth. J Matern 
Fetal Neonatal Med 2012;25:272-6.
10. Aukes AM, De Groot JC, Aarnoudse JG, Zeeman GG. Brain lesions several years after 
eclampsia. Am J Obstet Gynecol 2009;200:504.e1-5.
11. Aukes AM, De Groot JC, Wiegman MJ, Aarnoudse JG, Sanwikarja GS, Zeeman GG. Long-term 
cerebral imaging after pre-eclampsia. BJOG 2012;119:1117-22.
12. Zeeman GG. Neurologic complications of pre-eclampsia. Semin Perinatol 2009; 33:166-72.
13. Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG. Cerebral infarction in eclampsia. 
Am J Obstet Gynecol 2004;190:714-20.
14. Wiegman M, Zeeman G, Aukes A, Faas M, Aarnoudse J, de Groot J. Regional distribution 
of cerebral white matter lesions years after preeclampsia and eclampsia. Obstet Gynecol 
2014; In Press.
15. Brussé I, Duvekot J, Jongerling J, Steegers E, De Koning I. Impaired maternal cognitive 
functioning after pregnancies complicated by severe pre-eclampsia: A pilot case-control 
study. Acta Obstet Gynecol Scand 2008;87:408-12.
16. Postma IR, Wessel I, Aarnoudse JG, Zeeman GG. Neurocognitive functioning in women 
with a history of eclampsia: Executive functioning and sustained attention. Am J Perinatol 
2010;27:685-90.
17. Brown MA, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, 
diagnosis and management of the hypertensive disorders of pregnancy: A revised statement 
from the ISSHP. Pregnancy Hypertens 2014 In Press.
18. Schmand B, De Sterke S, Lindeboom J. Amsterdamse Korte Termijn Geheugen Test. 








NeurocogNitive fuNctioNiNg followiNg preeclampsia aNd eclampsia
19. Bouma A, Mulder J, Lindeboom J, Schmand B. Handboek Neuropsychologische Diagnostiek. 
2nd ed. Amsterdam:Pearson Assessment and Information B.V.; 2012.
20. Schmand B, Lindeboom J, Van Harskamp F. De Nederlandse Leestest Voor Volwassenen. 
Amsterdam: Pearson Assessment and Information B.V.; 1992.
21. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire 
(CFQ) and its correlates. Br J Clin Psychol 1982;21:1-16.
22. Ponds R, Van Boxtel MPJ, Jolles J. De Cognitive Failures Questionnaire als maat voor 
subjectief cognitief functioneren. Tijdschrift Voor Neuropsychologie 2006;1:37-45.
23. Rast P, Zimprich D, Van Boxtel M, Jolles J. Factor structure and measurement invariance of 
the Cognitive Failures Questionnaire across the adult life span. Assessment 2009;16:145-58.
24. Lezak MD, Howieson DB, Loring DW. Neuropsychological assessment. 5th ed. Oxford: Oxford 
University Press. 2012.
25. Luteijn F, Barelds DPH. Herziening Van De GIT. Handleiding Bij De GIT-2. Amsterdam: 
Pearson Assessment and Information B.V.; 2004.
26. Wechsler D. WAIS-III-NL: Nederlandstalige Bewerking: Technische Handleiding (Herziene 
Uitgave). Amsterdam:Pearson Assessment and Information B.V.; 2005.
27. Hammes JG. De Stroop Kleur-Woord Test. Handleiding. Amsterdam:Pearson Assessment and 
Information B.V.; 1971.
28. Matthews CG, Klove H. Instruction Manual for the Adult Neuropsychology Test Battery. 
Madison:University of Wisconsin Medical School; 1964.
29. Delis DE, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System (D-KEFS). 
Amsterdam:Pearson Assessment and Information B.V.; 2007.
30. Kessels RP, Van Zandvoort MJ, Postma A, Kappelle LJ, De Haan EH. The Corsi Block-tapping 
task: Standardization and normative data. Appl Neurophysiol 2000;7:252-8.
31. Kessels RPC, Buck RS, Willison JR, Byrne LMT. Location Learning Test - Herziene Uitgave. 
Amsterdam:Hogrefe Uitgevers; 2012.
32. Saan RJ, Deelman BG. De 15-Woorden Tests A En B. Groningen:Afdeling Neuropsychologie, 
UMCG.; 1986.
33. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. 
Tucson:Neuropsychology Press.; 1985.
34. Mulder JL, Dekker PH, Dekker R. Woord-Fluency Test/Figuur-Fluency Test. Leiden:PITS 
Uitgeverij B.V.; 2006.
35. Ruff RM. Ruff Figural Fluency Test: Professional Manual. Lutz:Psychological Assessment 
Resources, Inc.; 1996.
36. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation 
study of the hospital anxiety and depression scale (HADS) in different groups of Dutch 
subjects. Psychol Med 1997;27:363-70.
37. Fritz CO, Morris PE, Richler JJ. Effect size estimates: current use, calculations, and 
interpretation. J Exp Psychol Gen 2012;141:2-18. 
38. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis 








39. Chaytor N, Schmitter Edgecombe M. The ecological validity of neuropsychological tests: A 
review of the literature on everyday cognitive skills. Neuropsychol Rev 2003;13:181-97.
40. Van der Linden D, Keijsers GP, Eling P, Van Schaijk R. Work stress and attentional difficulties: 
An initial study on burnout and cognitive failures. Work Stress 2005;19:23-36.
41. Day AJ, Brasher K, Bridger RS. Accident proneness revisited: the role of psychological stress 
and cognitive failure. Accid Anal Prev 2012;49:532-5
42. Bridger RS, Johnsen SÅ, Brasher K. Psychometric properties of the Cognitive Failures 
Questionnaire. Ergonomics 2013;56:1515-24.
43. Arnsten AF. Development of the Cerebral Cortex: XIV Stress Impairs Prefrontal Cortical 
Function. J Am Acad Child Adolesc Psychiatry 1999;38:220-2.
44. Engelhard IM, Van Rij M, Boullart I, Ekhart TH, Spaanderman ME, van den Hout MA, et 
al. Posttraumatic stress disorder after pre-eclampsia: An exploratory study. Gen Hosp 
Psychiatry 2002;24:260-4.
45. Van Pampus MG, Wolf H, Weijmar Schultz WC, Neeleman J, Aarnoudse JG. Posttraumatic 
stress disorder following preeclampsia and HELLP syndrome. J Psychosom Obstet Gynaecol 
2004;25:183-7.
46. Porcel J, Feigal C, Poye L, Postma IR, Zeeman GG, Olowoyeye A, et al. Hypertensive 
disorders of pregnancy and risk of screening positive for Posttraumatic Stress Disorder: A 
cross-sectional study. Pregnancy Hypertens 2013;3:227-34.
47. Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O. Depression and anxiety in early 
pregnancy and risk for preeclampsia. Obstet Gynecol 2000;95:487-490.
48. Vianna P, Bauer ME, Dornfeld D, Chies JA. Distress conditions during pregnancy may lead 
to pre-eclampsia by increasing cortisol levels and altering lymphocyte sensitivity to 
glucocorticoids. Med Hypotheses 2011;77:188-91. 
49. Stewart R, Godin O, Crivello F, Maillard P, Mazoyer B, Tzourio C, et al. Longitudinal 
neuroimaging correlates of subjective memory impairment: 4-year prospective community 







NeurocogNitive fuNctioNiNg followiNg preeclampsia aNd eclampsia

6
CEREBRAL WHITE MATTER 
LESIONS AND NEUROCOGNITIVE 
FUNCTIONING IN FORMERLY 
















Objective: Women who suffered (pre)eclampsia report cognitive dysfunction but are not 
impaired on objective neurocognitive tests several years later. Eclamptic and preterm 
preeclamptic women more often have brain white matter lesions (WML) on follow-up 
compared to women who had a normotensive pregnancy. We aimed to determine whether 
WML presence is related to subjective/objective cognitive dysfunction, anxiety and 
depression in (pre)eclamptic women.
Methods: 41 eclamptic, 49 preeclamptic and 47 control women who had a normotensive 
pregnancy completed the Cognitive Failures Questionnaire (CFQ), the Hospital Anxiety and 
Depression Scale (HADS) and neurocognitive tests for visual perception, motor functions, 
working memory, long-term memory, attention and executive functioning. All underwent 
brain MRI. Median elapsed time since index pregnancy was 6 years.
Results: Average age was 40. WML were more prevalent in women who had suffered preterm 
(pre)eclampsia (40%) compared to controls (21%). CFQ/HADS scores were significantly 
higher in (pre)eclamptic women (44 ± 16.1/11 ± 6.3) compared to controls (36 ± 11.0/ 
8 ± 5.5), but not associated with WML presence. Women with WML or (pre)eclampsia did 
not score worse on neurocognitive tests.
Conclusions: Brain WML are more prevalent and more cognitive failures are reported 
following (pre)eclampsia. WML do not seem related to subjective/objective cognitive 
functioning nor anxiety/depression at on average 6 years follow-up. Women with symptoms 
of anxiety/depression may experience cognitive failures in complex and stressful daily 
life events. This does however not exclude the possibility for development of cognitive 







Cerebral white matter lesions and neuroCognitive funCtioning
Introduction
Formerly preeclamptic and eclamptic women report cognitive dysfunction, related to 
memory, concentration and vision-related tasks of everyday life,1-5 but these women do not 
exhibit overt cognitive impairment when objectively tested several years following their 
pregnancy.5 Subjective cognitive complaints may reflect actual neurocognitive dysfunction 
in complex daily life situations in which there is less structure and numerous distractions, 
requiring more flexibility compared to a quiet, structured test setting. In the elderly, 
cognitive complaints are an early indicator for cognitive decline in later life.6-8 Subjective 
cognitive complaints may therefore reflect early changes in cognitive functioning that are 
not yet detectable using cognitive tests.
Subjective cognitive complaints may be related to emotional factors. (Pre)
eclamptic women report more anxiety and depression,5,9 and more often seem to develop 
posttraumatic stress disorder10 which may persist for several years.11 Self-reported cognitive 
problems may be interpreted as a measure of executive control of behavior, in which 
people with anxiety and depression experience cognitive failures mainly in complex and 
stressful daily life events.12
In the elderly, both depression13 and subjective cognitive complaints were found 
to be related to cerebral structural abnormalities, such as white matter lesions (WML), 
even in the absence of cognitive impairment in a test setting6-8. Eclamptic women and 
women who suffered preterm preeclampsia more often have WML on long-term follow-
up compared to control women who had a normotensive pregnancy.14,15 The significance 
of WML in women who suffered preeclampsia is currently unknown and studies on the 
association between WML and cognitive functioning in women following a preeclamptic 
pregnancy have not been reported.
This study aimed to determine whether the presence of WML in formerly eclamptic 
and preeclamptic women is related to 1) measures of objective cognitive functioning and 2) 
perceived cognitive dysfunction and anxiety and depression as reported in a questionnaire.
Methods
Subjects
All formerly eclamptic, preeclamptic and control women with normotensive pregnancies, 
who were enrolled in a previous follow-up study, received an invitation to participate 
in the study now reported.5,14-16 Recruitment and selection criteria have been published 
previously.5,14-16 Eclampsia and preeclampsia were defined according to international 
criteria.17 Preterm (pre)eclampsia was defined as medically indicated delivery before 37 
weeks of gestational age. Medical records were reviewed for accuracy of diagnosis and 







a brief questionnaire concerning basic demographic characteristics and medical history. 
Neurocognitive measurements were performed between November 2008 and January 
2012, whereas neuroimaging studies were performed between July 2005 and January 2012.
Exclusion criteria were epilepsy, a known cerebrovascular accident, demyelinating 
disorders, a history of intracranial infection or any cranial neurosurgical procedure, the 
inability to understand Dutch, MRI contraindications or pregnancy at the moment of testing. 
For all women, elapsed time since the index pregnancy had to be at least 12 months. 
41/46 (89%) eclamptic women, 49/51 (96%) formerly preeclamptic women and 47/48 (98%) 
controls who participated in the neurocognitive test battery5 also underwent MR imaging. 
This project was approved by the University Medical Center Groningen Institutional Review 
Board and all women signed informed consent.
Cognitive failures questionnaire (subjective cognitive functioning)
The Cognitive Failures Questionnaire (CFQ) evaluates cognitive failures committed in the 
completion of daily tasks.18 Subjects were asked to fill out the questionnaire based on their 
experiences in the past 6 months. The CFQ consists of 25 items, each scored on a 5-point 
scale (0-4). The total scale ranges from 0-100, with higher scores indicating more cognitive 
failures.
The Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) is a self-assessment scale, developed to 
detect states of depression, anxiety and emotional distress amongst patients with a variety 
of clinical problems. It consists of 14 items scored on a 4-point scale (0-3). Higher scores 
indicated more symptoms.19 Items were divided into two subscales: anxiety and depression, 
both with a maximum score of 21, with higher scores indicating more symptoms.
Neurocognitive tests (objective measures of cognitive dysfunction)
Participants completed a battery of 16 standardised, reliable and valid neurocognitive tests 
divided into 6 cognitive domains. These tests are sensitive to cognitive impairments and 
widely used in a variety of clinical and research populations.20,21 Tests were administered in 
a fixed sequence according to standardised instructions for each measure by two advanced 
doctoral students who were well-trained by a neuropsychologist. Measures were scored in 
a standardised fashion outlined in the administration manual of each test. 
The 6 domains consisted of Visual perception (Dutch Incomplete Figures Test (GIT-
2)22, Digit Symbol Coding (WAIS-III-NL)23, Symbol Search (WAIS-III-NL)23, Stroop Color Word 
Test (part 1 and 2)24), Motor functions (Grooved Pegboard25, Trail Making Test (D-KEFS)26 
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Number Sequencing (WAIS-III-NL)23), Long-term memory (Location Learning Test28, 15-Word 
Learning Test20), Attention (Trail Making Test (D-KEFS)26 part 1, 2 and 3) and Executive 
functioning (Stroop Color-Word Test part 324, Trail Making Test (D-KEFS)26 part 4, Verbal 
fluency task29, Figure fluency task29, Tower test (D-KEFS)26).
Cerebral MR imaging protocol
Participants were invited to the Neuro-Imaging Centre of the School for Behavioural and 
Cognitive Neurosciences in Groningen. The MRI protocol has been previously published by 
our group.14-16 All studies were performed on a 3-T MRI system (Philips Intera; Philips Medical 
Systems, Best, the Netherlands). An experienced neuroradiologist rated the presence and 
number of WML and other structural brain abnormalities. WML were considered to be 
present if hyperintense on fluid-attenuated inversion recovery (FLAIR), proton density-
weighted and T2-weighted images and not hypointense on T1-weighted images. Correction 
for inclusion of partial volume misclassification was performed as described previously.15,16
Blood pressure was measured manually with an aneroid sphygmomanometer on 
the day of MR imaging. A blood pressure of ≥ 140/90 mmHg, or current antihypertensive 
medication use, was used for the diagnosis of current hypertension.
Statistical analyses
Statistical analysis was performed using IBM Statistical Package for the Social Sciences 
version 20 for Windows (IBM inc., Chicago IL, USA). Raw test scores were used. All data 
were checked for normality of distribution using distribution curves, Shapiro-Wilk test and 
Levene’s test for homogeneity of variance. Small deviations from a normal distribution due 
to an outlier were accepted. For measures (Trail Making Test) which were not-normally 
distributed, logarithmic transformation was employed. There were no differences in 
outcomes between these transformations and non-parametric tests. Formerly preeclamptic 
and eclamptic women were analysed as one group (n = 90), since no differences in 
subjective and objective neurocognitive functioning as well as WML presence were found 
between these two groups.
Patient characteristics were analysed using t-test for normally distributed data, 
Mann-Whitney U test for non-normally distributed data and χ2 test for categorical data. 
Single imputation was used to replace two missing values in the questionnaire (due to 
a missed question) and two missing values (due to missing test forms) in the tests using 
estimated means for the whole group. Mean and median values were calculated before and 
after imputation to ensure the absence of differences. The presence of WML and other 
structural MRI abnormalities between groups was compared using one-sided Fisher’s Exact 
Test. A two-way analysis of variance (ANOVA) was conducted to explore the effect of group 







analysis of variance (MANOVA) was performed to explore the impact of the group variable 
and WML per test domain. Analyses were corrected for age, since the WML positive group 
was found to be significantly older than the WML negative group. Effect sizes (partial η2) 
were calculated in order to estimate the strength of significant effects between groups.30 
An effect size of partial η2 = 0.01 was defined as small, η2 = 0.06 as medium and η2 = 0.14 
as large.30 In order to detect a medium effect size of η2 = 0.06 on the two-way multivariate 
analysis of the test domains for 4 groups (namely (pre)eclampsia and WML, (pre)eclampsia 
without WML, controls with WML and controls without WML), with 2 predictors (group, 
WML), with a power of 0.80 and α of 0.05, inclusion of 34 women in each group ((pre)




90 formerly (pre)eclamptic women and 47 controls underwent both neuroimaging and 
neurocognitive testing. As shown in Table 1 and as expected, there was a significant 
difference in gestational age at delivery and birth weight. (Pre)eclamptic women currently 







Age (y) 39 (6.6) 40 (7.3) 0.38
Ethnicity (n Caucasian) 88 (98%) 45 (98%) 0.74
Elapsed time since index pregnancy (y) 6 (1-20) 6 (1-27) 0.50
Birth weight (grams) 1572 (300-4470) 3520 (2210-4620) < 0.01
EGA at delivery (wk) 32+3 (22-41) 40 (36+1-42+3) < 0.01
Preterm (pre)eclampsia < 37 wk (n) 62 (69%)
Nulliparous at index pregnancy (n) 69 (77%) 21 (45%) < 0.01
Level of education
Average 38 (42%) 16 (35%)
0.26
High 52 (58%) 30 (65%)
Current systolic blood pressure (mmHg) 125 (100-175)* 120 (95-158)** < 0.01
Current diastolic blood pressure (mmHg) 80 (60-110)* 75 (60-95)** < 0.01
Current hypertension (n) 30 (37%)* 5 (11%)** < 0.01
Results are expressed as mean (SD), median (min-max) or number (percentage). EGA = Estimated 
Gestational Age. * 9 cases missing, ** 2 cases missing.
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WML and subjective cognitive functioning
Formerly (pre)eclamptic women tended to have subcortical WML more often than controls 
(Table 2, p = 0.06). Women with preterm (pre)eclampsia had subcortical WML significantly 
more often than controls (Table 2, p = 0.03). There was no significant difference between 
groups in the presence of periventricular WML or infarcts (cortical, subcortical or lacunar) 
(Table 2).
(Pre)eclamptic women scored worse than controls on the CFQ (Table 2); two-way 
ANOVA F(2, 134) = 7.75, p < 0.01, η2 = 0.06. The presence of WML was not associated 
with worse CFQ scores (Table 2), two-way ANOVA F(2, 134) = 0.02, p = 0.89, η2 = 0.00. 
Also, the relationship between WML and CFQ score was not different in (pre)eclamptic 
women compared to controls, as indicated by the interaction factor, two-way ANOVA 
F(2, 134) = 0.22, p = 0.64, η2 = 0.00. When the above-mentioned analyses were repeated 
comparing only women with preterm (pre)eclampsia to controls, the results were similar. 
Exclusion of those women who had infarctions or periventricular WML (n = 10) did not alter 
the results.
WML, anxiety and depression
(Pre)eclamptic women scored worse than controls on the HADS total scale (Table 2), two-
way ANOVA F(2, 134) = 12.22, p < 0.01, η2 = 0.09. They also scored worse on the HADS 
anxiety subscale, two-way ANOVA F(2, 134) = 11.02, p < 0.01, η2 = 0.08 and HADS depression 
(Pre)eclampsia (n = 90) Controls (n = 47) p-value
Subcortical WML (n) 32 (36%) 10 (21%) 0.06
Periventricular WML (n) 4  (4%) 0 (0%) 0.18
Infarcts (n) 6 (7%) 1 (2%) 0.25
CFQ Total score 44 (16.1) 36 (11.0) < 0.001









CFQ Total score 44 (15.0) 45 (16.7) 33 (8.0) 37 (11.7)






Subcortical WML (n) 25 (40%) 10 (21%) 0.03
Results are expressed as mean (SD), median (min-max) or number (percentage). WML = White 
Matter Lesions, CFQ = Cognitive Failures Questionnaire.
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subscale, two-way ANOVA F(2, 134) = 8.43, p < 0.01, η2 = 0.06. The presence of WML was 
not associated with worse HADS total score (Table 2), two-way ANOVA F(2, 134) = 0.40, 
p = 0.53, η2 = 0.00. Women with WML also did not score worse on the HADS anxiety subscale, 
two-way ANOVA F(2, 134) = 0.14, p = 0.71, η2 = 0.00 and HADS depression subscale, two-way 
ANOVA F(2, 134) = 0.59, p = 0.44, η2 = 0.00. The effect of WML was not different between 
(pre)eclamptic women and controls for the HADS total score (F(2, 134) = 3.22, p = 0.08, 
η2 = 0.02), anxiety (F(2, 134) = 2.26, p = 0.14, η2 = 0.02) and depression (F(2, 134) = 2.90, 
p = 0.09, η2 = 0.02), as indicated by the interaction factor. When the above-mentioned 
analyses were repeated comparing women with preterm (pre)eclampsia to controls, the 
results were similar; there was a significant effect of preterm (pre)eclampsia vs. controls 
but not of WML presence. Exclusion of those women who had infarctions or periventricular 
WML did not reveal any different results.
WML and objective cognitive functioning
In Table 3, tests results are shown comparing both formerly (pre)eclamptic women and 
controls with and without WML. Neither the presence of WML nor a history of (pre)eclampsia 
was significantly associated with worse scores on any of the neurocognitive test domains. 
The effect of WML was not different between (pre)eclamptic women and controls, as 
indicated by the interaction factors. Results were not different when comparing women 
with preterm (pre)eclampsia to controls, except for a significant effect of preterm (pre)
eclampsia on the motor functions domain (p = 0.02), which was the result of a significant 
difference in the Trail Making Test part 5 (motor speed), p < 0.01. Exclusion of those 
women who had infarctions or periventricular WML did not reveal any different results.
Discussion
Both preeclamptic and eclamptic women reported more subjective cognitive problems 
in daily life and reported more anxiety and depression at, on average, 7 years follow-up 
compared to control women who had a normotensive pregnancy. Preeclamptic and eclamptic 
women did not show cognitive impairment as measured by objective neurocognitive tests. 
This study demonstrates that preeclamptic and eclamptic women more often have WML 
on neuroimaging, however, the presence of these WML was not related to subjective or 
objective measures of cognitive functioning nor to anxiety and depression in preeclamptic 
and eclamptic women or in women who had a normotensive pregnancy.
Subcortical WML are found more often in women with (pre)eclampsia, and the 
presence of WML was especially high in women with preterm (pre)eclampsia. This is in line 
with the finding that especially those women with preterm preeclampsia have an increased 
risk of hypertension, ischaemic and haemorrhagic stroke in later life.32







range of neurocognitive functions and incorporates sensitive tests for measuring cognitive 
impairment. Therefore, other factors need to be taken into consideration to explain the 
lack of a relationship between WML and objective neurocognitive deficits.
First, young women with an average age of 40 years may not (yet) suffer overt 
sequelae related to WML. Since most associations between WML and cognitive impairment 
are found in the elderly,33,34 WML in women who suffered (pre)eclampsia may start to 
demonstrate an impact in later life. With aging, the WML burden may increase and gray 
matter volume decrease, and the aging brain may have reduced ability to compensate for 
cognitive dysfunction.35 Second, not the mere presence of WML, but more so their location 
or severity, may prove to be the main determinant of impaired cognitive functioning. Mostly 
periventricular, and not subcortical WML seem to be associated with cognitive impairment 
and dementia in the elderly, while both coincide often and are related to hypertensive 
disease.36-40 In contrast, subcortical WML seem mostly associated to depressive symptoms in 
the elderly.13 Periventricular WML are thought to disrupt long connections from subcortical 
structures to cortical areas, whereas subcortical WML are thought to disrupt intermediate 
cortico-cortical connections.41,42 In the present study, most WML were located in the 
subcortical regions and only 4 women had periventricular WML. It remains to be elucidated 
whether subcortical WML are a precursor for later development of periventricular WML.
Another finding in this study is the absence of a relationship between subjective 
cognitive failures in formerly (pre)eclamptic women and the presence of WML. This was 
against our view that subjective cognitive complaints may be related to WML, even in the 
absence of cognitive dysfunction in a test setting. Therefore, other factors need to be 
taken into consideration. First, although a sample size calculation was performed, the 
sample size of this study is considerably smaller than studies performed in the elderly 
population. In addition, while in the elderly, subjective complaints as well as depression 
seem to be related to WML,7,38,43 this might not hold true for younger individuals. In younger 
individuals, the CFQ may probably best be interpreted as a measure of executive control 
of behavior, in which people with anxiety and depression experience cognitive failures 
mainly in complex and stressful daily life events. Indeed, previous research has found that 
in formerly (pre)eclamptic women subjective cognitive complaints appear strongly related 
to anxiety and depression,5 which is in agreement with findings in the general population 
of young (< 50 years) individuals, in which cognitive problems are also strongly correlated 
with affective status.44 (Pre)eclampsia is a serious life event, following which women who 
are more sensitive to stress may be more likely to develop anxiety and depression. In 
addition, depression and anxiety in early pregnancy seem to be associated with subsequent 
development of preeclampsia and it is possible that symptoms of anxiety and depression 
were already present prior to the index pregnancy.45 Furthermore, women who suffered 
(pre)eclampsia more often express symptoms of posttraumatic stress disorder.11 Although 
subcortical WML seem associated to depressive symptoms in the elderly,13,43 in the present 
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cannot, however, be excluded that subjective cognitive failures may be an early indicator 
for later development of objective cognitive impairment even in the absence of a clear 
relationship with subcortical WML. There may be a different pathological substrate, 
other than WML, for such subjective cognitive failures, such as hippocampal volume46,47 
or cerebral microbleeds48 which are, in the elderly, related to increased risk factors of 
vascular disease.
This study is the first to report on the presence of cerebral white matter lesions 
and its relationship with subjective as well as objective cognitive functioning and anxiety 
and depression in a relatively large group of formerly eclamptic and preeclamptic women. 
Moreover, it is one of the few studies in the literature to date to report on the relationship 
of WML and neurocognitive functioning in such a young cohort in general.
There are some limitations to this study that should be mentioned. The measurements 
in this study have a cross-sectional design. Therefore, the study does not provide imaging 
data of participants prior to their index pregnancy; whether WML were present prior to 
the index pregnancy is therefore unknown. This design also limits conclusions related to 
cause-effect relationships and possible changes in cognitive functioning in daily life due 
to pregnancy in and of itself. Second, approximately 70% of the women who participated 
in the study of Aukes et al.14,15 could be contacted again and were willing to participate 
in the study now reported which may have given rise to selection bias. It is possible that 
participating women experience more cognitive dysfunction compared to non-participating 
women, however, most non-participating women could not be contacted because of 
change of address and/or phone number. Other non-participating women mentioned the 
time and travel burden as the main reason not to participate, although some declined 
because of fear of confrontation with the traumatic experience of their complicated 
pregnancy. Third, the wide range in elapsed time since index pregnancy reflects the rare 
incidence of eclampsia. Despite careful matching, elapsed time since index pregnancy was 
slightly longer in formerly eclamptic women, however, correction for elapsed time did not 
significantly alter the results. Fourth, the effect of subsequent pregnancies following the 
index pregnancy cannot be excluded. Nine women had preeclampsia during a subsequent 
pregnancy. Last, it was not possible to reliably recruit more previously eclamptic women 
into this study. In the context of the rare incidence of eclampsia this represents a sizeable 
study the results of which are clinically important.
In summary, cerebral subcortical WML are more prevalent following preterm (pre)
eclampsia and formerly (pre)eclamptic women report cognitive dysfunction, but do not 
exhibit overt cognitive impairment when objectively tested on average 7 years following 
their pregnancy. The presence of WML is related to neither objective nor subjective 
cognitive impairment, anxiety and depression. Although the subjective cognitive 
complaints seem to be related to symptoms of anxiety and depression years after the 
(pre)eclamptic pregnancy, cognitive complaints constitute a variety of different symptoms 







trivialise the perceived cognitive dysfunction these women report nor does it exclude the 
possibility that (subgroups of) these women develop cognitive impairment in later life. 
Either way, following a (pre)eclamptic pregnancy, attention needs to be paid to adequate 
psychosocial treatment and follow-up. Future studies in women who suffered eclampsia 
and preeclampsia should focus on long-term follow-up (20-30 years) of cerebral structural 
abnormalities and cognitive functioning.
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Objective: Women who suffered eclampsia or preterm preeclampsia are twice as likely 
to demonstrate cerebral white matter lesions (WML) on MRI compared to age-matched 
women who had normotensive pregnancies, and they report more cognitive dysfunctions in 
everyday life. We aimed to determine whether pregnancy in and of itself has a relationship 
with the presence of WML and subjective cognitive dysfunction.
Methods: 81 parous women who had a normotensive pregnancy were matched for age with 
65 nulliparous women and all underwent cerebral MRI. Presence of cerebral WML was rated 
and blood pressure was measured. Subjective cognitive functioning was assessed using the 
Cognitive Failures Questionnaire (CFQ).
Results: There was no difference in the presence (22% vs. 19%) of WML between parous and 
nulliparous women. Age was a predictor for the presence of WML, whereas the presence of 
current hypertension was not. Average CFQ score was not different between both groups, 
nor related to WML.
Conclusions: A history of pregnancy in and of itself is not related to the presence of 
cerebral WML and the perception of cognitive dysfunction. Because of the relationship 
with preterm preeclampsia and eclampsia, future research should focus on the clinical 
importance and development throughout the years of such cerebral WML in young women 
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Introduction
With the aging population, diseases such as dementia and stroke will become major health 
issues in the near future. A feature of such conditions is that preclinical structural cerebral 
changes, such as white matter lesions (WML) may be present years before clinically 
recognizable disease. The presence of such WML may be an important risk marker for 
the development of cognitive impairment, vascular dementia, Alzheimer’s disease and 
stroke.1-4 In individuals in their 50s and 60s WML are especially seen in combination with 
risk factors for small vessel disease such as hypertension and diabetes.3-5
White matter lesions are a frequent neuroimaging finding in elderly individuals, 
but their prevalence as well as their relationship with cognitive dysfunction in younger 
asymptomatic populations is unknown.6 The prevalence of WML and perceived cognitive 
dysfunction in women who experienced (pre)eclampsia has recently been investigated by 
our group.7-11 Women who suffered (pre)eclampsia report cognitive problems years following 
the index pregnancy, which appear to be related to memory, concentration and vision-
related tasks of everyday life.9-11 In addition, women who suffered eclampsia, or preterm 
preeclampsia (< 37 weeks), appeared  twice as likely to demonstrate WML compared to 
age-matched women who had normotensive pregnancies.7,8 The relationship between WML 
and perceived cognitive dysfunction in women who suffered preeclampsia/eclampsia is 
the focus of our ongoing work. While a direct causal relationship remains to be elucidated, 
we hypothesize that an underlying predisposition for vascular disease contributed to both 
the development of (pre)eclampsia as well as WML. However, in our previous studies, we 
found that one in five women who experienced a normotensive pregnancy also had WML 
at an average age of 37. This raises the question whether pregnancy and parity in and of 
itself have a relationship with the presence of such lesions and the perception of cognitive 
difficulties.
Therefore, the aim of this study was to compare the prevalence of cerebral WML 
in women who had normotensive pregnancies compared to nulliparous women and to 
determine the relationship with self-perceived cognitive dysfunction.
Methods
Participants
Participants who had a normotensive pregnancy formed the control group in follow-up 
studies assessing cerebral long-term consequences of preeclampsia. Recruitment and 
selection criteria have been published previously.7-9,12 This project was approved by the 








75 parous controls from our previous studies underwent MR imaging and six additional 
parous controls were included, leaving 81 controls for analysis. Nulliparous women were 
recruited between March 2012 and June 2013 by means of an invitation in local newspapers, 
on the Internet and among hospital personnel. Nulliparous women willing to participate 
were matched for age (± 2 years) and level of education to one of the parous women. A 
total of 65 women out of 134 eligible nulliparous women who responded to the recruitment 
advertisement could be matched and did not have MRI contraindications. 20 parous women 
did not complete the cognitive failures questionnaire (CFQ), (n = 60).
Women were excluded if they had MRI contraindications, neurological disorders 
such as epilepsy, demyelinating disorders, a known cerebrovascular accident, intracranial 
infections or a history of any intracranial surgery or were currently pregnant. Nulliparous 
women were excluded if they had experienced a pregnancy of more than 12 weeks 
duration, or if they had recent contact with a hospital concerning fertility treatment or 
diagnostic procedures.
All patients completed a short questionnaire about their current and past medical 
health. At the time of imaging, weight and blood pressure (manually, using an aneroid 
sphygmomanometer) were measured. Current hypertension was defined as a blood pressure 
of ≥ 140/90 mmHg and/or current antihypertensive medication use.
MRI protocol
Participants were invited to the 3-T MRI facilities (Philips Intera; Philips Medical Systems, 
Best, the Netherlands) of the Neuro-Imaging Center of the School for Behavioural and 
Cognitive Neurosciences in Groningen. The MRI protocol has been previously published 
by our group.7,8 An experienced neuroradiologist rated the prevalence, size and number 






Age (total range 21-59) (y) 37 (6.9) 37 (7.9) 0.81
Caucasian ethnicity 75 (93%) 63 (97%) 0.25
Weight (kg) 72 (10.8)* 73 (17.3) 0.59
Current hypertension 8 (10%)** 8 (13%)‡ 0.60
Smoking 13 (16%) 8 (12%) 0.52
History of migraine 17 (21%) 15 (24%) 0.69
Elapsed time since 
index pregnancy (y) 6 (4.9)
Primipara 40 (49)
Results are expressed as mean (SD) or number (percentage). * n = 80, ** n = 78, ‡ n = 61.
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hyperintense on fluid-attenuated inversion recovery (FLAIR), proton density-weighted and 
T2-weighted images and not as hypointense as liquor on T1-weighted images. A correction 
for inclusion of partial volume misclassification was made as described previously.8
Subjective cognitive functioning
The Cognitive Failures Questionnaire (CFQ) evaluates the number of errors committed in 
the completion of daily tasks.13 Subjects were asked to complete the questionnaire based 
on their experiences in the past 6 months. The CFQ consists of 25 items, each scored on a 
5-point scale (0-4). The total scale ranges from 0-100, with higher scores indicating more 
cognitive failures. A cut-off point for high CFQ total scores based on the Dutch population 
was set at 44, indicating cognitive problems.14 The CFQ was developed as a valid self-report 
instrument to measure the tendency to make mistakes in everyday life.13 In a healthy 
population, the CFQ is a valid measure of a stable cognitive resource that is involved in 
attention, memory and action in daily life, with good test-retest reliability for groups of 
individuals and good internal reliability.15
Statistical analysis
To achieve sufficient statistical power with α of 0.05 and β of 0.20, a total sample size of 
150 women was needed to detect a difference in prevalence of WML of 20% (one-sided 
test), based on the difference found in our previous studies in eclamptic/preeclamptic 
women (41/37%) as compared to controls (21%).7,8 In addition, with α of 0.05 and β of 0.20, 
we estimated that a total sample size of 100 women was needed to detect a difference 
in CFQ score (one-sided test) of 7 with a standard deviation of 14.9 Statistical analysis was 
performed using IBM SPSS Statistics for Windows version 20 (IBM Corp., Chicago IL, USA). 
All data were checked for normality of distribution using Shapiro-Wilk test and Levene’s 
test for homogeneity of variance. Demographic data were compared using χ2 test for 
categorical data or Student’s t-test for normally distributed data. The presence of WML 
was compared between groups using χ2 test. CFQ total score was analyzed using Student’s 
t-test, χ2 test was used for cut-off scores. Univariate and multivariate regression analyses 
were used to identify possible determinants related to the presence of WML (binary logistic 
regression) and CFQ score (linear regression), i.e. age, current hypertension, migraine, 
smoking and weight. A determinant was selected for the multivariate analysis if p < 0.25 









In total, 81 parous and 65 nulliparous women with an average age of 37 years underwent 
cranial MR imaging. Groups were not significantly different as to weight, current 
hypertension and smoking (Table 1).
White matter lesions
WML were present in 18 (22%) parous and 12 (19%) nulliparous women (p = 0.58). Small 
lesions were present in 10 (12%) parous and 10 (15%) nulliparous women (p = 0.61). 
Medium or large lesions were present in 11 (14%) parous and in 7 (11%) nulliparous women 
(p = 0.60). Presence of WML within the parous group was not different between women 
who experienced one (8; 20%) vs. multiple pregnancies (10; 24%) (p = 0.64). Univariate 
regression analysis revealed that age, OR 1.07 (1.01-1.13) p = 0.03, was a significant predictor 
for the presence of WML. Figure 1 shows the distribution of WML according to age in parous 
and nulliparous women.
Subjective cognitive functioning
125 women (60 parous and 65 nulliparous women) completed the CFQ. There was no 
significant difference in CFQ total score between the groups (36 ± 11.0 for parous women 
and 33 ± 9.6 for nulliparous women, p = 0.16). No difference was found in the percentage 
of women scoring higher than the cut-off score of 44 (indicating cognitive problems): 
11 (18%) parous women and 8 (12%) nulliparous women, p = 0.35. The presence of WML 
was not related to subjective cognitive function (CFQ score 34 ± 7.5 for women with WML 
and 35 ± 10.9 for women without WML), p = 0.77. Subjective cognitive function was not 
significantly different within the parous group between women who experienced one 
vs. multiple pregnancies (CFQ score of 36 ± 11.2 and 35 ± 11.1, respectively), p = 0.75. 
Univariate regression analysis revealed that none of the determinants in the equation were 
a significant predictor for CFQ scores.
Discussion
This study demonstrates that approximately one in five women in a population-based 
cohort with an average age of 37 has WML independent of pregnancy in and of itself. 
Furthermore, this study confirms that the prevalence of WML is associated with increasing 
age. Neither the prevalence of WML in this age category nor a history of pregnancy on 







Cerebral white matter lesions and perCeived Cognitive dysfunCtion: the role of pregnanCy
Previous studies demonstrated brain WML twice as often in formerly eclamptic 
women and women with preterm preeclampsia compared to women following normotensive 
pregnancies.7,8 An increased propensity for vascular disease in women with a history of 
preeclampsia may be an associated factor in the development of such lesions even though 
their pathogenesis has not become clear to date.16 The present study shows that the 
presence of WML seems independent of pregnancy and parity.
The prevalence of WML in one-fifth of participants in this study with an average age 
of 37 years (range 21-59 years) is remarkable. Many studies have reported a high prevalence 
of WML in the elderly from 22.7% up to 100% in individuals aged 60 and over.1,6,17-23 Few 
studies have been performed in younger cohorts; the reported prevalence at < 40 years 
of age is 0.5%-32%.19,24-29 Differences in prevalence in the abovementioned studies might 
be due to different MRI field strengths and scanning sequences, different methods of 
WML rating, presence or absence of cardiovascular risk factors and differences in age 
range. For instance, two studies that found lower prevalence rates excluded patients with 
cardiovascular risk factors.20,29 Higher prevalence in females compared to males has been 
reported in some, but not all studies.5,6,23,29,30 The present study showed that WML presence 
was related to increasing age (OR 1.06), which is comparable to the OR found in the study 
of Chowdhurrey et al.,20 however lower than in some other studies21,29, which may be due 
to inclusion of different age ranges. The present study failed to show a significant effect of 
blood pressure on the presence of WML, while this relationship has been often described 









































in the literature as well as in prior studies of our own group.8,31,32 This might be due to the 
relatively young and healthy population in the cohort now reported and, subsequently, 
the small number of women with hypertension, which is  similar to the prevalence in the 
general Dutch population.33 In this study we found no effect of parity on WML presence. 
Parity seems associated to cardiovascular disease in later life,34 however, this association 
may be due to socioeconomic variables and may only hold true for women with ≥ 4 
pregnancies, which were not present in our study.
The clinical implications of WML in young women are only speculative so far and are 
subject of further investigation. In the elderly, WML are related to cognitive decline and 
dementia.35 Although perceived cognitive failures in formerly eclamptic and preeclamptic 
women have been previously reported,9,10,36 minor neurocognitive impairment was found on 
neurocognitive tests.37-39
Up to several months postpartum, women frequently report cognitive deficits 
which are clustered under the terms ‘mommy brain’ or ‘maternal amnesia’.40 Postpartum 
women indeed show a small, but significant, impairment on some measures of cognition 
that place relatively high demands on executive cognitive control.40 The animal literature 
views cognitive changes occurring during pregnancy and postpartum from an adaptive 
perspective. Rather than being a negative consequence of pregnancy, these cognitive 
changes may be seen as cognitive reorganization based on structural changes in the 
form of neuronal plasticity, in which social  cognition which is relevant to maternal or 
fetal wellbeing is enhanced to the cost of other cognitive tasks.40 In humans, fMRI studies 
investigating the parental response to infants show increased gray matter volumes in large 
regions of the prefrontal cortex, parietal lobe, and midbrain suggesting similar neuronal 
plasticity in humans.41,42 Prenatal hormone levels seem to play a role in these changes.43
While such adaptations have not been assessed longitudinally, one could expect 
these postpartum cognitive changes to have subsided 6 years following pregnancy and 
indeed, we did not find significant differences in CFQ scores between parous and nulliparous 
women. In this study we found no effect of parity on CFQ scores. Glynn et al. found 
that adverse effects of pregnancy on memory function are compounded with successive 
pregnancies.44 However, these measurements were only performed during gestation and at 
3 months postpartum, but not more than 1 year postpartum.
To our knowledge, this is the first study to assess the long-term relationship between 
pregnancy and WML as well as subjective cognitive function. Moreover, it is one of the 
few studies in the literature to date to report on the relationship of WML and subjective 
cognitive dysfunction in such a young cohort in general. There are some methodological 
limitations to this study; no imaging data of the parous participants are available prior to 
their index pregnancy. Whether WML were present prior to pregnancy is therefore unknown. 
Second, determinants related to cardiovascular disease other than included in this study 
may play a role, such as blood glucose, family history, physical activity and hyperlipidemia. 
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exclude that pregnancy does induce long-term structural brain changes. If so, such changes 
likely develop on a micro level and below a threshold for detection by the current state of 
the art neuroimaging techniques.
The examination of WML and their possible neurocognitive sequelae in younger 
individuals is important for a variety of reasons. It may help to understand the pathogenesis 
of such lesions and identify potentially modifiable factors in the early stages of their 
development. Moreover, since the presence of neuropsychiatric syndromes like Alzheimer, 
vascular dementia and depression has been related to WML the functional consequences of 
these lesions in mid-life are of utmost interest.1,3,4,31 This age group should therefore be the 
focus of further work to identify risk and protective (modifiable) factors as it may prove to 
be the age at which preventive strategies need to be introduced to have an optimal impact 
on brain health in the future.
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SUMMARY, GENERAL DISCUSSION, 









Preeclampsia is the leading cause of maternal morbidity and mortality worldwide and 
may have implications for future health in a substantial number of young women. In the 
past decade, focus has shifted from the paradigm that preeclampsia is a disease from 
which pregnant women could expect full recovery, towards preeclampsia as a risk 
marker for future cardiovascular and cerebrovascular events.3 With the aging population, 
cerebrovascular disease will become a major health issue in the near future. Although 
unraveling the consequences of preeclampsia for the maternal brain remains challenging, 
in this thesis some important insight is gained towards understanding future brain health in 
women who suffered preeclampsia and eclampsia.
Summary
Chapter 1 gives a general introduction to the maternal brain in (pre)eclampsia. Preeclampsia 
is a hypertensive, multisystem disorder of pregnancy, and a leading cause of maternal and 
fetal/neonatal morbidity and mortality. The central nervous system can be involved during 
the course of preeclampsia in the form of hyperreflexia, headaches, visual disturbances, 
mental status changes, eclampsia and in the most severe cases intracranial haemorrhage. 
Preeclampsia is an endothelial cell disorder characterised by poor placentation resulting 
in release of substances by the placenta, which enter the maternal circulation. Eclampsia 
is defined as the occurrence of tonic-clonic convulsions in a woman with preeclampsia and 
is considered a form of the Posterior Reversible Encephalopathy Syndrome (PRES). With 
PRES a combination of endothelial dysfunction and an increase in blood pressure is thought 
to result in failure of autoregulation of cerebral blood flow, with hyperperfusion and 
consequently vasogenic edema. Neuroimaging studies (MRI), carried out several years after 
(pre)eclampsia, may reveal hyperintense signals, so called cerebral white matter lesions 
(WML). WML in the general population and preeclampsia are associated with similar risk 
factors such as chronic hypertension, obesity, metabolic syndrome and insulin resistance 
and women with preeclampsia have higher risk of cardiovascular events and stroke later 
in life. In addition, both on short and long-term follow-up of formerly eclamptic women, 
self-reported memory complaints and symptoms of depression and anxiety have been 
described. These findings provided the fundament for this thesis.
Chapter 2 provides a review of the literature concerning potential long-term consequences 
of the Posterior Reversible Encephalopathy Syndrome (PRES) in eclampsia and non-obstetric 
patients. Although the encountered literature mainly consisted of case-studies, and long-
term sequelae of PRES have been ill-described, some general conclusions can be made. In 
brief, eclampsia-related PRES has been associated less often with long-term neuroimaging 
abnormalities as well as cognitive problems, epilepsy or visual impairment as compared 
to non-obstetric PRES-related conditions. The main determinant for long-term problems 
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the PRES episode itself. Most reports suggest that late diagnosis or inadequate therapy 
of PRES may negatively influence the course of this syndrome. Although evidence-based 
therapeutic and long-term monitoring strategies are lacking to date, attention should be 
paid to timely and adequate treatment and follow-up of PRES patients.
Chapter 3 presents an observational study regarding self-reported cognitive functioning 
following pregnancies complicated by preeclampsia and normotensive pregnancies. A 
web-based survey was conducted in 966 women with a history of preeclampsia and 342 
parous controls. The survey included 1) self-reported cognitive failures in daily life (short 
version (18 items) of the Cognitive Failures Questionnaire, CFQ), 2) social functioning 
(Social Functioning Questionnaire, SFQ) and 3) quality of life (abbreviated WHO Quality 
Of Life Questionnaire, WHOQOL-BREF). Women with a history of preeclampsia reported 
cognitive failures significantly more often as compared to controls (median CFQ score 35 
and 27 respectively). In addition, they reported worse quality of life on the WHOQOL-BREF 
domains physical health (median 15 and 17), psychological health (median 13 and 15), social 
relationships (median 13 and 15) and environment (median 15 and 16), as well as more 
problems with social functioning (median SFQ score 8 and 7). Posttraumatic stress symptoms 
were found to account for part, but not all of this difference between preeclamptic women 
and controls. Although the study may have encountered selection and recall bias and the 
difference in scores appear modest, women with a history of preeclampsia perceive more 
cognitive and social problems, and report poorer quality of life compared to women who 
had normotensive pregnancies.
In chapters 4 and 5, objective cognitive functioning in formerly eclamptic and preeclamptic 
women was evaluated using a battery of neurocognitive tests. Chapter 4 describes a pilot 
study assessing executive functioning (specifically inhibition and updating/monitoring) and 
sustained attention (the ability to sustain mindful processing of repetitive stimuli that 
would otherwise lead to habituation) several years following a eclamptic or preeclamptic 
pregnancy. 26 eclamptic women, 20 preeclamptic women and 18 controls who had a 
normotensive pregnancy performed the Sustained Attention to Response Task (SART) and 
the Random Number Generation (RNG) task. No significant differences were found on 
SART and RNG scores between groups, nor in women who experienced multiple seizures 
suggesting that there was no influence of severity of eclampsia. Chapter 5 subsequently 
describes a larger study conducted in formerly preeclamptic and eclamptic women several 
years following the index pregnancy, encompassing an extensive range of 6 neurocognitive 
domains using sensitive, standardized neurocognitive tests: visual perception, motor 
function, working memory, long-term memory, attention and executive functioning. In 
addition, anxiety and depression were measured by the Hospital Anxiety and Depression 
Scale (HADS) and subjective cognitive functioning was measured by the CFQ. 46 eclamptic, 







the neurocognitive test battery, the 25-item CFQ, and the HADS. Formerly eclamptic and 
preeclamptic women demonstrate no objective cognitive impairment in a test setting, 
aside from slighty lower visuomotor speed, as compared to controls (Trail Making Test part 
5: 26, 22 and 20 seconds respectively). They did report more cognitive failures (average 
CFQ score of 43, 47 and 36 respectively) and more symptoms of anxiety and depression 
(average HADS score of 12, 11, and 8 respectively) as compared to controls, but no difference 
between eclamptic and preeclamptic women was found. Concluding, even though women 
who suffered eclampsia or preeclampsia do report more cognitive failures in daily life, in 
a well-structured test setting they do not demonstrate clear cognitive impairment. The 
reported cognitive failures (CFQ) by formerly preeclamptic and eclamptic women had a 
strong association with symptoms of anxiety and depression. The CFQ may be interpreted 
as a measure of executive control of behavior, in which individuals with symptoms of 
anxiety and depression experience cognitive failures mainly in complex and stressful daily 
life events. In this scheme it is hypothesized that high levels of stress hormones may be 
detrimental for executive control and increase susceptibility for experiencing cognitive 
failures.
Chapter 6 describes the relationship between cerebral white matter lesions (WML) found on 
MRI, subjective and objective measures of cognitive functioning and self-reported symptoms 
of anxiety and depression. Objective neurocognitive test results and questionnaires 
pertaining to subjective cognitive functioning and symptoms of anxiety and depression 
(chapter 5) were compared in women with and without WML on MRI. 41 eclamptic, 49 
preeclamptic and 47 control women underwent both neurocognitive testing and MRI and 
completed the questionnaires. On average 6 years following the index pregnancy, women 
who suffered eclampsia or preterm preeclampsia (< 37 weeks) more often have WML 
(40%) as compared to women who had a normotensive pregnancy (21%). The presence of 
cerebral WML neither seem to bear a relationship with subjective or objective measures 
of cognitive functioning nor with symptoms of anxiety and depression in all groups. On the 
other hand the report of cognitive failures in these formerly preeclamptic and eclamptic 
women seems strongly related to the presence of symptoms of anxiety and depression. 
Complex and stressful situations, which require planning, may lead to cognitive failures in 
women who experience symptoms of anxiety. Because most associations between WML 
and cognitive impairment are found in the elderly, young women with an average age of 40 
years may not (yet) suffer overt sequelae related to WML. Therefore, whether there may 
be development of cognitive impairment in later life in women who suffered eclampsia or 
preterm preeclampsia is currently unknown.
Since WML are also found in one fifth of women who had a normotensive pregnancy chapter 
7 describes the effect of pregnancy in and of itself on the prevalence of cerebral WML on 
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were compared to 65 age-matched nulliparous women. Average age was 37 years in both 
groups and average elapsed time since pregnancy was 6 years. No difference was found 
in the prevalence of WML between parous and nulliparous women (prevalence of 22% vs. 
19%). Parous and nulliparous women scored similar on the 25-item CFQ (average of 36 and 
33). Only age was found to be a predictor for the prevalence of WML, whereas the presence 
of chronic hypertension was not. This may be due to the relatively young and healthy 
population in the cohort, and consequently, a low incidence of chronic hypertension. 
Whereas a high prevalence of WML (up to 100%)  has been reported in individuals aged 
60 and over, the few studies in younger cohorts (< 40 years of age) report a prevalence of 
0.5%-32%, which is in the same range as the 20% described in this chapter. In short, 6 years 
later a history of pregnancy in and of itself does not seem to be related to the presence of 








Following the summary of the studies presented in this thesis, a background will be 
provided against which eclampsia and preeclampsia can be seen as an important marker 
for future brain health. Subsequently, the results of this thesis will be discussed below and 
allow for a number of conclusions and future recommendations to be made.
The maternal brain in (pre)eclampsia
Preeclampsia is a disorder in which generalized endothelial dysfunction, altering the 
vascular reactivity, plays an important role.1 The maternal brain can be involved in 
preeclampsia, characterized by hyperreflexia, headaches, visual disturbances, mental 
status changes, tonic-clonic convulsions (eclampsia) and, in the most severe cases, 
intracranial haemorrhage. Although the exact pathophysiology of eclampsia remains to be 
elucidated, it is generally thought that it develops in preeclamptic women when, in the 
presence of endothelial dysfunction, blood pressure exceeds the upper limit of cerebral 
autoregulation.2 Evidence is increasing that the effects of a preeclamptic pregnancy for 
women’s health may not be restricted to the pregnancy and early postpartum period, but 
represent a risk marker for future health.
Preeclampsia, cerebral small vessel disease and white matter lesions
In the past decade, research has revealed an association between preeclampsia and 
cerebrovascular and cardiovascular disease later in life, especially in women who suffered 
early-onset preeclampsia.3 The incidence of cardiovascular disease such as stroke and 
ischaemic heart disease is higher following a preeclamptic pregnancy compared to women 
who had normotensive pregnancies.3,4 Preeclampsia likely reveals a failure to adapt to the 
metabolic and vascular challenge of pregnancy. Pregnancy may therefore be a ‘stress test’ 
for later life health issues. It has been proposed that there is a shared constitutional risk 
for both the development of preeclampsia and cardiovascular disease in later life rather 
than a causal pathway between preeclampsia and cardiovascular disease.5 Preeclamptic 
women have an unfavourable cardiovascular risk profile with higher fasting glucose levels, 
larger waste circumference and hypertension.5 Although it is possible that much of the 
excess risk of future ischaemic heart disease and stroke is explained by the association of 
preeclampsia and chronic hypertension, preeclampsia itself appears to be an independent 
risk marker.6
Cardiovascular disease is one of the main causes of mortality in elderly females. The 
early identification of women with risk factors could possibly prevent future cardiovascular 
morbidity and mortality. Therefore, a history of preeclampsia has been added as a risk 
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risk would render preeclamptic women eligible for lifestyle interventions and preventive 
therapy at lower thresholds.7
The prevalence of cerebral white matter lesions (WML) on MR imaging in formerly 
eclamptic women and women who suffered preterm preeclampsia is higher compared to 
controls who had a normotensive pregnancy (chapter 6).8,9 WML prevalence was similar 
in eclamptic and preeclamptic women (chapter 6). The white matter of the cerebrum 
consists of nerve fibers (axons surrounded by a myelin sheath), neuroglial cells and vascular 
structures. In regions of white matter pathology, such as destruction of axons, cavitation 
or infarction, WML are seen as a high intensity signal on T2-weighted and fluid-attenuated 
inversion recovery (FLAIR) MRI scans, revealing a high water content. In the elderly, 
postmortem studies demonstrate areas of WML showing a hypoxic response, arteriolar 
sclerosis, amyloid angiopathy and reduced endothelial vascular integrity which suggest 
chronic hypoperfusion.10,11 WML are often divided into subcortical and periventricular 
WML. Subcortical WML mainly seem to disrupt intermediate corticocortical connections 
(association fibers), which have a high density in the white matter areas close to the gray 
matter.12 Periventricular WML are thought to disrupt long connections from subcortical 
structures to cortical areas.
In older subjects WML are a frequent finding on MRI and, together with lacunar 
infarction and cerebral microbleeds, they are considered part of the continuum of 
neuroimaging features representing cerebral small vessel disease.13 Cerebral small vessel 
disease, or cerebral microangiopathy, is a term used for a syndrome of clinical, cognitive 
and neuroimaging findings which are thought to arise from affected perforating arterioles, 
capillaries and venules resulting in insidious brain damage in the cerebral white and deep 
grey matter.13 The mechanisms underlying cerebral small vessel disease are thought to be 
related to arteriolosclerosis, hypertension and early endothelial failure. The permeability 
of the cerebrovascular endothelium increases with age.14 Cerebral small vessel disease 
develops over many years before it becomes clinically relevant but is the most common 
cause of vascular dementia and may also be seen in Alzheimer’s disease.15,16 Most available 
neuroimaging studies concerning WML are performed in the elderly. However, of 200 
patients admitted for a TIA or stroke, who had cerebral small vessel disease, 31% was 
younger than 55 years. When cerebral small vessel disease (WML) is seen in younger 
individuals, vascular risk factors like hypertension and smoking likely play an important 
role.17 It is suggested that some degree of cerebral small vessel disease is related to the 
normal process of aging while the presence of cardiovascular risk factors may accelerate 
this development.
In the past decade it has been hypothesized that the WML seen following a pregnancy 
complicated by eclampsia8 may be a consequence of the cerebral edema in the posterior 
brain areas seen in the acute moment (PRES).18 However, several findings in this thesis and 
previous studies now question a direct causal relationship between PRES and WML. First, 







term neuroimaging abnormalities such as infarction or haemorrhage than non-obstetric 
PRES-related conditions and the main determinant for the abnormalities following non-
obstetric PRES-related conditions seems to be the underlying condition instead of the PRES 
episode in and of itself.19 Second, since WML are found just as often in women who suffered 
preterm preeclampsia without seizures9 it is less likely that there is a causal relationship 
between an episode of PRES (eclampsia) and the presence of WML several years later. 
Third, whereas brain edema in PRES is mainly located in the posterior areas, WML in 
formerly eclamptic and preeclamptic women as well as parous controls seem to be located 
mainly in the frontal areas of the brain (chapter 6).20 Finally, as discussed in chapter 7, 
WML are also present in about one-fifth of women who had a normotensive pregnancy8,9 
as well as in one-fifth of nulliparous women of the same age category (average age of 37 
years). All of the aforementioned arguments make a causal relationship between vasogenic 
edema in PRES and subsequent WML on follow-up less likely. However, an additive effect 
of the PRES episode in and of itself, specifically in cases who are confronted with cytotoxic 
edema, remains a possibility.
An alternative, more plausible, explanation for the pathogenesis of WML in women 
who suffered eclampsia and preterm preeclampsia and, to a lesser extent in women of 
childbearing age in general, may be that they are a part of the continuum of cerebral 
small vessel disease seen in the normal aging process, with an important additional  role 
for cardiovascular risk factors. The latter may particularly be the case in women who 
suffered eclampsia and preterm preeclampsia, as the presence of WML in these women 
appears associated with the presence of chronic hypertension.9 Especially women with 
preterm preeclampsia have an increased risk of hypertension, ischaemic and haemorrhagic 
stroke in later life.4 Indeed, we found that mainly those women who suffered eclampsia 
and preterm preeclampsia more often have WML as compared to controls. The lack of a 
relationship between WML and chronic hypertension in women who had a normotensive 
pregnancy and nulliparous women (chapter 7) might be due to the relatively young and 
healthy population in the cohort now reported and, subsequently, the small number of 
women with chronic hypertension.
 A history of migraine headaches has been associated with a higher incidence of 
hypertensive disorders during pregnancy, with odds-ratios ranging from 1.1 to 3.7.21-34 In 
addition, migraine, just like preeclampsia, has been associated with a higher prevalence 
of cerebral white matter lesions and stroke.35-38 Whether preeclampsia and migraine are 
independent determinants of cerebral WML remains to be elucidated.
Measures for subjective and objective cognitive functioning
Chapters 3 and 5 describe a substantial number of women reporting some degree of impaired 
cognitive, social and mental wellbeing years following (pre)eclampsia. The Cognitive Failures 
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had a normotensive pregnancy. In chapter 5, there was no difference between eclamptic 
and preeclamptic women in subjective cognitive functioning, nor in symptoms of anxiety 
and depression. In chapter 3 however, eclampsia seemed to have a small but significant 
additional effect on subjective cognitive functioning. These findings confirm what has been 
found in earlier studies reporting problems related to (prospective) memory, concentration, 
attention, indecisiveness, and vision-related tasks of everyday life.39-42 Preeclamptic and 
eclamptic women did not reveal difficulties on objective measures of cognitive functioning 
(chapters 4 and 5).  In general, there are some difficulties interpreting subjective as well 
as objective measures of cognitive functioning which will be now be outlined.
How can the Cognitive Failures Questionnaire be interpreted?
Two important aspects of the CFQ should be mentioned. First, the CFQ has been associated 
with emotional factors such as anxiety and depression. The CFQ can also be interpreted 
as a trait measure of adverse psychological reactions, such as anxiety, to complex 
stressful situations.43,44 The direction of causality has not been clearly demonstrated. 
The CFQ appears to relate strongly to the view that individuals display in regard to their 
own worth/worries about one’s cognition.45,46 Second, more recently, the CFQ has also 
been associated with executive control of behavior. It may be viewed as a reflection of a 
person’s experience of difficulties with executive functioning in everyday life (e.g. “Do you 
have trouble making up your mind?” and “Do you start doing one thing at home and get 
distracted into doing something else (unintentionally)?”).43 It may be difficult to capture 
these difficulties using a neurocognitive test battery in a laboratory environment. Executive 
functioning is represented by a higher level system which integrates several basic cognitive 
functions and surpass separate functions.47 It directs and controls cognitive processes when 
faced with non-routine situations. Executive functioning is especially appealed to in new, 
complex and unknown situations, in which rapid and efficient adjustment of behavior to 
the environment is needed because routine solutions do not suffice. In a test setting, 
cognitive failures are more likely to occur by using standardized tasks in which cognitive 
processes such as planning, working memory, response inhibition and cognitive flexibility 
are required. However, even when a person functions well in a structured test setting, 
there may still be problems in novel and complex situations of everyday life. A standardized 
test setting is usually quiet with few distractions, there are clear instructions and time 
points for task initiation and completion, and the subject is asked to complete one task at 
a time. In contrast, in daily-life situations the individual needs to initiate, plan, organize 
and monitor his own behavior (e.g., self-initiation, self-organizing, self-monitoring and 
evaluating their purposeful behavior). Problems mainly occur in complex, unexpected 
and novel situations, which are usually unstructured and with numerous distractions, and 
require multitasking.43,47,48 Interestingly, high levels of stress hormones have been linked to 
executive control49 and thus symptoms of anxiety and depression may give rise to cognitive 







Expectations about cognitive failures may have caused women with a history of 
eclampsia or preeclampsia to overestimate the frequency of these failures and to attribute 
them to the experience of their complicated pregnancy. Indeed patients with pre-existing 
knowledge about a possible relationship of their medical condition and cognitive complaints 
report significantly more complaints than patients without this knowledge.50 Whether this 
phenomenon is at play in women with a history of (pre)eclampsia is unclear. Knowledge 
concerning possible cognitive deficits following preeclampsia is not widespread in the 
general population, with very few studies performed so far.
Taken together, on the basis of these findings, we suggest that the everyday cognitive 
failures measured by the CFQ may be interpreted as difficulties in executive control of 
behavior, which manifest themselves primarily in unstructured, complex and stressful daily 
life events, which require a high level of executive functioning. Chapters 4 and 5 did 
not reveal cognitive impairment on neurocognitive testing in a structured task setting in 
formerly eclamptic and preeclamptic women who report subjective cognitive failures. In 
addition, women who suffered eclampsia and preeclampsia have higher levels of stress 
(symptoms of anxiety and depression), which may be the result of stress as a trait as well 
as environmental stress factors (such as a preeclamptic pregnancy and preterm birth). 
How can dissimilar results for subjective and objective cognitive functioning be reconciled?
While the CFQ did seem to be significantly correlated to objective neurocognitive 
functioning concerning the (sub)domains of visual perception, visuomotor speed, attention 
and executive functioning in this thesis (chapter 5), for most other domains this was not 
the case. Several studies concerning subjective and objective cognitive functioning have 
been performed in the non-obstetric domain, i.e. following brain injury, epilepsy, bipolar 
disorder, menopausal symptoms, Parkinson’s disease, multiple sclerosis and cancer.51 Similar 
findings (i.e. subjective cognitive problems without objective cognitive dysfunction) have 
been described as compared to the studies in this thesis. In patients with multiple sclerosis, 
subjective cognitive failures (CFQ) were not associated with neurocognitive functioning, 
and patients seem to underestimate their performance on neurocognitive tasks.52 Patients 
with multiple sclerosis and mild cognitive complaints suffered more symptoms of anxiety, 
depression and mental fatigue.53 Treatment of these factors did not influence scores on 
neurocognitive tests, but did improve subjective impairment.54 Similar relationships have 
been described in women receiving breast cancer treatment; while subjective cognitive 
complaints partially reflected neurocognitive performance and were related to white 
matter integrity, they seemed to be multifactorial and related to emotional distress.55-58 
These similar findings in other, relatively young patient groups endorse our finding that 
subjective cognitive functioning is determined by other factors than solely objective 
cognitive functioning as measured in a test setting. In young individuals the CFQ is likely to 
mainly reflect executive control of behavior, in which symptoms of  anxiety and depression 
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requiring executive functioning.
Another important consideration pertaining to the disparate results between 
subjective and objective cognitive functioning is related to the ecological validity of 
neurocognitive tests. The term ecological validity is used in reference to generalizability 
(the extent to which performance on a test will be predictive of daily life functioning) and 
representativeness (the extent to which a test corresponds to situations in daily life).47 
Development of neurocognitive tests over the years has diverged into several directions. 
While some tests were developed in order to correlate neurocognitive functioning with 
structural brain lesions seen on neuroimaging, others have focused mainly on evaluating 
everyday cognitive (dis)abilities with ecologically valid tests. Subtle cognitive complaints 
may not come to surface in a test setting, which is usually quiet with few distractions, 
with clear task initiation and completion, and a one-task-at-a-time programme.47 This is in 
contrast to daily life behavior, which is usually unstructured with numerous distractions 
and requires flexibility, ability to plan, organize and monitor.
What is the relationship between subjective and objective cognitive functioning and 
cerebral white matter lesions (WML)?
In the elderly, measures of both objective and subjective cognitive functioning (CFQ) are 
associated with the presence of WML.59,60 However, as elaborated in chapter 6, this does not 
seem to be the case in younger individuals. We studied whether WML in formerly eclamptic 
and preeclamptic women are associated with cognitive functioning. Several years following 
pregnancy, in women with an average age around 40, the presence of WML does not seem 
related to either subjective or objective cognitive functioning. It is quite possible that the 
topographical location of WML contributes to whether or not cognitive dysfunction comes 
to surface. White matter lesions in women who had eclampsia or preeclampsia are mainly 
located in the subcortical regions, while periventricular, and not subcortical WML, seem 
to be associated with cognitive impairment and dementia in the elderly.61 Furthermore, in 
the elderly, subcortical WML seem mostly associated to depressive symptoms,62 while in 
women with a history of eclampsia or preeclampsia, subcortical WML did not seem related 
to higher depression scores. While this seems reassuring, it cannot be excluded that WML 
in women who suffered eclampsia or preterm preeclampsia may start to demonstrate 
an impact in later life. The WML in these women are mainly located in the frontal brain 
areas (chapter 6), which are the areas involved in executive functioning in complex daily 
life situations. At younger age, these women may still be able to compensate for minor 
dysfunction, which may cost effort and contribute to fatigue. At older age, and increasing 
WML burden, compensatory mechanisms may no longer suffice. Indeed, not the mere 
presence, but rather the severity of WML may play a major role with regards to cognitive 
sequelae. With aging, the WML burden may increase and gray matter volume decrease, 
and the aging brain may have reduced ability to compensate for cognitive dysfunction.63 







as hypertension, have not come to surface in individuals in their 30-40’s, and require 
longitudinal follow-up of ≥ 20 years. In this regard, limited research involving (epi)genetic 
features suggests possible parallels between preeclampsia and late-onset Alzheimer’s 
disease for several loci. For example, genes located on 10q22, among which the STOX1A 
transcription factor, are expressed both in the placenta in preeclampsia and the brain in 
Alzheimer’s disease and possibly regulate genes involved in cognitive decline.64,65
Emotional factors and subjective cognitive failures; cause or consequence?
In general, the association between subjective cognitive complaints and emotional 
aspects is quite complex with unclear direction of causality. As alluded to in the prior 
paragraph some major components deserve to be mentioned in light of this thesis. First, 
emotional and subjective cognitive complaints may both be a consequence of a common 
neurovascular pathogen such as cerebral structural abnormalities (e.g. WML).59,62 However, 
while this has been demonstrated in the elderly population we were unable to demonstrate 
this in our younger cohort of women with a history of eclampsia or preeclampsia (chapter 
6). Second, cognitive failures may not just be epiphenomena of symptomatology of anxiety 
and depression.66 An explanation for the cognitive failures often seen with anxiety and 
depression is that they may be interpreted as a measure of executive control of behavior. 
Anxiety and depression may give rise to cognitive failures in complex and stressful daily-life 
events.48 High levels of stress hormones seem detrimental for executive control and make 
a person susceptible for cognitive failures.67
Due to the cross-sectional nature of the measurements in this thesis, it is obviously 
not possible to draw firm conclusions about cause and effect relationships. It is possible 
that symptoms of anxiety and depression were already present prior to pregnancy. 
Both depression and anxiety in early pregnancy seem associated with the subsequent 
development of preeclampsia (odds-ratio of 2.5 and 3.2 respectively).68 The experience of 
cognitive problems in daily life may have caused these women to enter a negative cycle 
revealing symptoms of anxiety and depression and vice versa. The precise biochemical 
mechanism behind this course of events remains speculative: distress conditions during 
pregnancy may lead to preeclampsia by increasing cortisol levels, which are associated 
with hypertension and endothelial dysfunction.69 Alternatively, symptoms of anxiety 
and depression may come to surface following a (pre)eclamptic pregnancy. Indeed, and 
in accordance with earlier studies, this thesis reveals more symptoms of anxiety and 
depression in women with a history of (pre)eclampsia (chapter 5).70-73 In this thesis no 
significant effect of preterm birth was found on subjective or objective neurocognitive test 
results, anxiety or depression (chapter 5).
In addition to anxiety and depression, women with a history of preeclampsia are at 
increased risk (OR = 3.48) for screening positive for Posttraumatic Stress Disorder (PTSD).74 
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a traumatic stressor such as threatening death or injury associated with helplessness or 
great fear. It is characterized by re-experiencing the trauma through intrusive memories, 
avoidance and a state of arousal. Indeed, a pregnancy complicated by preeclampsia might 
be a traumatic experience. These pregnancies are often associated with interventions, 
infant hospitalization and even perinatal mortality. Having a premature child is associated 
with negative job-related, relational, financial and social effects.75 Moreover, preeclampsia 
and eclampsia can potentially be life threatening for both mother and fetus. PTSD has 
been related to cognitive deficits, even in the absence of comorbid conditions such as 
depression.76 Self-reported complaints following PTSD pertain to concentration, attention, 
new learning and recall.76 Indeed, PTSD score was positively related to the number of 
subjective cognitive failures in our study (chapter 3). Stramrood et al.70 found a similar 
rate of PTSD in women with premature rupture of membranes, suggesting that the delivery 
itself is not necessarily the factor causing the traumatic experience but the trauma might 








This thesis demonstrates that women who experienced a pregnancy complicated by 
eclampsia or preeclampsia experience more cognitive failures and symptoms of anxiety 
and depression several years following their pregnancy while neurocognitive testing did not 
reveal evidence for (sub)clinical cognitive dysfunction. Women with preterm preeclampsia 
and eclampsia more often have WML compared to women with a normotensive pregnancy 
and nulliparous women of the same age. Pregnancy in and of itself does not seem to play a 
role in the presence of WML. The presence of WML was not associated with neurocognitive 
test results, self-reported cognitive failures, or symptoms of anxiety and depression. 
Subjective cognitive failures are difficult to interpret and are probably multifactorial. Self-
reported cognitive failures in the studies now described can be interpreted as a measure 
of executive control of behavior, in which symptoms of anxiety and depression, whether or 
not preexistent, may contribute to the development of cognitive failures mainly in complex 
and stressful daily-life events. The role of PTSD should not be underestimated, although 
not studied in this thesis. It cannot be ruled out that the WML and subjective cognitive 
complaints might be an indicator for development of cognitive dysfunction as women age. 
The findings in this thesis support the transition in the obstetrical literature from 
the paradigm that preeclampsia is a condition from which women can expect full recovery, 
towards evidence that preeclampsia is an event occurring in the scheme of long-term 
emotional, cardiovascular and cerebrovascular health. Even though no objective cognitive 
impairment was demonstrated in our cohorts their report of subjective cognitive complaints 
deserve careful attention. We extrapolate that follow-up and timely intervention to restore 
emotional well-being may be important. In addition, offering more structure in planning, 
execution and monitoring of primary relevant tasks in daily life, and to explore its effect 
on subjective cognitive problems may be worthwhile. Considering the presence of WML and 
often chronic hypertension in women with a history of eclampsia or preterm preeclampsia, 
such women should be considered an important group for targeting early interventions to 
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Future perspectives
Future research should mainly cover two pathways: (1) to determine the influence of 
intervention strategies for symptoms of anxiety and depression and subsequent self-
reported cognitive difficulties and (2) long-term follow-up (i.e. 30-40 years) of preeclamptic 
women to determine the risk of development of cognitive decline at older age.
Intervention strategies for perceived cognitive dysfunction
Contemporary interventions are mainly aimed at elderly individuals who express subjective 
cognitive deficits but who lack objective cognitive impairment. Such interventions seem 
effective in reducing emotional reactions towards cognitive functioning.77,78 Some elements 
of these programs may also be useful in younger individuals, such as negative stereotyping, 
personal goals and beliefs (an approach targeting knowledge, perception and beliefs about 
cognitive functioning) in addition to compensatory strategies. These interventions are 
not specifically aimed, however, at cognitive problems arising in complex and stressful 
situations.
Future studies in women with a history of (pre)eclampsia could aim at possible 
treatment strategies incorporating two different aspects which have to be attuned. First, 
treatment may focus on dysexecutive problems in daily life. This may consist of psycho-
education in combination with providing women with an organized structure in daily life. 
Improved goal setting and planning skills may be obtained by gaining insight and awareness 
in ones limitations and development of effective compensatory strategies. Individuals may 
also be encouraged to effectively anticipate unexpected situations. Clinically relevant 
therapy should be multifaceted, since multiple aspects are needed for adequate executive 
functioning: self-awareness, concrete goal-setting, planning, selfinitiating, self-monitoring 
and evaluating, self-inhibiting, flexibility and problem solving and strategic behavior.79 
Such a multifaceted treatment program has proven to be successful in improving daily 
life executive functioning in individuals with acquired brain injury.80 Second, as far as 
the symptoms of anxiety, depression and PTSD are concerned, treatment could focus on 
cognitive behavioral therapy or EMDR, which have been sparsely studied for PTSD following 
childbirth.81-83 There may also be an additional role of debriefing and counselling, although 
there are inconsistencies regarding their therapeutic effect.84 Finally, intervention studies 
should evaluate the effects on subjective cognitive outcome measures, symptoms of 
anxiety and depression, quality of life measurements as well as ecologically valid cognitive 
tests.
Preeclampsia and future risk of cognitive decline?







eclampsia or preeclampsia, at an average age of 40 years, women show no clear cognitive 
impairment employing an extensive neurocognitive testing battery, but they do report 
considerable subjective cognitive dysfunction. These subjective cognitive problems should 
not be trivialized since it cannot be excluded that (subgroups of) these women may develop 
cognitive impairment when they are older. Longer follow-up studies of 20-30 years would 
provide insight whether there is a relationship between (pre)eclampsia and subjective 
cognitive difficulties earlier in life and cerebrovascular disease and overt cognitive decline 
later in life. Since cognitive decline is thought to be a result of a long-term processes taking 
place over at least 20-30 years85, the importance of preventive strategies during adult life 
is emphasized. Since life expectancy continues to increase, the understanding of cognitive 
ageing will be one of the main challenges in the next decade.
Cerebrovascular disease and life style intervention
Women with a history of preeclampsia are at increased risk of developing cardiovascular 
or cerebrovascular disease in later life.3,4 Midlife cardiovascular risk factors (such as 
obesity, hypertension and sedentary life style) are associated with an increased risk of 
cognitive impairment at 20 years follow-up (individuals ≥ 65 years).86 Longtime exposure 
to elevated blood pressures or poor control of hypertension are particularly detrimental. 
Lifestyle interventions after preeclampsia are thought to reduce cardiovascular risk 
with about 4-13%.6 Lifestyle intervention may therefore be an important focus for future 
studies evaluating prevention of the development or aggravation of white matter lesions in 
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Pre-eclampsie is een zwangerschapsgerelateerde aandoening en is wereldwijd één van de 
meest voorkomende oorzaken van maternale en foetale ziekte en sterfte. De aandoening 
wordt gekenmerkt door het ontstaan van hypertensie en proteïnurie tijdens de tweede 
helft van de zwangerschap bij een voorheen normotensieve vrouw. In Nederland komt 
pre-eclampsie voor bij ongeveer 3% van de zwangerschappen, maar in ontwikkelingslanden 
ligt het percentage een stuk hoger (rond de 15%). Pre-eclampsie is een systemische 
aandoening, waarbij gegeneraliseerde endotheeldysfunctie kan leiden tot de verstoring 
van de doorbloeding van verschillende organen, waaronder de hersenen (in de vorm van 
eclampsie). Eclampsie wordt gekenmerkt door het optreden van tonisch-clonische insulten 
bij een vrouw met pre-eclampsie. Andere neurologische verschijnselen zijn hyperreflexie, 
hoofdpijn, visusstoornissen, veranderingen in het bewustzijn, en in het meest ernstige 
geval intracerebrale bloedingen. Hoewel eclampsie weinig voorkomt in Nederland (tijdens 
0,1% van de zwangerschappen), is het wel verantwoordelijk voor een substantieel deel van 
de maternale sterfte (3,5 per 100.000 levend geborenen).
Hoofdstuk 1 is een inleiding op dit proefschrift. Er wordt hier ingegaan op de 
veronderstelde pathofysiologie van eclampsie. Eclampsie wordt gezien als een uiting 
van het Posterior Reversible Encephalopathy Syndrome (PRES). PRES wordt beschreven 
als een reversibele, neurotoxische en neurometabole aandoening met een karakteristiek 
klinisch en radiologisch beeld. Neuroradiologische beeldvorming wordt gekenmerkt door 
hersenoedeem, voornamelijk in de witte en grijze stof van de pariëtaal- en occipitaalkwab. 
Bij eclampsie wordt verondersteld dat wanneer, in combinatie met endotheeldysfunctie, 
de bloeddruk boven de maximale grens van de autoregulatie stijgt er sprake is van 
geforceerde vasodilatatie. Hierdoor ontstaat hyperperfusie en beschadiging van de bloed-
hersenbarrière en wordt er vasogeen oedeem gevormd. Vanwege de ernst van de klinische 
ziektebeelden en het hersenoedeem wordt wel gedacht dat PRES en eclampsie gevolgen 
kunnen hebben voor de maternale gezondheid op kortere en langere termijn. In hoofdstuk 
2 wordt de huidige literatuur over de langetermijngevolgen van PRES bij eclampsiepatiënten 
en bij niet-obstetrische patiënten samengevat en besproken. Eerder onderzoek liet zien 
dat er, jaren na de zwangerschap, meer wittestoflaesies in de hersenen worden gezien 
bij vrouwen na eclampsie en preterme pre-eclampsie. Waar eerst werd gedacht dat deze 
laesies een direct gevolg waren van het hersenoedeem ten tijde van het eclamptisch insult 
wordt nu meer een samenhang verondersteld met de aanleg voor hart- en vaatziekten 
bij deze vrouwen. Pre-eclampsie en wittestoflaesies zijn geassocieerd met vergelijkbare 
risicofactoren, zoals chronische hypertensie, obesitas, metabool syndroom en een 
verhoogd risico op cardiovasculaire en cerebrovasculaire aandoeningen op latere leeftijd. 
De betekenis van wittestoflaesies bij vrouwen na eclampsie en preterme pre-eclampsie 
is vooralsnog onbekend en in dit proefschrift wordt beoogd daar meer duidelijkheid in te 
brengen.
Naast de aanwezigheid van wittestoflaesies, rapporteren vrouwen die eclampsie 
doormaakten vaker subjectieve cognitieve problemen. In hoofdstuk 3 wordt dit 
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geïnventariseerd door middel van een vragenlijst en in hoofdstuk 4 en 5 wordt door 
middel van neurocognitieve testen onderzocht of er daadwerkelijk sprake is van cognitieve 
dysfunctie. Ook wordt de samenhang met emotionele factoren besproken. In hoofdstuk 
6 wordt de relatie tussen de aanwezigheid van wittestoflaesies en cognitief functioneren 
geanalyseerd. Tot slot wordt in hoofdstuk 7 het voorkomen van witte stof laesies 
beschreven na het doormaken van een zwangerschap  die niet gecompliceerd werd door 
preeclampsie of eclampsie.
In hoofdstuk 2 wordt een literatuuroverzicht gegeven over de langetermijngevolgen van het 
Posterior Reversible Encephalopathy Syndrome (PRES) bij eclampsie en bij niet-obstetrische 
aandoeningen. De literatuur bestaat voornamelijk uit casestudies en slechts weinig is 
beschreven over mogelijke langetermijngevolgen. Een aantal algemene conclusies kunnen 
worden geformuleerd. PRES bij eclampsie lijkt minder vaak geassocieerd te worden met 
langetermijnafwijkingen bij neuroradiologische beeldvorming, cognitieve problemen en 
epilepsie, dan PRES bij niet-obstetrische aandoeningen. De belangrijkste determinant voor 
het ontstaan van deze langetermijnproblemen na PRES bij niet-obstetrische aandoeningen 
lijkt eerder de onderliggende aandoening te zijn, die vaak langere tijd bestaat. Dit in 
tegenstelling tot eclampsie, wat een “voorbijgaande” aandoening is. Daarnaast lijkt een 
niet-tijdige diagnose of inadequate behandeling van PRES een rol te spelen bij het al dan 
niet ontstaan van langetermijngevolgen. Hoewel er momenteel geen evidence-based 
therapie noch zinvolle follow-up strategie beschreven zijn, wordt in de literatuur het 
belang van tijdige en adequate behandeling en follow-up van PRES patiënten benadrukt.
Hoofdstuk 3 bespreekt de resultaten van een observationele studie over zelfgerapporteerd 
cognitief functioneren na een zwangerschap gecompliceerd door pre-eclampsie vergeleken 
met een normotensieve zwangerschap. 966 vrouwen die pre-eclampsie doormaakten en 
342 controles die een normotensieve zwangerschap hadden, vulden een online vragenlijst 
in. Deze vragenlijst bestond uit 1) vragen over cognitieve problemen in het dagelijks 
leven (een verkorte versie van de Cognitive Failures Questionnaire met 18 items, CFQ), 2) 
vragen over sociaal functioneren (de Social Functioning Questionnaire, SFQ) en 3) vragen 
over kwaliteit van leven (de verkorte WHO Quality of Life Questionnaire, WHOQOL-BREF. 
Vrouwen die pre-eclampsie doormaakten rapporteerden significant meer cognitieve 
problemen dan controles (CFQ mediaanscore van 35 en 27). Tevens rapporteerden zij 
een slechtere kwaliteit van leven op de WHOQOL-BREF domeinen fysieke gezondheid 
(mediaanscore van 15 en 17), psychologische gezondheid (mediaanscore van 13 en 15) en 
sociale relaties (mediaanscore van 13 en 15) en omgeving (mediaanscore van 15 en 16) 
en ook scoorden zij slechter op sociaal functioneren (SFQ mediaanscore van 8 en 7). De 
aanwezigheid van posttraumatische stresssymptomen verklaarde gedeeltelijk, maar niet 
volledig, de slechtere score van vrouwen die pre-eclampsie doormaakten. Hoewel de kans 
bestaat dat er sprake is van selectiebias en recall bias en hoewel de gevonden verschillen 
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op de WHOQOL-BREF en SFQ in deze studie van matige grootte zijn, geven deze data 
een indicatie dat vrouwen die pre-eclampsie doormaakten vaker cognitieve en sociale 
problemen en een lagere kwaliteit van leven ervaren in het dagelijks leven dan vrouwen 
na een normotensieve zwangerschap.
In hoofdstuk 4 en 5 is het cognitief functioneren van vrouwen die pre-eclampsie en/
of eclampsie doormaakten beoordeeld door middel van een neurocognitieve testbatterij. 
In hoofdstuk 4 wordt een pilotstudie beschreven waarin voornamelijk is gekeken naar 
executief functioneren (de sturing en controle over cognitieve processen, meer specifiek 
inhibitie en updating/monitoring) en volgehouden aandacht (de vaardigheid om de 
aandacht vast te houden bij de bewuste verwerking van herhaaldelijke stimuli die anders 
tot gewenning zouden leiden), meerdere jaren na het doormaken van een zwangerschap 
gecompliceerd door pre-eclampsie of eclampsie. 26 vrouwen met eclampsie, 20 vrouwen 
met pre-eclampsie en 18 controles met een normotensieve zwangerschap voerden de 
Sustained Attention to Response Task (SART) en de Random Number Generation task (RNG) 
uit. Er werden geen significante verschillen gevonden tussen de groepen en evenmin  was 
er een duidelijk effect aantoonbaar van het aantal  eclamptische insulten: vrouwen die 
meerdere eclamptische insulten doormaakten scoorden vergelijkbaar. In hoofdstuk 5 
wordt vervolgens een grotere studie beschreven, bij vrouwen die verscheidene jaren eerder 
pre-eclampsie of eclampsie doormaakten. Er werd gebruik gemaakt van een uitgebreide 
testbatterij met gevoelige en gestandaardiseerde neurocognitieve testen verdeeld over 
6 domeinen. De domeinen bestonden uit visuele perceptie, motorisch functioneren, 
werkgeheugen, langetermijngeheugen, aandacht en executief functioneren. Daarnaast 
werden symptomen van angst en depressie gemeten door middel van de Hospital Anxiety 
and Depression Scale (HADS) en subjectieve cognitieve problemen werden gemeten aan de 
hand van de Cognitive Failures Questionnaire (CFQ). 46 vrouwen die eclampsie doormaakten, 
51 vrouwen die pre-eclampsie doormaakten en 48 controles met een normotensieve 
zwangerschap voerden de neurocognitieve testen uit en vulden de 25-item CFQ en HADS in. 
Er werd geen neurocognitieve dysfunctie gezien in vrouwen die eclampsie of pre-eclampsie 
doormaakten vergeleken met controles, behalve een iets lagere visuomotorische snelheid 
(Trail Making Test deel 5: respectievelijk 26, 22 en 20 seconden). Ze rapporteerden echter 
wel meer subjectieve cognitieve problemen (gemiddelde CFQ score van respectievelijk 
43, 47 en 36) en meer symptomen van angst en depressie (gemiddelde HADS score van 
respectievelijk 12, 11 en 8), waarbij er geen verschil bleek tussen vrouwen met eclampsie 
en pre-eclampsie. Concluderend rapporteren vrouwen die eclampsie of pre-eclampsie 
doormaakten wel meer subjectieve cognitieve problemen in het dagelijks leven, maar in 
een gestructureerde testsetting is er geen objectief aantoonbare cognitieve dysfunctie. 
De gerapporteerde subjectieve cognitieve problemen bleken sterk samen te hangen met 
symptomen van angst en depressie. Men kan de CFQ interpreteren als een maat voor 
executieve controle, waarbij individuen met symptomen van angst en depressie cognitieve 
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problemen ervaren, met name in complexe en stressvolle situaties in het dagelijks leven. 
Hoge stressniveaus zijn nadelig gebleken voor executieve controle en deze maken een 
individu gevoelig voor cognitieve misstappen.
In hoofdstuk 6 wordt de relatie onderzocht tussen cerebrale wittestoflaesies, en 
subjectief en objectief cognitief functioneren en symptomen van angst en depressie. 
De resultaten van de testbatterij en vragenlijsten zoals beschreven in hoofdstuk 5 bij 
vrouwen met en zonder wittestoflaesies (MRI) werden vergeleken. Van 41 vrouwen die 
eclampsie doormaakten, 49 vrouwen die pre-eclampsie doormaakten en 47 controles 
waren zowel neurocognitieve testresultaten als beeldvorming beschikbaar. De prevalentie 
van wittestoflaesies bij vrouwen die preterme (pre-)eclampsie doormaakten, is gemiddeld 
6 jaar na de zwangerschap hoger (40%) dan bij controles (21%). Er waren geen duidelijke 
verschillen zichtbaar tussen vrouwen met pre-eclampsie en eclampsie. De aanwezigheid 
van deze wittestoflaesies hangt echter niet samen met subjectief of objectief cognitief 
functioneren, en ook niet met symptomen van angst en depressie. Er bleek wel een 
sterk verband te bestaan tussen zelfgerapporteerd cognitief dysfunctioneren in vrouwen 
die pre-eclampsie of eclampsie doormaakten en symptomen van angst en depressie. In 
aanwezigheid van deze symptomen kan, in geval van complexe en stressvolle situaties 
waarin een beroep wordt gedaan op het vermogen tot plannen, verminderd cognitief 
functioneren ervaren worden. De meeste associaties tussen wittestoflaesies en cognitieve 
dysfunctie zijn beschreven in oudere populaties. Het is mogelijk dat de relatief jonge 
vrouwen die meededen aan de studies uit dit proefschrift, met een gemiddelde leeftijd 
van 40 jaar, (nog) geen gevolgen van wittestoflaesies ondervinden. Toekomstig onderzoek 
moet aantonen of vrouwen die (pre-)eclampsie doormaakten op latere leeftijd alsnog 
meetbare cognitieve dysfunctie zullen ontwikkelen.
In hoofdstuk 7 wordt het effect van het doormaken van een zwangerschap op zich op de 
aanwezigheid van wittestoflaesies en subjectieve cognitieve problemen beschreven, omdat 
wittestoflaesies ook worden gezien bij eenvijfde van de vrouwen die een normotensieve 
zwangerschap doormaakten. 81 vrouwen die een normotensieve zwangerschap doormaakten 
werden vergeleken met 65 nullipare vrouwen van vergelijkbare leeftijd. De gemiddelde 
leeftijd was 37 jaar in beide groepen en de verstreken tijd sinds de zwangerschap was 
6 jaar. Het percentage vrouwen met wittestoflaesies verschilde niet tussen de twee 
groepen (prevalenties van respectievelijk 22% en 19%). Terwijl er een hoge prevalentie 
van wittestoflaesies (tot 100%) is beschreven bij ouderen boven de 60 jaar, laten de 
schaarse studies in individuen jonger dan 40 jaar een prevalentie zien van 0,5-32%, in 
overeenstemming met de in deze studie gevonden 20%. De groepen scoorden vergelijkbaar 
op de 25-item CFQ (met een gemiddelde score van 36 en 33). Alleen leeftijd bleek een 
voorspeller te zijn voor de aanwezigheid van wittestoflaesies, maar de aanwezigheid van 
chronische hypertensie was dat niet. Dit kan mogelijk veroorzaakt worden door de relatief 
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jonge en gezonde populatie in deze studie, en daardoor een lage incidentie van chronische 
hypertensie. Concluderend, het doormaken van een zwangerschap op zich lijkt geen rol 
te spelen in de aanwezigheid van wittestoflaesies en subjectieve cognitieve problemen, 6 
jaar na dato.
Hoofdstuk 8 betreft een algemene discussie en conclusies. Dit proefschrift toont 
aan dat vrouwen die een zwangerschap doormaakten die gecompliceerd werd door 
eclampsie of pre-eclampsie jaren later vaker cognitieve problemen en symptomen van 
angst en depressie ervaren in het dagelijks leven terwijl er geen sprake is van objectief 
aantoonbare (sub)klinische cognitieve dysfunctie op neurocognitieve tests. Vrouwen die 
pre-eclampsie en eclampsie doormaakten hebben vaker neuroradiologisch aantoonbare 
wittestoflaesies dan vrouwen die een normotensieve zwangerschap doormaakten en 
nullipare vrouwen. Zwangerschap op zichzelf lijkt geen rol te spelen in de aanwezigheid 
van deze wittestoflaesies en de aanwezigheid van deze wittstoflaesies lijkt niet gerelateerd 
aan objectieve neurocognitieve testresultaten, zelfgerapporteerde cognitieve problemen 
en symptomen van angst en depressie. Subjectieve cognitieve problemen zijn lastig 
te interpreteren omdat zij sterk multifactorieel bepaald zijn. De zelfgerapporteerde 
cognitieve problemen in dit proefschrift zouden kunnen worden geïnterpreteerd als een 
maat voor executieve controle, waarbij individuen met symptomen van angst en depressie 
cognitieve problemen ervaren, met name in complexe en stressvolle situaties van alledag. 
Executief functioneren is een systeem dat verschillende cognitieve functies met elkaar in 
verband brengt, integreert en de afzonderlijke functies overstijgt. Het geeft sturing en 
controle over cognitieve processen. Op de executieve functies wordt vooral een beroep 
gedaan in nieuwe, complexe en onbekende situaties  waarin een snelle en efficiënte 
aanpassing van het gedrag aan de omgeving vereist is en wanneer bekende routinematige 
oplossingen niet voldoen. In een testsetting zouden problemen kunnen ontstaan op tests 
die een beroep doen op plannen, werkgeheugen, responsinhibitie en cognitieve flexibiliteit. 
Echter, een goede prestatie in een gestructureerde testsetting sluit problemen op taken 
in complexe alledaagse situaties niet uit. In een gestandaardiseerde testsetting is de 
situatie gestructureerd, worden instructies gegeven en de taken worden een voor een 
aangeboden.  In het dagelijks leven moeten de taken echter zelf gepland en bijgestuurd 
worden, waarbij vooral problemen optreden in situaties waar multitasking vereist is. De rol 
van posttraumatische stresssymptomen, hoewel geen onderwerp in dit proefschrift, moet 
in toekomstig onderzoek worden meegenomen. Het kan, tot slot, niet uitgesloten worden 
dat de aanwezigheid van cerebrale wittestofaflaesies en subjectieve cognitieve problemen 
in vrouwen na eclampsie of pre-eclampsie een voorbode zijn voor de ontwikkeling van 
cognitieve dysfunctie op latere leeftijd. De bevindingen in dit proefschrift onderstrepen 
het recente gedachtegoed dat pre-eclampsie een aandoening is met gevolgen voor het 
geheel van emotionele, cardiovasculaire en cerebrovasculaire gezondheid op de lange 
termijn. Alhoewel dit proefschrift geen objectief cognitieve dysfunctioneren heeft kunnen 
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aantonen bij vrouwen na eclampsie of pre-eclampsie, verdienen de gerapporteerde 
subjectieve cognitieve problemen zorgvuldige aandacht. Hiertoe kunnen follow-up en 
tijdige interventie om emotioneel welzijn te bevorderen van belang zijn. Daarnaast zou 
onderzocht kunnen worden of het aanbieden van meer structuur in de planning, uitvoering 
en monitoring van taken die primair relevant zijn in het alledaags leven mogelijk een 
effect kan hebben op de subjectieve cognitieve problemen die deze vrouwen ervaren. 
Toekomstig onderzoek richt zich ook op evaluatie en implementatie van leefstijladviezen 
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